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Abstract
Intractable or drug-resistant epilepsy occurs in over 30% of epilepsy patients, with many of these pa-
tients undergoing surgical excision of the affected brain region to achieve seizure control. Advances in
MRI have the potential to improve surgical treatment of epilepsy through improved identification and
delineation of lesions. However, validation is currently needed to investigate histopathological correlates
of these new imaging techniques. The purpose of this work is to investigate histopathological corre-
lates of quantitative relaxometry and DTI from hippocampal and neocortical specimens of intractable
TLE patients. To achieve this goal I developed and evaluated a pipeline for histology to in-vivo MRI
image registration, which finds dense spatial correspondence between both modalities. This protocol
was divided in two steps whereby sparsely sectioned histology from temporal lobe specimens was first
registered to the intermediate ex-vivo MRI which is then registered to the in-vivo MRI, completing a
pipeline for histology to in-vivo MRI registration. When correlating relaxometry and DTI with neuronal
density and morphology in the temporal lobe neocortex, I found T1 to be a predictor of neuronal density
in the neocortical GM and demonstrated that employing multi-parametric MRI (combining T1 and FA
together) provided a significantly better fit than each parameter alone in predicting density of neurons.
This work was the first to relate in-vivo T1 and FA values to the proportion of neurons in GM. When
investigating these quantitative multimodal parameters with histological features within the hippocam-
pal subfields, I demonstrated that MD correlates with neuronal density and size, and can act as a marker
for neuron integrity within the hippocampus. More importantly, this work was the first to highlight the
potential of subfield relaxometry and diffusion parameters (mainly T2 and MD) as well as volumetry
in predicting the extent of cell loss per subfield pre-operatively, with a precision so far unachievable.
These results suggest that high-resolution quantitative MRI sequences could impact clinical practice for
pre-operative evaluation and prediction of surgical outcomes of intractable epilepsy.
Keywords: Temporal lobe epilepsy, MRI, histology, correlation, hippocampus, re-
laxometry, DTI, neuronal density
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If our brains were simple enough for us to understand them, we’d be so
simple that we couldn’t.
Ian Stewart
iii
Acknowlegements
I cannot be more grateful to my supervisor, Terry Peters, for introducing me
to the world of neuroimaging and image guided interventions, and for the
continuous support and encouragement throughout my summer internships
and graduate years. I am very thankful for providing me with the oppor-
tunity to work on this exciting project and perform cutting edge research
at Robarts, for providing all the possible resources a student can ask for to
succeed, and for his superb mentorship personally and professionally.
I also want to emphasize how grateful I am to Ali Khan -then post-doctoral
fellow, now professor- who for the past three years mentored me and micro-
managed the project on daily-basis. I am very thankful for all the knowl-
edge, whether technical or research methodology, that he shared with me
over the past years, for directing all aspects of the project to reach its cur-
rent form, for his constant guidance and for being an exceptional mentor
and friend.
Deep admiration and gratitude to the patients who, despite the difficult
times they are going through and their debilitating disease, agreed to un-
dergo lengthy and often-times multiple scanning sessions and agreed as
well for their resected specimens to be imaged and processed through our
research pipeline.
I would also like to thank Catherine Currie and Cathie Crukley for man-
aging the tedious work of handling the tissue and histological processing,
and for all their technical support during the project. Moreover, I want to
greatly thank Trevor Szekeres for scanning the patients and for teaching me
how to operate a magnet, Joe Gati for his guidance and help in developing
a 7T protocol and troubleshooting/testing the sequences, and David Rudko
for his help on the QSM project.
This thesis would not have been in this form if it was not for our many, out-
standing, clinical collaborators, specifically: Sandrine de Ribaupierre, Rob
Hammond, Seyed Mirsattari, Jorge Burneo, David Steven, Andrew Par-
rent and Jonathan Lau. I am thankful for your openness to novel research
methodologies, for the many hours you put in developing the project and
teaching me the clinical aspects of epilepsy, and for your feedback to im-
prove the quality of this thesis. Many thanks to Aaron Ward for being on
my committee and for his continuous encouragement. In addition, I want
to thank the summer students, Brendan Santyr and Susan Buchanan, for all
their hard work on the project.
iv
I would like to thank the CIHR and NSERC agencies for financial support.
Furthermore, I would like to mention all my colleagues at the Peters VASST
lab specifically: Martin Rajchl, Abraam Soliman, Kamyar Abhari, Golaf-
soun Ameri, and the epilepsy team: Diego Cantor, Charlotte Blinston and
Jonathan Mcleod for sharing the ups and downs along the way and for
sharing their knowledge with me; and John Moore, Elvis Chen and Chris
Wedlake, for providing a collaborative work environment in the lab and for
their support.
The biggest thank you goes to my mom and my sister who have been the
pillars in my life. Without you I would not have had the chance to get
here and I owe my success to your love. Lastly, words cannot express my
gratitude to my close friends (whether in Canada or Egypt) and girlfriend
for their immense care and support.
v
Contents
Abstract ii
Acknowlegements iii
List of Figures x
List of Tables xvii
List of Abbreviations, Symbols, and Nomenclature xx
1 I Introduction & Background 1
1.1 Temporal Lobe Epilepsy . . . . . . . . . . . . . . . . . . 1
1.2 Epilepsy surgery . . . . . . . . . . . . . . . . . . . . . . . 3
1.2.1 Temporal lobe function, anatomy and connections . 3
1.2.2 Anterior Temporal Lobectomy . . . . . . . . . . . 7
1.3 Pathological substrates of TLE . . . . . . . . . . . . . . . 9
1.3.1 Hippocampal sclerosis . . . . . . . . . . . . . . . 9
1.3.2 Malformations of cortical development . . . . . . 10
1.4 Diagnostic techniques for pre-operative evaluation . . . . . 12
1.4.1 Electroencephalography . . . . . . . . . . . . . . 12
1.4.2 Imaging modalities . . . . . . . . . . . . . . . . . 14
1.4.3 Magnetic Resonance Imaging . . . . . . . . . . . 14
MRI in epilepsy . . . . . . . . . . . . . . . . . . . 18
1.4.4 Novel MRI techniques . . . . . . . . . . . . . . . 20
Diffusion Tensor Imaging . . . . . . . . . . . . . . 20
Functional MRI . . . . . . . . . . . . . . . . . . . 24
Quantitative Susceptibility Mapping . . . . . . . . 26
High resolution 3D Relaxometry . . . . . . . . . . 26
1.5 MRI-Histology correlation . . . . . . . . . . . . . . . . . 28
1.6 Image Registration . . . . . . . . . . . . . . . . . . . . . 30
1.7 Thesis objectives . . . . . . . . . . . . . . . . . . . . . . 32
1.8 Thesis outline . . . . . . . . . . . . . . . . . . . . . . . . 32
1.8.1 Chapter II Histology to ex-vivo registration . . . . 33
vi
1.8.2 Chapter III in-vivo to ex-vivo registration, Histol-
ogy to in-vivo pipeline . . . . . . . . . . . . . . . 33
1.8.3 Chapter IV MRI-Histology neocortical correlation 34
1.8.4 Chapter V MRI-Histology hippocampal correlation 34
1.8.5 Chapter VI Conclusions and future work . . . . . . 35
1.8.6 Appendix A Quantitative Atlas of hippocampal sub-
fields . . . . . . . . . . . . . . . . . . . . . . . . 35
2 II Registration of Histology to Ex-vivo MRI 51
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . 51
2.2 Methods & Materials . . . . . . . . . . . . . . . . . . . . 55
2.2.1 Recruitment, surgery & specimen acquisition . . . 55
2.2.2 Specimen ex-vivo MR Imaging . . . . . . . . . . . 56
Scan Protocol I . . . . . . . . . . . . . . . . . . . 58
Scan Protocol II . . . . . . . . . . . . . . . . . . . 58
2.2.3 Histological processing . . . . . . . . . . . . . . . 59
2.2.4 Image registration . . . . . . . . . . . . . . . . . . 60
2.2.5 Iterative registration algorithm . . . . . . . . . . . 63
MR image pre-processing . . . . . . . . . . . . . . 64
Histology image pre-processing . . . . . . . . . . 67
Rigid registration . . . . . . . . . . . . . . . . . . 67
Non-rigid registration . . . . . . . . . . . . . . . . 68
Coregistration of additional staining . . . . . . . . 69
2.2.6 Registration validation . . . . . . . . . . . . . . . 70
Landmark-based validation . . . . . . . . . . . . . 70
Localization error and statistical analysis . . . . . . 71
2.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
2.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . 75
3 III Registration of Ex-vivo to In-vivo MRI 88
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . 88
3.2 Methods & Materials . . . . . . . . . . . . . . . . . . . . 90
3.2.1 Recruitment, surgery & specimen acquisition . . . 90
3.2.2 Patient in-vivo MR imaging & map generation . . . 92
3.2.3 Specimen ex-vivo MR imaging . . . . . . . . . . . 94
3.2.4 Histological processing . . . . . . . . . . . . . . . 96
3.2.5 Image registration . . . . . . . . . . . . . . . . . . 96
Initialization . . . . . . . . . . . . . . . . . . . . . 98
Landmark-based similarity transformation . . . . . 100
Non-rigid registration: Hippocampus . . . . . . . . 101
Non-rigid registration: Neocortex . . . . . . . . . 104
vii
In-vivo MRI to Histology registration . . . . . . . 105
3.2.6 Registration validation & statistical analysis . . . . 105
3.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
3.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . 112
4 IV Correlation of Neocortical MRI and histology 123
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . 123
4.2 Materials & Methods . . . . . . . . . . . . . . . . . . . . 125
4.2.1 Patients and Samples . . . . . . . . . . . . . . . . 125
4.2.2 In-vivo Magnetic Resonance Imaging . . . . . . . 125
4.2.3 Histological processing and quantitative histology . 127
4.2.4 ROI Placement and Image Registration . . . . . . 129
4.2.5 Statistical analysis . . . . . . . . . . . . . . . . . 133
4.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134
4.3.1 MRI parameters-Histology features correlation . . 134
4.3.2 Multivariate vs. univariate MRI . . . . . . . . . . 134
4.3.3 Correlation with clinical variables . . . . . . . . . 138
4.3.4 MRI-MRI parameters correlation . . . . . . . . . . 138
4.3.5 Histology-Histology features correlation . . . . . . 138
4.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . 139
4.4.1 Neurobiological interpretations and considerations 139
4.4.2 Benefit of registration-based correlation . . . . . . 144
4.4.3 Limitations and future work . . . . . . . . . . . . 145
5 V Correlation of Hippocampal MRI and histology 154
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . 154
5.2 Materials & Methods . . . . . . . . . . . . . . . . . . . . 156
5.2.1 Patients and Samples . . . . . . . . . . . . . . . . 156
5.2.2 In-vivo MRI and Qualitative classification . . . . . 157
5.2.3 Histological processing and quantitative histology . 157
5.2.4 Histology subfields segmentation . . . . . . . . . . 160
5.2.5 MRI subfields segmentation . . . . . . . . . . . . 162
5.2.6 Statistical analysis . . . . . . . . . . . . . . . . . 164
5.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166
5.3.1 MRI-histology correlation analysis . . . . . . . . . 167
5.3.2 Correlations with clinical variables . . . . . . . . 167
5.3.3 Multiple linear regressions . . . . . . . . . . . . . 170
5.3.4 Discriminant function analysis . . . . . . . . . . . 172
5.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . 175
5.4.1 Biological Interpretations . . . . . . . . . . . . . . 175
5.4.2 Clinical findings and insights . . . . . . . . . . . . 177
viii
5.4.3 Limitations and technical considerations . . . . . . 179
6 VI Conclusions and future work 188
6.0.4 Current Limitations & Future Directions . . . . . . 190
A App. A - In vivo atlas of the hippocampal subfields 194
A.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . 194
A.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . 197
A.2.1 Materials & Imaging . . . . . . . . . . . . . . . . 197
A.2.2 MRI Phase Processing . . . . . . . . . . . . . . . 198
A.2.3 Susceptibility Weighted Image Calculation . . . . 199
A.2.4 Quantitative Susceptibility Maps . . . . . . . . . . 200
A.2.5 Subfield Labeling . . . . . . . . . . . . . . . . . . 202
A.2.6 Average Atlas construction . . . . . . . . . . . . . 204
A.2.7 R2* validation . . . . . . . . . . . . . . . . . . . . 205
A.2.8 Quantitative susceptibility validation . . . . . . . 206
A.2.9 Statistical comparison . . . . . . . . . . . . . . . . 206
A.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . 207
A.4 Discussion & conclusion . . . . . . . . . . . . . . . . . . 212
Copyright Licenses 229
CV 243
ix
List of Figures
1.1 Anatomy of the temporal lobe highlighting some of its promi-
nent structures: the hippocampus, parahippocampal gyrus,
uncus, fimbria and fornix. These images are modified from
the original work of Henry Gray’s anatomy: “Gray739”,
“Gray747” and “Gray 740”. Licensed under Public domain
via Wikimedia Commons. . . . . . . . . . . . . . . . . . . 5
1.2 Characterization of the hippocampus into different subfields
(CA1-4,DG and subiculum). Left: Delineation of the sub-
fields on a high field 7T MRI average (Top) and NeuN IHC
(bottom). Right: 3D surface rendering of the hippocampus
with the subfield segmentations of the hippocampal body. . 6
1.3 Comparison of normal and pathologic hippocampi, pre-
senting hippocampal sclerosis on a FLAIR MRI scan and a
histology NeuN IHC. Hippocampal atrophy and increased
T2-weighted signal are visible on the FLAIR image and
prominent neuronal loss within the different subfields specif-
ically CA1, CA3 and CA4 is visible on the histology slide. 10
1.4 Example visualization of the diffusion maps FA and MD
(with the first eigen vector overlaid on the maps), as well
as fibers from deterministic (bottom left) and probabilistic
tractography (bottom right) of the cortico-spinal tract. . . . 23
1.5 Comparison of MRI T1 & T2-weighted images (acquired at
1.5T & 3T) and relaxometry maps of the same subject. . . 28
x
2.1 Example of encountered deformations. Red arrows repre-
sent cortical sulci on the pre-operative MRI and blue ar-
rows represent the corresponding sulci on the resected neo-
cortex specimen. a) Photograph of surgical view before
resection, b) Volume rendering of a pre-operative MRI of
the patient with a zoomed view showing the temporal pole,
c) Coronal view of the pre-operative MRI demonstrating
temporal gyri with red arrows, d) Photograph of the tem-
poral lobe neocortex post resection, e) Surface rendering of
the resected neocortex with blue arrows showing the corre-
sponding sulci to part b), and f) Coronal view of the ex-
vivo MRI with blue arrows indicating sulci corresponding
to part c); the small window in the top left corner demon-
strates the mesial (interior) side of the neocortex with an
intersection of the shown MRI slice. . . . . . . . . . . . . 53
2.2 Overview of histological processing from specimen gener-
ation to digitization. Processed performed at in a standard
clinical work flow at the hospital are included in dashed
boxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
2.3 Registration pipeline showing pre-processing steps of the
data and our iterative 2D-3D approach. The left column
demonstrates the pre-processing steps applied to the histol-
ogy slides sequentially from top to bottom. Likewise, the
right column represents the pre-processing steps applied to
the MRI of the specimens. The resulting histology stack
acts as a fixed image to transform the MR image in a 3D
rigid registration. The transformed image as well as the
stack are split into slices 4.4 mm apart where each histol-
ogy slice has a corresponding MRI slice. These MR slices
act as fixed images to deform the histology slices rigidly
then non-rigidly. The resulting deformed histology slices
are stacked and fed back into the 3D rigid registration for
the next iteration. . . . . . . . . . . . . . . . . . . . . . . 66
2.4 Example of the chosen intrinsic landmarks on histology
and their localized corresponding landmark on a neocorti-
cal ex-vivo MRI specimen. The arrows in blue pinpoint the
micro vasculature used as targets for the TLE calculations
on both histology and MRI. A zoomed in window demon-
strates the targets on both modalities with cross hairs indi-
cating the target coordinates on MRI and a circle showing
the chosen coordinates on histology. . . . . . . . . . . . . 70
xi
2.5 3D visualization revealing the wide spatial distribution of
validation landmarks (blue spheres) within an exemplar neo-
cortical specimen in sagittal and coronal views. . . . . . . 72
2.6 Boxplots with 5-95% whiskers of Hippocampal and Neo-
cortical registration target registration errors at each stage
of the iterative registration scheme. . . . . . . . . . . . . . 76
2.7 Example of a neocortex rigid and deformable registration
showing: a) photograph of a neocortical specimen after re-
sected with orientation labels placed by the operating sur-
geon, b) volume rendering of the MRI of the specimen
showing the location of three consecutive histology slices.
c) rendering of both sides of the specimen where the mid-
dle slice of histology was cut, d) the three histology slices
shown in b), e) the corresponding MRI slices after 3D rigid
registration, and f) the deformed histology slices after non-
rigid registration to their corresponding MRI slices. . . . . 77
2.8 Example of a hippocampal rigid and deformable registra-
tion showing: a) photograph of a hippocampus before gross-
ing, b) volume rendering of the MRI of the hippocampus
demonstrating the location of a histology slice through the
specimen, c) rendering of both sides of the hippocampus
where the histology slice was cut, and d) three orthogo-
nal views of the hippocampal MRI (left to right: coronal,
sagittal, axial). The bottom row depicts: e) a coronal view
of the same histological slice with a registration mask over
a breakage region shown in blue, f) a checkerboard image
showing the MRI and histology before non-rigid registra-
tion, and g) a checkerboard image showing the MRI and
non-rigidly deformed histology slice. . . . . . . . . . . . . 78
3.1 In-vivo MRI to histology registration scheme depicting the
transformations obtained through each registration step and
the resulting images. . . . . . . . . . . . . . . . . . . . . 99
3.2 Landmark placement for in-vivo to ex-vivo registration of
hippocampal specimens. a) An example hippocampus be-
fore grossing. b) Surface rendering of the ex-vivo MR of
the specimen. c) Distribution of landmarks (green) within
the volume of the specimen. d) Three pairs of correspond-
ing landmarks chosen on orthogonal planes of in-vivo (blue)
and ex-vivo (red) images. . . . . . . . . . . . . . . . . . . 102
xii
3.3 Landmark placement for rigid registration of neocortical
specimens. The white arrows point to homologous points
and their corresponding gyri. a) Neocortex specimen be-
fore grossing. b) Volume rendering of the in-vivo MR im-
age of the patient with registration landmarks overlaid on
top (red). c) Surface rendering of the ex-vivo MR image of
the specimen with registration landmarks overlaid on top
(blue). . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
3.4 Boxplots with standard deviation of Hippocampal and Neo-
cortical registration target registration errors at rigid and
non-rigid registration stages. . . . . . . . . . . . . . . . . 108
3.5 Comparison of landmark-based rigid and non-rigid regis-
trations for the hippocampus. The white arrows depict ar-
eas where deformable registration outperformed rigid reg-
istration. a) Cropped in-vivo MR image, Ic, b) Rigidly
registered ex-vivo specimen (purple), c) Merged view of
rigidly registered ex-vivo to in-vivo image, d) Non-rigidly
registered ex-vivo specimen (red), e) Merged view of non-
rigidly registered ex-vivo to in-vivo image, f) Difference in
shape and volume between the hippocampus specimen af-
ter rigid transformation and deformable warping. . . . . . 110
3.6 Comparison of landmark-based rigid and non-rigid regis-
trations for the neocortex. The white arrows depict areas
where deformable registration outperformed rigid registra-
tion. a) Cropped in-vivo MR image, Ic, b) Rigidly reg-
istered ex-vivo specimen, c) Merged view of rigidly reg-
istered ex-vivo to in-vivo image, d) Non-rigidly registered
ex-vivo specimen, e) Merged view of non-rigidly registered
ex-vivo to in-vivo image. . . . . . . . . . . . . . . . . . . 111
3.7 Mapping of in-vivo MR images to the aligned space for
a neocortical specimen. The spatial resolution decreases
vertically (top to bottom) in the figure. The top row de-
picts the ex-vivo MR (left) and three stains of a histologi-
cal section (right). The 2nd, 3rd and 4th rows show warped
images taken at 7, 3 and 1.5 Tesla respectively. The last
row demonstrates warped diffusion maps (FA= fractional
anisotropy, MD= mean diffusivity). . . . . . . . . . . . . . 113
xiii
3.8 3D histological reconstruction and registration to MR. a) A
resected temporal lobe neocortical specimen from epilepsy
surgery. b) Rendering of the specimen from a 9.4T MR im-
age registered to histological slices. c) 3D consecutive his-
tology slices in the MR space. d) Rendering of both sides
of the specimen where a histology slice was cut. e) Reg-
istered MRI slice to the cut histology slice. Four different
immunohistochemistry and staining techniques are shown
as well for the cut histology section: f) Hematoxylin &
Eosin (H&E), g) Neuronal Nuclei (NeuN), h) Microtubule
associated protein (MAP)2 and i) Luxol fast blue (LFB). . 115
4.1 Histological processing and semi-quantitative features ex-
traction, for both NeuN and GFAP IHC stains. . . . . . . . 129
4.2 ROI placement and MRI parameters extraction. A) Grey
matter and white ROI on 100um H&E histology slice in
histology native space. B) Registered ex-vivo MRI slice
corresponding to the histology slice in Hist3D space. C)
Warped ROIs overlaid on the registered and obliquely re-
sampled T1 map in Hist3D space where MRI parameters
extraction is performed. The registered histology slice is
shown in the top left corner. D) Warped ROIs in the native
in-vivo MRI space overlaid on three consecutive slices of
the T1 map for illustration purposes. . . . . . . . . . . . . 132
4.3 Overview of our registration pipeline depicting registration
results and the four different spaces of MRI and histol-
ogy including the intermediate Hist 3D space where recon-
structed histology slices are stacked parallel to the A-P axis. 132
4.4 Relationships between quantitative MRI parameters (T1 and
FA) and neuronal density in GM (Top left: Total neuronal
density, Top right: Neuronal density for small-caliber neu-
rons, Bottom: Neuronal density for large-caliber neurons).
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135
xiv
4.5 Representation of T1-FA multi-parametric space, revealing
that combining T1 and FA provides better discrimination
of normal and abnormal neuron density in neocortical grey
matter. Each dot in this plot refers to a grey matter ROI
on a histology slide, with representative dots being labeled
with patient IDs from Table 1. It is clear from the fig-
ure that low and high neuron densities are not well sep-
arated when using T1 or FA (see projections on horizon-
tal and vertical axes), but in the two-dimensional space the
data demonstrate are more clearly separable (demonstrated
by the dashed line), suggesting that multivariate or multi-
parametric analysis would be more beneficial in predict-
ing or classifying pathology in-vivo. Since the presented
ROIs are extracted from sparsely sectioned histology slices
(4 mm apart), this figure highlights the potential of imaging
parameters in detecting local pathology within the neocortex.137
4.6 Significant relationships between diffusion and relaxom-
etry MRI parameters, as well as the association between
neuronal density and NeuN field fraction. . . . . . . . . . 140
4.7 Summary of MRI parameters and histological features cor-
relations in both tissues of the temporal lobe neocortex,
along with possible neurobiological explanations for the
highlighted relations. . . . . . . . . . . . . . . . . . . . . 143
5.1 Overview of some of the quantitative histological features
including: neuron density (for both CA and DG), mean
neuron size, and GFAP field fraction. . . . . . . . . . . . . 160
5.2 Subfield delineation on histology slices from three patients
from our cohort (Top: Mild sclerosis, Middle: Moderate
sclerosis, Bottom: Severe sclerosis). The labeling scheme
(colour representing each subfield) is described at the bot-
tom of the figure. . . . . . . . . . . . . . . . . . . . . . . 163
5.3 In-vivo MRI parameter extraction scheme. A target region
was chosen around the corresponding (registered) MRI slice
to the cut histology slice for parameter extraction. Man-
ual segmentation of the subfields was employed within the
target region and a sagittal weighting kernel was applied,
whereby slices closer to the corresponding MRI slice in the
sagittal plane had higher weighting. . . . . . . . . . . . . 165
xv
5.4 Boxplots of in-vivo MRI parameters (Volume, T1, T2, FA
and MD) as well as histological neuronal density catego-
rized by the qualitative HS subtype classification. . . . . . 168
5.5 Most significant associations from Spearman’s correlation
analysis for subfield-specific MRI parameters with histo-
logical features. . . . . . . . . . . . . . . . . . . . . . . . 171
5.6 Multiple linear regression results for subfield-specific pa-
rameters depicting predicted vs. actual percent neuron loss
for each of the four CA subfields. . . . . . . . . . . . . . 173
A.1 Single subject (Middle) as well as atlas-based images of av-
erage magnitude across echoes (Top Left), R2* (Top Right),
qualitative SWI (Bottom Left) and QS maps (Bottom Right).
The adjacent image to each map shows a zoomed-in repre-
sentation of a hippocampal slice in the coronal view. The
same slice is chosen for all maps to compare CNR and SNR
across the different maps. . . . . . . . . . . . . . . . . . . 208
A.2 Two sets of three consecutive coronal slices as seen in atlas
space in the magnitude across echoes, R2* and QS maps,
with the top row of each block showing segmentation la-
bels overlaid on the images. The location of the slices is
indicated on a sagittal view of the hippocampus at the top
of the figure. . . . . . . . . . . . . . . . . . . . . . . . . . 211
A.3 Validation of pre-operative R2* with 9.4T ex-vivo imaging
of a resected hippocampus. Left: Coronal slice of the pre-
op R2* at 7T with a zoomed-in view of the sclerotic hip-
pocampus before epilepsy surgery excision. Middle: Mag-
nitude image of the patient’s resected hippocampus imaged
at 9.4T resulting in a 0.1 mm isotropic resolution (top); R2*
image of the hippocampus, where the subfield delineation
was performed (bottom). Right: Graph of comparison be-
tween pre-op (blue) and ex-vivo (purple) R2* values within
the subfields. . . . . . . . . . . . . . . . . . . . . . . . . 214
A.4 Figure 4. Validation of our QS values in the basal ganglia
with Deistung et al. [31] and Wharton and Bowtell [32].
Left: Axial slice of a QS map from a single subject showing
the outlines of the basal ganglia structures. Right: Graph
demonstrating QS values within the basal ganglia for three
papers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 215
xvi
List of Tables
2.1 Summary of demographics and clinical data, including MRI
and histopathological findings, for the seven recruited pa-
tients in the study. Registration was performed on both
hippocampus and neocortex specimens for all patients. In
two cases (denoted by ?) registration was only performed
on the neocortex due to a missed scan and a fragmented
hippocampus specimen. MTS: Mesial Temporal Sclerosis.
FCD : focal cortical dysplasia. . . . . . . . . . . . . . . . 57
2.2 Summary of ex-vivo subvolumes, the numbers of histolog-
ical blocks and sections, as well as NeuN and GFAP sections. 62
2.3 TRE values for hippocampal registration across iterations.
H.B.E: Non-rigid with a High Bending Energy penalty, L.B.E:
Non-rigid with a Low Bending Energy penalty. † : P ≤
0.01 between means registration step and Rigid Iteration 1.
‡ : P ≤ 0.01 between means of registration step and Rigid
Iteration 5. . . . . . . . . . . . . . . . . . . . . . . . . . 75
2.4 TRE values for neocortical registration across iterations.H.BE:
Non-rigid with a High Bending Energy penalty,L. B.E: Non-
rigid with a Low Bending Energy penalty. † : P ≤ 0.01
between means registration step and Rigid Iteration 1. ‡
: P ≤ 0.01 between means of registration step and Rigid
Iteration 5. . . . . . . . . . . . . . . . . . . . . . . . . . . 76
3.1 Overview of the studies reporting algorithms for in-vivo
MRI to histology of the brain in the last 15 years. . . . . . 91
3.2 Summary of demographics and clinical data, including MRI
and histopathological findings, for the ten recruited patients
in the study. Registration was performed on both hippocam-
pus and neocortex specimens eight patients. Registration
was only performed on the neocortex for cases denoted by
?. HS: Hippocampal Sclerosis. FCD : Focal Cortical Dys-
plasia. TS: Tuberous Sclerosis. . . . . . . . . . . . . . . . 94
xvii
3.3 Summary of ex-vivo subvolumes, the numbers of histolog-
ical blocks and sections, as well as NeuN and GFAP sec-
tions. In two cases (denoted by ∗) registration was only
performed on the neocortex . . . . . . . . . . . . . . . . . 97
3.4 Summary of Dice similarity metric coefficient and root mean
squared error (RMSE) for both tissue types (GM & WM) . 107
4.1 Patient demographics and clinical information including age,
gender, onset age, seizure origin as well as clinical MRI
and pathology findings for our patient cohort. MTS = mesial
temporal sclerosis, MAA= minor architectural abnormali-
ties, Neo. Path. = Neocortical Pathology, Hp. Path. =
Hippocampal Pathology,† Previous resection of left tem-
poral lobe tumour (DNET), * not enough tissue to make
diagnosis of MTS . . . . . . . . . . . . . . . . . . . . . . 126
4.2 Results of the linear mixed-effects models with random ef-
fects for subjects, showing parameter estimates (β), stan-
dard error (SE) and p-values for all variables. Density (L.N)=
Large Neurons, Density (S.N) = Small Neurons, NeuN F.F
= Field Fraction. * Variable with fixed effect significant at
p < 0.05, ** Variable with fixed effect significant at p <
0.01 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
4.3 Significance of Spearman Rho correlations between MR
parameters. All p-values were corrected for family wise
error. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
5.1 Patient demographics and clinical information including age,
gender, onset age, seizure origin as well as clinical MRI
and pathology findings for our patient cohort. HS = mesial
temporal sclerosis, MAA= minor architectural abnormal-
ities, Neo. Path. = Neocortical Pathology, Hp. Path. =
Hippocampal Pathology † Previous resection of left tem-
poral lobe tumour (DNET), ‡ not enough tissue to make
diagnosis of HS . . . . . . . . . . . . . . . . . . . . . . . 158
5.2 Percent neuron loss per subfield and qualitative and Quan-
titative HS subtype classifications. . . . . . . . . . . . . . 161
5.3 Significance of Spearman’s correlations between MR pa-
rameters and histological features for whole hippocampus
and subfield-specific analyses. . . . . . . . . . . . . . . . 169
5.4 Model fit of multiple linear regression analysis for predict-
ing percent neuron loss per subfield using whole hippocam-
pus MRI parameters. . . . . . . . . . . . . . . . . . . . . 172
xviii
5.5 Model fit of multiple linear regression analysis for predict-
ing percent neuron loss per subfield using subfield-specific
MRI parameters. . . . . . . . . . . . . . . . . . . . . . . . 174
A.1 Table I: Dice similarity coefficient, absolute percentage vol-
ume error and Intra-class correlation coefficient metrics in
conducted patient space . . . . . . . . . . . . . . . . . . . 209
A.2 Table II: Hippocampal subfield volumes normalized by in-
tracranial volume (ICV), reported in mm3. . . . . . . . . . 209
A.3 Table III: Subfield volumes, R2* and QS values as a mean
across all subject in subject space . . . . . . . . . . . . . . 212
A.4 Table IV: One-way analysis of variance (ANOVA) between
all subfields for R2* and QS maps . . . . . . . . . . . . . 213
xix
List of Abbreviations, Symbols, and Nomenclature
AD Alzheimer’s Disease
AD Axial Diffusivity
ADC Apparent Diffusion Coefficient
ANOVA ANalysis Of VAriance
ATL Anterior Temporal Lobectomy
bSSFP balanced Steady-State Free Precession
BOLD Blood-Oxygen-Level Dependant
CA Cornu Ammonis
CC Cross Correlation
CHARMED Composite Hindered And Restricted ModEl of Diffusion
COSMOS Calculation Of Susceptibility through Multiple Orientation Sampling
CR Correlation Ratio
CT Computerized Tomography
CGNR Conjugate Gradient Normal Residual
CUSA Cavitron Ultrasonic Surgical Aspirator
DBS Deep Brain Stimulation
DESPOT1 Driven Equilibrium Single Pulse Observation of T1
DG Dentate Gyrus
DNET Dysembryoplastic NEuroepithelial Tumour
DSC Dice Similarity Coefficient
DTI Diffusion Tensor Imaging
DWI Diffusion Weighted Imaging
EEG ElectroEncephaloGraphy
ERP Event Related Potentials
ET Echo Time
ETL Echo Train Length
ERC Entorhinal Cortex
EPI Echo-Planar Umaging
FA Fractional Anisotropy
FCD Focal Cortical Dysplasia
FDG Fludeoxyglucose
FIESTA Fast Imaging Employing Steady sTate Acquisition
FLAIR Fluid Attenuated Inversion Recovery
FLASH Fast Low Angle SHot
FM Frequency Mask
FMRI Functional Magnetic Resonance Imaging
FOV Field Of View
FSE Fast Spin Echo
FWER Family-Wise Error Rate
FWHM Full Width Half Maximum
xx
GFAP Glial Fibrillary Acidic Protein
GM Gray Matter
GRE GRadient-Echo
H&E Hematoxylin and Eosin
HP Hippocampus
HS Hippocampal Sclerosis
ICC Intraclass Correlation Coefficient
ICV IntraCranial Volume
IED Interictal Epileptiform Discharges
IHC ImmunoHistoChemistry
IR Inversion Recovery
IVIM IntraVoxel Incoherent Motion
LFB Luxol Fast Blue
LFS Local Frequency Shift
MAP Microtubule Associated Protein
MCD Malformations of Cortical Development
MD Mean Diffusivity
MEDI Morphology Enabled Dipole Inversion
MI Mutual Information
MPRAGE Magnetization Prepared RApid Gradient Echo
MRI Magnetic Resonance Imaging
MTLE Mesial Temporal Lobe Epilepsy
MTS Mesial Temporal Sclerosis
NCC Normalized Cross Correlation
NEUN NEUronal Nuclei
NF NeuroFilament
NMI Normalized Mutual Information
NODDI Neurite Orientation Dispersion and Density Imaging
NR Non-rigid Registration
NRM Nuclear Magnetic Resonance
PET Positron Emission Tomography
PD Proton Density
PDF Projection onto Dipole Fields
QSM Quantitative Susceptibility Mapping
RBF Radial Basis Functions
RD Radial Diffusivity
RF Radio-Frequency
ROI Region Of Interest
RMS Root-Mean Square
SAH Selective AmygdaloHippocampectomy
SE Spin-Echo
xxi
SHARP Sophisticated Harmonic Artifact Reduction on Phase data
SNR Signal-to-Noise Ratio
SPECT Single Photon Emission Computed Tomography
SPGR SPoiled Gradient Echo
SSD Sum of Squared Differences
SSFP Steady State Free Precession
SWI Susceptibility Weighted Imaging
SUB SUBiculum
SyN Symmetric traNsformation
TKD Truncated K-space Division
TLE Temporal Lobe Epilepsy
TLE Target Localization Error
TR Repetition Time
TRE Target Registration Error
TrueFISP True Fast Imaging with Steady state Precession
TSE Turbo Spin Echo
VBM Voxel Based Morphometry
WH Whole Hippocampus
WM White Matter
xxii
Chapter 1
Introduction & Background
1.1 Temporal Lobe Epilepsy
Epilepsy is a chronic neurological disorder characterized by recurrent seizures. Epilep-
tic seizures are alteration in neurological function resulting from episodes of exces-
sive or synchronous neuronal electrical activity [1]. There are two main categories
of seizures based on the International League Against Epilepsy ILAE classification
[1]: generalized or partial (focal), depending on their clinical type, interictal elec-
troencephalography findings and propagation. Generalized seizures involve both hemi-
spheres often from the onset of the attack, with tonic-clonic/grand mal (involving mus-
cle spasm and jerking movements) and absence seizures/petit mal (involving lapses of
consciousness) being the most common subtypes. Partial seizures start in a specific re-
gion of the brain and may be contained or spread to the whole brain, and are subdivided
into focal seizure with consciousness preserved (old terminology: simple partial) or
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with loss of consciousness (complex partial/dyscognitive). Epilepsy affects around 50
million people worldwide [2]. In Canada, epilepsy is one of the most common chronic
neurological disorders with a prevalence of about 1% in the population (approximately
350,000 people)[3].
Anticonvulsant or antiepileptic pharmacotherapy is for the vast majority of cases
the primary means of treatment. However, over 30% of epileptic patients suffer from
intractable seizures (that are drug-resistant or medically refractory) despite multiple
trials of drugs [3, 4, 5]. These uncontrolled seizures are associated with a decreased
quality of life (inability to work, drive and complete schooling), as well as increased
psychiatric co-morbidities [6], mortality [7] and a higher risk of suicide [8], placing a
significant burden on the patients, families, and the Canadian health care system and
services.
Temporal lobe epilepsy (TLE) is the most common, and best-defined, form of symp-
tomatic adult focal epilepsy [9]. TLE can originate from either mesial or lateral struc-
tures. Mesial temporal lobe seizures typically involve limbic structures, specifically
the hippocampus, the amygdala and the parahippocampal gyrus, while lateral temporal
lobe seizures involve the temporal neocortex. The common features of these seizures
are auras (somatosensory, auditory, visual, or olfactory), memory distortions (deja vu or
jamais vu), epigastric sensations or anxiety [10]. The etiology of temporal lobe seizures
remains unknown; however they can be caused by a number of factors including hip-
pocampal sclerosis, infections (such as meningitis or encephalitis), traumatic brain in-
jury, cerebral tumours or stroke [10]. While mesial TLE (mTLE) commonly starts in
adolescence and even adulthood, the initial insult is believed to be neurodevelopmental
and to occur after prolonged febrile seizures in early life [11]. Numerous histopatho-
logical and electrophysiological studies have suggested that the sclerotic hippocampus
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and closely related structures may be the origin of epileptic activity common to the
disorder, possibly arising from the reorganization of networks in the dentate gyrus [12]
and subiculum [13]. When there is a localized seizure focus, the standard of care for
refractory patients is surgical excision of the affected brain region in order to achieve
seizure control [14]. Intractable TLE patients form the majority of surgical candidates
for epilepsy surgery [15].
1.2 Epilepsy surgery
Understanding the anatomy and connectivity of the temporal lobe is a key prerequi-
site for interpretation of the surgical protocols and pathological substrates of the TLE
syndrome.
1.2.1 Temporal lobe function, anatomy and connections
The temporal cortex comprises regions concerned with the perception of written and
spoken language, as well as auditory, vestibular, olfactory and visual senses [16]. The
medial side of the temporal lobe consists of areas involved in semantic memory and
olfaction, namely the the hippocampal formation and amygdala [17], as well as the
uncus and nearby cortex respectively [16]. The hippocampus is not only responsible
for encoding and consolidation of short-term memories, but also for their retrieval [18].
The amygdala responds to sensory stimuli that have been analyzed in other regions of
the brain, such as feelings, emotions and involuntary responses mediated by the au-
tonomic system [17]. Figure 1.1 presents an overview of the anatomy of the human
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temporal lobe highlighting some of its main structures: the uncus, parahippocampal
gyrus, fimbria, hippocampus (an enfolded gyrus next to the parahippocampal gyrus),
fornix and neocortical gray and white matter. This section focuses on the hippocampal
formation and the cerebral cortex (neocortex) of the temporal lobe. The constituents
of the hippocampal formation include the hippocampus, the dentate gyrus, the fimbria,
alveus and fornix [16]. The entorhinal cortex is the cortex neighbouring the hippocam-
pus and it is found along the length of the parahippocampal gyrus. The subiculum
is a transitional region located between the hippocampal and entorhinal cortices. The
hippocampus proper is divided into multiple subfields, the dentate gyrus and the cornu
ammonis (CA), or Amun’s horn (from the Egyptian deity, Amun, with a ram’s head)
[19]. The dentate gyrus is made up of the hilus and fascia dentata, while CA is di-
vided into four fields CA1, CA2, CA3, and CA4 (based on their anatomical location,
cytoarchitecture and fiber connections), as shown in Figure 1.2.
Many structures of the temporal lobe are constituents of the limbic system, a col-
lection of brain areas that regulate endocrine as well as autonomic function, namely
in response to emotional stimuli, including the hippocampus, amygdala and parahip-
pocampal gyrus [20]. The two major efferent and afferent pathways of the hippocampus
within the limbic system are the fornix and entorhinal cortex (via the cingulate cortex),
which are part of the Papez circuit. Many structures such as temporal lobe neocortex,
amygdala and cingulate cortex are major sources of afferent pathways to the hippocam-
pus via the entorhinal cortex [21]. The hippocampus also receives inputs through the
pre-commissural and post-commissural branches of the fornix. The amygdala receives
pathways from visceral inputs, mainly the hypothalamus, as well as auditory, visual and
somatosensory inputs from the temporal and anterior cingulate cortices [22, 21]. It also
has major efferent pathways to the hippocampus, entorhinal cortex and thalamus. The
1.2. Epilepsy surgery 5
Figure 1.1: Anatomy of the temporal lobe highlighting some of its prominent
structures: the hippocampus, parahippocampal gyrus, uncus, fimbria and fornix. These
images are modified from the original work of Henry Gray’s anatomy: “Gray739”,
“Gray747” and “Gray 740”. Licensed under Public domain via Wikimedia Commons.
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Figure 1.2: Characterization of the hippocampus into different subfields (CA1-4,DG
and subiculum). Left: Delineation of the subfields on a high field 7T MRI average
(Top) and NeuN IHC (bottom). Right: 3D surface rendering of the hippocampus with
the subfield segmentations of the hippocampal body.
1.2. Epilepsy surgery 7
three principal pathways within the hippocampus are: 1) The perforant pathway which
connects the dentate gyrus, as well as the remaining subregions of the hippocampal
formation to the entorhinal cortex, 2) Mossy fiber pathways from the granular cells of
the dentate gyrus to the pyramidal cells of the CA3 subfields and finally 3) the Schaffer
collaterals which are the most prominent projections from CA3 to CA1.
There are three main populations of neural tracts in the brain: Association fibers con-
nect regions in the cerebral cortex in the same hemisphere, commissural fibers generally
link regions between hemispheres (not exclusively), and finally projection fibers pro-
vide a connectional route from subcortical regions to cortical regions. As for the white
matter circuitry of the temporal lobe, the arcuate fasciculus (part of the superior lon-
gitudinal fasciculus) provides a two-way communication between posterior region of
the superior temporal gyrus (Wernicke’s language comprehension area) and the frontal
cortex, namely Broca’s speech development area. The uncinate fasciculus connects the
temporal pole cortex with the pre-frontal cortex. The most notable association bundle
in the temporal lobe is the anterior commissure which connects the middle and inferior
temporal gyri of both hemispheres and runs anterior to the fornix. An important pro-
jection fiber bundle as well in the temporal lobe is Meyer’s loop, which connects the
upper quadrants visual fields to their associated, contralateral primary visual cortex of
the inferior bank within the calcarine sulcus [16].
1.2.2 Anterior Temporal Lobectomy
Surgical excision of the affected brain region, the seizure focus, is the standard of
care for the majority of cases of drug-resistant focal epilepsy [14, 23]. A random-
ized controlled trial that was carried out in 2001 demonstrated this to be an effective
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treatment [24]. Anterior temporal lobectomy (ATL) remains the most common pro-
cedure performed for adults suffering from hippocampal sclerosis, with other options
including more limited removal of only the medial structures such as selective amyg-
dalohippocampectomy (SAH) [23]. In the ATL procedure, the mesial structures, the
hippocampus and amygdala, and up to 3-5 cm of the temporal neocortex are removed
[23]. Surgical risks commonly comprise neurological deficits, as well as a 6% chance
of temporary complications, a 2% chance of severe chronic complications, and a 0.24%
chance of death [25]. These common neurological deficits may include superior quad-
rant visual field defects contralateral to the side of surgery, verbal memory deficits (if
the operated hemisphere is language dominant), non verbal/spatial memory deficits (if
right sided) as well as language and speech deficits (dysphasia) such as word-finding
ability and reading difficulties [26]. Other neurosurgical operative complications such
as the risk of wound infections needing antibiotics, cerebrospinal fluid leaks or stroke
are comparable to other neurosurgical operations [27].
However, seizure outcomes for epilepsy patients following surgical resection re-
main suboptimal, despite advances in localizing techniques, with a recent long-term
study of surgical outcomes reporting that only half of such patients are seizure-free at
10 years follow-up [26]. It is believed that early seizure recurrence is mainly due to
inadequate removal of the epileptic lesion itself or a critical component of the epileptic
network [28]. Novel techniques have emerged to perform minimally invasive proce-
dures for seizure control of TLE patients, such as stereotactic radio frequency amyg-
dalohippocampectomy (where thermocoagulation of the hippocampus and amygdala is
performed using a string electrode) [29] or selective laser hippocampectomy (where
hippocampal ablation is conducted through a laser fiber under real-time MR monitor-
ing) [30]. However, the long-term outcomes and effectiveness of such procedures on
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seizure freedom and remission, as well as complications are yet to be established.
1.3 Pathological substrates of TLE
The findings in excised specimens from ATL surgery characterize different pathologies,
including hippocampal sclerosis, congenital lesions, ischemic or inflammatory lesions,
traumatic brain injuries and tumors. In this work, we focus on hippocampal sclerosis
and malformations of cortical development.
1.3.1 Hippocampal sclerosis
Hippocampal sclerosis (HS), the hallmark of TLE and originally named mesial tempo-
ral sclerosis (MTS) to include amygdala and mesial structures, is the most common un-
derlying pathology and the most common epileptogenic lesion encountered in patients
with focal epilepsy [31]. The prevalence of HS varies between different reports, ranging
from about 48% up to 73% [32]. HS is characterized by atrophy in the hippocampal for-
mation associated with neuronal loss and gliosis of the CA1 (Sommer sector), CA3 and
CA4 (end folium) subfields, as well as the dentate gyrus with a relative sparing of the
CA2 subfield [33]. Moreover, the dentate gyrus shows reorganization of excitatory and
inhibitory neuronal networks, which is characterized by granule cell dispersion, axonal
sprouting of excitatory and inhibitory neurons as well as loss of interneurons [31]. HS
presents a broad spectrum of structural and molecular changes, which are categorized
into different subtypes based on a neuropathologic grading system [33, 34, 35]. Each
distinct pattern or subtype demonstrates a different postsurgical seizure outcome, as
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well as different clinical correlates such as memory impairment postoperatively [33].
Immunohistochemistry for neuronal nuclei (NeuN) has proven effective in detecting
loss of neurons in the hippocampal subfields (Figure 1.3), and immunohistochemistry
for glial fibrillary acidic protein (GFAP) commonly delineates gliosis related to neu-
ronal loss [31]. Dual pathology, or the coexistence of an extra-hippocampal pathology
in patients suffering from HS, has a reported incidence of 5% to 34% [32].
Figure 1.3: Comparison of normal and pathologic hippocampi, presenting
hippocampal sclerosis on a FLAIR MRI scan and a histology NeuN IHC.
Hippocampal atrophy and increased T2-weighted signal are visible on the FLAIR
image and prominent neuronal loss within the different subfields specifically CA1,
CA3 and CA4 is visible on the histology slide.
1.3.2 Malformations of cortical development
Malformations of cortical development (MCD) are developmental abnormalities of the
neocortex representing pathological processes throughout prenatal and postnatal brain
development [36]. These mechanisms can influence different developmental processes
such as cell proliferation or neuronal migration, apoptosis and cortical organization.
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Focal cortical dysplasia (FCD) is the most common subtype of MCD that causes med-
ically intractable, chronic epilepsy in children and young adults [37]. It encompasses a
broad range of lesions, including cytoarchitectural abnormalities, dyslamination of the
cerebral cortex, as well as underlying white matter pathology. Other subtypes of MCD
include grey matter heterotopia, polymicrogyria, agyria, pachygyria or porencephaly
[32].
FCD is categorized into three distinct clinicopathological types [38]. FCD Type
I describes isolated lesions that are either radial or tangential cortical dyslamination
(Type Ia and Ib respectively). FCD Type II are lesions, which present as cortical dys-
lamination plus dysmorphic neurons not including balloon cells (Type IIa) or including
them (Type IIb) [39]. Whereas FCD Type III, can be diagnosed as cortical lamina-
tion abnormalities in association with other epileptogenic lesions such as hippocampal
sclerosis (Type IIIa), tumors (Type IIIb), neighbouring vascular malformations (Type
IIIc), or lesions acquired in early life, that is ischemic injury, traumatic brain injury or
encephalitis (Type IIId) [38].
Surgical failures or seizure remission, may in some cases suggest the presence of
dual pathology or error in localizing/resecting subtle neocortical lesions, thus identifi-
cation and delineation of epileptogenic lesions in the neocortex is crucial to improving
surgical outcomes. Moreover, the landscape of epilepsy surgery is changing with more
neocortical lesions and focal cortical dysplasia (FCD) resections being performed [40],
as well as an increased demand for intracranial studies and invasive evaluations within
the neocortex. Patients with neocortical lesions present a higher degree of complex-
ity than mesial TLE since they may undergo invasive surgeries due to diffuse cortical
abnormalities or be denied surgery as non-surgical candidates [41].
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1.4 Diagnostic techniques for pre-operative evaluation
1.4.1 Electroencephalography
Electroencephalography (EEG), first recorded by Hans Berger in 1924, is a technique
for measuring spontaneous neuronal electrical activity using electrodes placed on or un-
der the scalp. EEG detects voltage fluctuations from ionic currents in the neurons [42].
It is a vital tool for analyzing the temporal dynamics of the human brain due to its high
intrinsic temporal resolution (on the order of milliseconds) [43]. EEG is convention-
ally analyzed as temporal waveforms over multiple channels, by looking at power of
rhythms, latency and amplitude of the peaks and troughs within event related potentials
(ERPs) [44]. The main limitation of EEG is its poor spatial resolution (centimeters)
and that the measured signal at the surface of the scalp surface does not directly point
to the site of the active neurons within the brain [45]. In addition, the signal at a given
electrode is the superposition of many different sources, hence it is difficult to local-
ize. EEG is mandatory to diagnose epilepsy though the characterization of interictal
epileptiform discharges (IED) and their propagation patterns. Accuracy of EEG is lim-
ited and is neither sufficiently sensitive nor specific for localization of the seizure focus
[20]. However, imaging findings on their own cannot determine the epileptogenicity of
structural lesions. The accuracy of ictal findings of scalp EEG in predicting the side of
the ipsilateral temporal lobe seizure onset (lateralization) is around 80% [46, 47].
Mesial temporal lobe epilepsy associated with hippocampal sclerosis commonly
presents either anterior or mid temporal interictal spikes that are ipsilateral to the af-
fected temporal lobe. The common epileptiform abnormality is the classic spike or
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sharp wave having a negative polarity and preceding a slow wave. The maximum neg-
ativity of spikes originating from the anterior temporal lobe is present over the basal
and sphenoidal electrodes (F7, F8, T1 and T2) [48]. In a mTLE surgical series, these
anterior temporal spikes were found in over 90% of cases [49]. The characteristic ictal
discharge is a buildup of sharp lateralized rhythmic activity (5-10 Hz) accompanying
seizures. Ictal onset in nTLE patients is commonly in the 2-5Hz frequency range. As
noted by Javidan [50], differentiating between nTLE and mTLE using scalp/clinical
EEG characteristics is a challenging task. It should be noted however, that in the for-
mer the EEG may have more variable amplitude and frequency at the onset, as well
as more widely spread changes, with more contribution of the fronto-central electrodes
[49].
Surgical insertion of intracranial electrodes, termed intracranial EEG, can provide
additional electrographic evidence for seizure focality. Techniques include placement
of subdural electrodes over cortical regions of interest and/or insertion of depth elec-
trodes for deeper neuronal structures. Since these techniques are invasive, and thus
associated with potential risks, they cannot reasonably be employed for the investiga-
tion of all epilepsy patients. Intracranial EEG is mainly used to validate findings for
patients with bi-temporal scalp EEG spikes (from both hemispheres) and when no visi-
ble lesion is identified on the imaging findings. Patients with epileptogenic lesions and
concordant findings from analysis of semiology, MRI, video-EEG and neuropsychol-
ogy undergo surgery without invasive recordings.
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1.4.2 Imaging modalities
Alternative imaging methods for diagnosis of TLE include Magnetic resonance imag-
ing (MRI), which will be discussed in details in the next subsection, interictal positron
emission tomography (PET), single photon emission computed tomography (SPECT)
and functional MRI (fMRI) which can be used for language laterization. PET and
SPECT methods rely on detecting gamma rays emitted from an injected radioactive
isotope (tracer) such as fludeoxyglucose (18F − FDG) (an analogue to glucose) or (11C
flumanzenil) [51]. Ictal SPECT studies are performed at the time of seizures to de-
tect hyper-metabolic areas (of increased blood flow) which reflect increased neuronal
activation, whereas inter-ictal PET relies on the detection of hypo-metabolic areas in
the brain. The localizing rates of PET and SPECT for seizure foci are about 75% and
60% respectively [52] but ictal SPECT can be interpreted with higher certainty than
PET when MRI findings are negative [53]. However, the in-plane resolution of these
functional imaging techniques remains on the order of few millimeters (> 2mm) with
thick slices along the field of view [52].
1.4.3 Magnetic Resonance Imaging
MRI is a non-invasive tomographic imaging technique, which generates images of in-
ternal physical as well as chemical characteristics of an object employing externally
measured nuclear magnetic resonance (NMR) signals [54]. MRI can produce 2D sec-
tional images at any orientation, volumetric 3D scans, or even 4D volumes including
spatial and time domains [55]. It operates in the radio-frequency (RF) range, and there-
fore does not employ ionizing radiation nor possesses its related detrimental effects. It
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relies on detecting an RF signal emitted by excited nuclei, which receive energy through
the application of a precessing RF pulse (oscillating magnetic field) at the proper res-
onant frequency [56]. The dominant (most frequently imaged) nucleus in MRI is the
proton in hydrogen.
Briefly, MRI relies on the phenomenon of nuclear spin, a magnetic property of nu-
clei (protons) where they behave like small rotating magnets represented by magnetic
moment vectors. At rest, the net magnetization (sum of all spins) is null since they are
randomly distributed, however within a large external magnetic field a small fraction
of the spins align with and precess about the field direction, producing a net magne-
tization. The magnetic vector of spinning protons (net magnetization) can be broken
down into two orthogonal components: a longitudinal component Mz in the direction
of the external magnetic field, and a transverse component Mxy or M⊥, lying on the XY
plane. The precession angular frequency, also called Larmor frequency, for the proton
magnetic moment vector is given by [54]
ω(x) = γB(x),
where γ is a constant called the gyromagnetic ratio and B(x) is the magnetic field.
The net magnetization, as well as energy levels and spin phases of these protons, can
be altered by applying an electromagnetic excitation RF pulse precessing at the same
Larmor frequency. The altered or tipped net magnetization returns to equilibrium in a
process called relaxation. During relaxation, electromagnetic energy is retransmitted
from excited nuclei, as the NMR signal that can be employed to induce current in the
MR coils.
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Longitudinal (T1) and transverse (T2) relaxation times are measures of the time taken
for the magnetization of water protons to revert back to equilibrium, following RF
excitation [55]. T1 (spin-lattice) relaxation time is the decay constant for the recovery
of the Mz component to its equilibrium M0, and is denoted by:
Mz(t) = M0(1 − e−t/T1),
T2 (spin-spin) relaxation is the decay constant of the Mxy component and is caused
by a de-phasing of individual magnetic moments of the protons, and starts immediately
following the application of the RF pulse. It is denoted by:
Mxy(t) = Mxy(0)(1 − e−t/T2),
The transverse relaxation arises from magnetic particles found within tissues, as
well as magnetic field inhomogeneities generated by the external magnet [55]. Pro-
tons de-phase, or rotate at different frequencies, as they experience a slightly different
magnetic field. T2 is always shorter than T1 for a given tissue [56]. T ∗2 , the observed
time constant of the free induction decay, is a measure of the combination of magnetic
field inhomogeneities and transverse relaxation times. Both T1 and T2 times are tis-
sue specific, and are dependent on the biophysical and chemical properties of tissue.
By altering the time-point of MRI signal acquisition during relaxation, contrast can be
created between different tissue types.
Most commonly, MRI can be weighted in T1 and/or T2 or proton density (PD),
whereby the contrast of the image is derived from comparative contributions of different
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tissues [54]. All MRI sequences comprise a series of excitation pulses that are separated
by repetition times (TR). The echo time (TE) is the time at which data are acquired after
applying the excitation pulses [57]. The contrast in the image changes with variations
to both TE and TR [57], with the MRI signal modeled as:
M⊥(T E) = M0(1 − e−TR/T1)e−T E/T2 ,
Proton density is related to the number of hydrogen atoms in a particular volume
[54]. In PD images, high PDs give high signal intensities. In T2 − weighted images,
tissues with long T2 give the highest signal intensities, producing a hyper-intense ap-
pearance. In T1 − weighted images long T1 tissues are the most hypointense, that is
bright pixels on T1 are associated with short T1s. One can also generate a quantita-
tive map, derived from the relaxation time, referred to as relaxometry, which will be
discussed in further detail in the following subsection. Selection of the slice plane
and spatial encoding of image voxels is performed through the use of magnetic field
gradients. The field gradients permit the encoding of spatial data as spatial frequency
information and mapping it into k-space (frequency domain). An inverse 2D Fourier
transform is employed to reconstruct the image [54]. The Fourier transform of a spatial
function f (x) is denoted by:
F(k) =
∫ ∞
−∞
f (x)e−2piikxdx,
To create an image the data are acquired using a combination of gradient and RF
pulses in a specific order, as part of an MRI acquisition sequence. There are two prin-
cipal types of pulse sequences, gradient echo (GRE) and spin echo (SE) [55]. Gradient
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echo (GRE) is the simplest type of MRI sequence, employing a single RF pulse fol-
lowed by a gradient pulse to create the echo [57]. The spin echo (SE) sequence is anal-
ogous to the GE sequence with the addition of a 180◦ refocusing pulse. This pulse is
applied between the excitation pulse and the echo at exactly half TE. Other types of se-
quences, such as inversion recovery, begins with a 180◦ inversion pulse [54]. There are
many more advanced types of sequences such as Fast or Turbo Spin Echo (FSE/TSE),
inversion recovery (IR), fluid attenuated inversion recovery (FLAIR) or advanced GE
sequences as, spoiled gradient echo (SPGR) and steady state free precession (SSFP)
[57].
MRI in epilepsy
A patient is considered a potential surgical candidate if they suffer from medically re-
fractory seizures, the seizure is focal in origin and an accurate pre-operative localization
on the ipsilateral side has been performed (based on concordant data from clinical his-
tory and exams, EEG, semiology and imaging findings). Localization of the seizure
focus is therefore a major task in preoperative evaluation of surgical candidates with
intractable epilepsy. In addition to EEG monitoring, MRI has the potential to identify
and detect lesions related to seizure onset, and surgical outcomes are more favorable
if an underlying lesion can be detected [58, 59]. Recent advances in MRI have revo-
lutionized the management and evaluation of intractable epilepsy. The advantages of
MRI, other than elimination of radiation dose, include excellent soft tissue contrast over
computerized tomography (CT), as well as the ability to acquire high resolution images
as compared to EEG sampling.
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The clinical standard MRI protocol for pre-operative localization of seizure focus
in TLE patients varies according to institutional practice and resources. The MRI pro-
tocol commonly includes a combination of the following sequences perpendicular to
the hippocampal axis: 1) a coronal SPGR (T1 − weighted) image, 2) a coronal FLAIR
image, 3) an axial relatively higher resolution FSE (T2 − weighted) through temporal
lobe, 4) an axial FSE IR (T1 − weighted) image and 5) a diffusion weighted imaging
(DWI) sequence (this list is by no means exclusive) [20]. The imaging parameters (im-
age resolution, slice thickness, number of averages, etc.) also vary according to the
epilepsy center and are dictated by the length of the scan and the sequence. However,
for structural sequences, the slices are commonly a few millimeters apart, and the in-
trinsic in-plane resolution ranges on average from 1 mm to 2 mm for higher resolution
scans.
Since the early 1990s, hippocampal sclerosis (HS) has been detectable on pre-
operative MRI [60]. The classic hallmark of HS on MRI is reduced hippocampal vol-
ume and increased signal intensity on T2 − weighted images and T2 relaxometry, and a
large body of research has established their reliability in reflecting hippocampal atrophy
[60, 61, 62, 63], however, the exact causal relationship between structural changes and
epileptogenesis in the hippocampus is still unclear. The radiological diagnostic criteria
for HS on MRI are as follows: hippocampal atrophy and malrotation, signal alterations
(mainly hyperintensity on T2 and FLAIR), loss of internal architecture [20]. Secondary
findings within temporal lobe are loss of hippocampal head digitations, dilation of tem-
poral horn, white matter changes and entorhinal cortex atrophy. Extratemporal lobe
findings include atrophy in the fornix, mammillary bodies or thalamus. In addition,
the MRI features for MCD include cortical thickening, blurring or irregularity of gray
matter/white matter junction, hyperintensity of gray matter, hyperintense signal in sub-
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cortical white matter and altered sulcal morphology.
However, more than 30% of TLE patients are MRI-negative, presenting no evidence
of brain lesions (non-lesional) [64, 65]. Histological evaluation of excised tissue in
these cases often reveals reactive changes or malformations of cortical development
(MCD) that were not detected in preoperative imaging [66, 67].
1.4.4 Novel MRI techniques
Current clinical imaging protocols and surface EEG techniques for epileptogenic focus
localization may not be sufficient for pre-operative planning due to limited sensitivity
to deeper brain structures, and low resolution of source localization techniques [68].
Novel magnetic resonance imaging (MRI) techniques such as diffusion tensor imaging
(DTI), relaxometry mapping, high resolution functional MRI (fMRI), voxel-based mor-
phometry (VBM), and cortical thickness analysis can detect abnormalities not identified
with conventional or diagnostic MRI protocols [69, 70, 71]. This is important since it
has been shown that post-operative outcomes can be predicted more accurately in pa-
tients where lesions can be identified [26, 72]. These techniques also have the potential
to improve pre-operative localization of the focus, paving the way towards less invasive
procedures and better surgical outcomes.
Diffusion Tensor Imaging
Diffusion tensor imaging (DTI) is an MRI technique that allows the study of brain
microstructure by mapping the diffusion process of water molecules [73]. Water diffu-
sion in the brain is a three-dimensional anisotropic process believed to originate from
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specific organization of fiber bundles, neural axons, membranes and macromolecules.
Diffusion anisotropy patterns in the white matter can therefore reveal tissue microstruc-
ture and architecture for both diseased and healthy states [74]. Diffusion is encoded in
the MR signal by using diffusion sensitizing magnetic field gradients and only molec-
ular diffusion that occurs along the direction of the gradient is visible [73]. If diffusion
was isotropic, it would be fully described by a single (scalar) parameter, the diffusion
coefficient, D. The effect of diffusion on the MRI signal is an attenuation, A, such as:
A = exp(−bD),
where b is a factor characterizing the gradient pulses (duration (δ), strength (g), time
between the gradient pair (∆) and shape) of the MRI sequence, and can be simplified
for a rectangular pulse pair as:
b = γ2g2Dδ
2(∆ − δ/3)
Since diffusion is anisotropic it requires a tensor D, which fully describes molecular
mobility in each direction and the correlation between them, to be characterized.
D =
Dxx Dxy Dxz
Dyx Dyy Dyz,
Dzx Dzy Dzz
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The tensor is commonly calculated from six or more different diffusion weighted
acquisitions, each obtained with a different orientation of the diffusion sensitizing gra-
dients [74]. The directional information is encoded as eigen vectors and can be used to
follow, whether in a deterministic or a probabilistic fashion, the orientations of the fiber
tracts through the brain, in a process called DTI tractography. Tractography can be used
to map eloquent fiber tracts for surgical planning. Figure 1.4 demonstrates an example
of the corticospinal tract mapped using deterministic and probabilistic tractography for
surgical planning of a tumour resection case. A standard clinical DTI sequences varies
across centers and has an image resolution on the order of a few millimeters, a b-value
of 1000 and 12 to 30 diffusion directions.
Several diffusion indices (maps) have been proposed to characterize anisotropy or
diffusivity within the brain. Fractional anisotropy (FA) and mean diffusivity (MD) are
the most commonly used indices in the epilepsy literature: They are described as fol-
lows:
FA =
√
3[(λ1 − 〈λ〉)2 + (λ2 − 〈λ〉)2 + (λ3 − 〈λ〉)2]√
2(λ21 + λ
2
2 + λ
2
3)
,
where
〈λ〉 = MD = (λ1 + λ2 + λ3)
3
,
and λ1, λ2, λ3, are the eigen values of the tensor. Previous studies have demonstrated
reduced FA and increased MD in the ipsilateral white matter in TLE [75, 76, 77, 78].
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Figure 1.4: Example visualization of the diffusion maps FA and MD (with the first
eigen vector overlaid on the maps), as well as fibers from deterministic (bottom left)
and probabilistic tractography (bottom right) of the cortico-spinal tract.
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These changes may be due to degeneration of axons, reduced packing, or demyelina-
tion [79]. The measured diffusion weighted (DW) signal in each voxel (estimate of rate
of water diffusion at that voxel) combines the signal arising from a variety of hetero-
geneous microstructural environments including multiple cell types, sizes, geometries
and orientations and extra-cellular space [80]. Most diffusion MR studies rely on sim-
plistic single-compartment models to model the DW signal, such as apparent diffusion
coefficient (ADC) or intravoxel incoherent motion (IVIM). Several models have been
proposed to characterize the white matter microstructure by modeling the underlying
biophysical mechanisms into multiple compartments. Most notably, the composite hin-
dered and restricted water diffusion (Charmed) model [81] represents the intra-cellular
compartment as impermeable parallel cylinders with a gamma distribution of radii;
and the neurite orientation dispersion and density imaging (NODDI) approach [82]
estimates the microstructural complexity using a three compartment (neurite density,
orientation dispersion and extra-cellular volume fraction) with a spherical Watson dis-
tribution. Although these multi-compartment models have the potential to better inves-
tigate the tissue microstructure and supplement standard clinical tractography results,
they require more time-consuming MRI acquisitions (with multiple b-values), which
may limit their efficacy in a clinical setting.
Functional MRI
Functional MRI, or fMRI, is a technique for measuring brain activity through the detec-
tion of changes in blood flow that occur in response to neural activity (hemodynamic
response). fMRI uses the blood-oxygen-level dependent (BOLD) method which re-
lies on the different reactions between oxygen-rich (oxyhemoglobin) and oxygen-poor
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(deoxyhemoglobin) blood to the magnetic field [83]. Cerebral blood flow and neu-
ronal activation are coupled, in that oxygenated blood flows at a greater rate to inactive
neurons and hence the difference in magnetic susceptibility between oxy and deoxyhe-
moglobin leads to signal variations detectable using an MRI scanner [84]. However,
the hemodynamic response lags the neuronal events or the stimulus by a few seconds
[83].
Advances in MRI hardware and post-processing statistical analysis techniques lead
to the possibility of acquiring a high-resolution fMRI sequence (typically on the or-
der of 2 mm resolution). In the standard fMRI paradigm, task and control states are
carefully constructed to isolate one component of brain function, and the analysis then
investigates areas that correlate with the known stimulus [84]. These states are alter-
nated in blocks, with each block also event related having a number of fMRI scans and
within each only one condition is presented [83]. Another paradigm is to map brain
networks correlations between spontaneous fluctuations of the BOLD signal during the
“resting state” of the brain. The idea of resting state fMRI, or rsFMRI, is to allow for
the exploration of functional connectivity between spatially remote areas based on their
synchronous BOLD activity [85]. While not assessed in this thesis, fMRI can have a
role in language mapping or lateralization of the seizure for epileptic patients. It can
also provide higher spatial resolution to complement the high temporal resolution of
EEG in EEG/fMRI studies, where EEG spikes are correlated with the fMRI time series
to determine regions in which a change in the BOLD signal resulted from an epileptic
discharge observed on scalp EEG [86].
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Quantitative Susceptibility Mapping
Quantitative susceptibility mapping (QSM) is a novel MRI technique that provides
measurements of the apparent tissue magnetic susceptibility from measurements of the
magnetic field perturbation. It requires filtering of the MR phase data and relies on
regularization techniques to solve the magnetic field to susceptibility ill-posed prob-
lem. QSM provides a different contrast than the traditional susceptibility weighted
imaging (SWI) and can be useful in the quantification and identification of magnetic
biomarkers such as iron and calcium. QSM and qualitative SWI have demonstrated
enhanced contrast and sensitivity compared to traditional T2-weighted imaging in sev-
eral clinical applications, including imaging of vascular malformations, calcifications,
and iron deposition [87, 88]. Furthermore, susceptibility-weighted contrast has demon-
strated clinical potential in the assessment of epilepsy [89] and Alzheimer’s disease
[90]. Moreover, QSM can detect cerebral microbleeds with a higher sensitivity than
gradient echo (GRE) magnitude imaging [91] and can be used to accurately quantify
iron content in deep grey matter nuclei [92].
High resolution 3D Relaxometry
Relaxometry is a voxel-wise quantification of intrinsic relaxation times from MR im-
ages. T1, T2 and T ∗2 can be estimated using the appropriate pulse sequence and pa-
rameters. Its advantages over qualitative T1 or T2 − weighted imaging is the relative
insensitivity to acquisition parameters and improved sensitivity to biochemical tissue
changes, and more importantly, the ability to acquire MRI data with consistent tissue
contrast at multiple time points and across different imaging centers, making it a quan-
titative mapping technique. Data measured during a conventional T1− or T2− weighted
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image acquisition is a function of a combination of numerous properties of the tissue
(T1, T2, and proton density), as well as extraneous effects associated with hardware
such as amplifier gains and RF coil sensitivity [93]. Quantitative T1 voxel-wise maps
present ‘pure’ T1 relaxation times that are not contaminated with T2 effects as compared
to T1-weighted images. However, conventional relaxometry techniques such as inver-
sion recovery (IR) for T1 mapping and spin-echo for T2, are rarely used in a clinical
setting due to the long scan times. In this work we employed the driven equilibrium
single pulse observation of T1 and T2, or DES POT1, 2 [94, 95], which provide accu-
rate mapping with high image resolution (1 mm isotropic) in clinically feasible time.
The method derives T1 maps from a series of two or more spoiled gradient recalled
echo (SPGR) or spoiled fast low angle shot (FLASH) scans with constant TR and in-
cremented flip angle (α) [96], as follows:
S S PGR =
M0(1 − E1)sinαT
1 − E1cosαT ,
where E1 = exp(−TR/T1), which results in T1 being calculated as T1 = −TR/ln(m)
and m being the slope of S spgr/sinα vs S spgr/tanα
and T2 maps from a series of five balanced steady-state free precession (bSSFP)
using flip angles 5◦, 35◦ and 68◦ with phase cycling patterns θRF = 0◦ and 180◦. The
signal from SSFP images is:
S S S FP
sinα
=
S S S FP
tanα
(
E1 − E2
1 − E1E2 ) + M0
(1 − E1)E2
1 − E1E2
where E2 = exp(−TR/T2), which allows calculation of T2 as T2 = −TR/ln[(m-
E1)/(mE1 -1)]. Figure1.5 demonstrates a visual comparison between weighted images
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and relaxometry maps. It should be noted however, that the simple T1 and T2 relaxom-
etry sequences assume a uni-exponential model for the relaxation mechanism in each
case, which may not always be a true representation of the underlying phenomena cre-
ating the relaxation. For this reason, more complex sequences have also been developed
that allow for multi-exponential decay [95].
Figure 1.5: Comparison of MRI T1 & T2-weighted images (acquired at 1.5T & 3T)
and relaxometry maps of the same subject.
1.5 MRI-Histology correlation
With the plethora of MRI sequences and analysis techniques available, the challenge
then becomes how to verify and evaluate the sensitivity and specificity of these tech-
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niques for detection of abnormal brain tissue. Prospective studies involving pre-operative
imaging and collection of resected tissue from surgery [97, 98] provide a unique op-
portunity for verification and tuning of these image analysis techniques, since direct
comparison can be made against high-resolution ex-vivo imagery, histology and im-
munohistochemistry. Histological verification of MRI is rare since tissue from surg-
eries or postmortem specimens are required, and when available validation is not a
straightforward task (many surgeons employ a cavitron ultrasonic surgical aspirator -
CUSA - that mitigates against intact resected surgical samples.
To carry out this validation effectively, accurate registration, or alignment, must be
performed to obtain a dense spatial correspondence between in-vivo MR images and
histology images of surgical specimens. Performing an accurate full image registration
allows for the spatially-localized and quantitative assessment of pathological corre-
lates in MRI by the fusion of information from both modalities. This in turn provides
the ability to evaluate the effectiveness of high resolution MRI to resolve underlying
pathologies of focal epilepsy, such as focal cortical dysplasia (FCD), gliosis or hip-
pocampal subfield sclerosis (which could be on the order of a few millimeters). Several
challenges are met in the process of finding spatial correspondence, or registration, be-
tween resected tissue and preoperative MRI. One of the main difficulties encountered is
tissue deformation introduced due to the physical stresses experienced during surgery,
as well as distortions to the tissue during histological processing. These deformations
can be divided into two types: those occurring during surgical resection, and those oc-
curring during histological processing . By obtaining an intermediate ex-vivo MRI of
the tissue specimen after surgical resection, we can divide this challenging registration
problem into two independent sub-problems that can be tackled individually.
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1.6 Image Registration
Registration is the process of aligning two images so that their features correspond or
can be related, by mapping a source image Is (or its coordinates) to the space of a tar-
get image It using a geometrical transformation, or a deformation field, φ [99]. Image
registration has numerous applications in brain image analysis such as registering dif-
ferent imaging modalities of the same subject (multi-modal registration), or computing
atlases to spatially normalize anatomy across a group of subjects, or bringing in-vivo
information to the operating room in image guided interventions. In our work, image
registration was employed for registration of different MR sequences for the same pa-
tient, and more importantly for multi-modal registration between MR and histology.
Registration algorithms involve a similarity metric, an optimizer and also a transforma-
tion model that specifies how the source (moving) image is to be deformed and what
constraints are placed on such deformations [99]. Depending on the dimensionality of
this transformation, registration can account for translation or rotation (rigid), global
scale and shear (affine) or local shape and volume changes (non-rigid) [100]. Low-
dimensional transformations (rigid or affine) are often used as an initial pre-processing
step before high-dimensional registration, to align the overall anatomy.
In order to learn the optimal transformation parameters using an automated process,
image registration utilizes similarity measures or metrics to determine when two im-
ages have achieved the best alignment (optimal result). There are many choices in the
literature for similarity metrics including, sum of squared differences (SSD), correlation
ratio (CR), cross correlation (CC) and mutual information (MI). The sum-of-squared
differences (SSD) [100] is the simplest and most straightforward similarity metric and
is denoted by,
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S S D(S ,T ) =
N∑
i
(S (i) − T (i))2,
However, it requires that the intensities between both images be matched, that is no
shifting or scaling of intensities exists. Hence the SSD similarity metric would not be a
good choice for multi-modal registration or registration of MR weighted images from
different scanning sessions. To adjust for this discrepancy, one may use a normalized
version of the metric. Another normalized metric, is the normalized cross correlation
(NCC): [101]
NCC(S ,T ) =
1
N
∑ (S − S )(T − T )
σsσt
,
which is more robust for rapid optimization, however, it may not be suitable for
multi-modal registration as it requires the source and target images to contain corre-
sponding intensity profiles. The most commonly used metric for multi-modal registra-
tion is mutual information. In information theory, mutual information (MI), or relative
entropy, is a measure of statistical dependence and information redundancy (amount of
shared information) between two variables. In image registration, the local MI between
two images is estimated using entropies obtained from spatially-local histograms of
each images and their joint histogram. However, the standard MI metric wrongly en-
courages large overlap between images where the optimal output involves a small one.
The normalized version of the metric accounts for the discrepancy [102], and is ex-
pressed as:
NMI(S ,T ) =
H(S ) + H(T )
H(S ,T )
,
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Where H(i) is the entropy of the random variable (image) and H(i,j) is the joint
entropy of both variables.
1.7 Thesis objectives
The overall goals of this work were defined as follows:
1. Develop and validate an accurate pipeline for histology to in-vivo MRI image
registration, which finds dense spatial correspondence between both modalities.
2. Investigate histopathological correlates of quantitative relaxometry and DTI from
neocortical specimens of intractable TLE patients.
3. Investigate quantitative MRI predictors of neuronal loss and gliosis within the
hippocampal subfields of intractable TLE patients and test the efficacy of their
prediction from in-vivo images.
1.8 Thesis outline
The following four chapters in this thesis describe how these objectives were achieved.
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1.8.1 Chapter II Histology to ex-vivo registration
This chapter focuses on finding spatial correspondence between the ex-vivo MR im-
ages and tissue-derived histology images, by modelling the transformations and defor-
mations that occur due to surgical resection and tissue handling (such as slicing, slide
mounting, fixation and other histological processing). It presents methodology and val-
idation for the specific application of automatically registering MRI images to sparsely
sampled histology images. The proposed method, based on an iterative 3D and 2D im-
age registration scheme, does not require implanted landmarks, block-face images, or
serially sectioned histology images.
1.8.2 Chapter III in-vivo to ex-vivo registration, Histology to in-vivo
pipeline
In the third chapter I focus on the problem of registering the in-vivo MRI to the interme-
diate ex-vivo MRI, and completing a pipeline for histology to in-vivo MRI registration
in temporal lobe epilepsy. The registration pipeline finds dense and accurate spatial
correspondence between in-vivo MRI and histology and allows for the spatially-local
and quantitative assessment of pathological correlates in MRI. The ex-vivo MRI is used
as intermediate reference between in-vivo and histology images. The registration ap-
proach for in-vivo to ex-vivo MRI registration uses an automated initialization as well
as a landmark-based rigid registration, followed by a landmark deformable registra-
tion for hippocampal specimens and an image-based non-rigid warping for neocortical
specimens.
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1.8.3 Chapter IV MRI-Histology neocortical correlation
Studies involving MRI and histology correlation from neocortical specimens in TLE
are employed to better understand the relationships between the two. Quantitative MRI
sequences and image processing techniques such as T2 relaxometry mapping, diffu-
sion tensor imaging (DTI) and voxel based morphometry may present correlations with
neocortical pathology that are absent with clinical MRI. In this chapter, I make use of a
validated non-rigid image registration protocol (from Chapter II & III) to obtain accu-
rate correspondences between quantitative in-vivo MRI and histology images to investi-
gate quantitative imaging-histopathological correlations within the temporal neocortex.
First quantitative histology parameters from the grey and white matter in each NeuN
(representing neuron integrity) and GFAP (representing gliosis) IHC slide are sampled,
and then used via image registration to obtain the corresponding MRI parameters from
high-resolution quantitative T1 and T2 maps along with DTI.
1.8.4 Chapter V MRI-Histology hippocampal correlation
Chapter 5 attempts to establish the pathological substrates of hippocampal volume and
intensity changes in TLE, as well as to correlate quantitative MRI parameters, includ-
ing relaxation and diffusion maps, with neuronal loss and gliosis within the subfields.
Furthermore, I investigate the efficacy of these quantitative MRI measures in predicting
subfield pathology from in-vivo imaging. The hippocampal subfields were manually
delineated on histology slices and an atlas-based segmentation protocol was employed
to extract the subfields on pre-operative maps.
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1.8.5 Chapter VI Conclusions and future work
This chapter summarizes the main findings of this work and their significance in the
field. It also includes comments and notes for future directions and possible research
questions to be investigated.
1.8.6 Appendix A Quantitative Atlas of hippocampal subfields
The hippocampus and its substructures are of great importance in the pre-operative
evaluation of neurological disorders. This appendix is based on work focusing on the
construction of a normative atlas of the hippocampal subfields from in vivo susceptibil-
ity weighted images of seventeen healthy volunteers on 7T MRI.
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Chapter 2
Registration of Histology to Ex-vivo
MRI
2.1 Introduction
The fundamental operation underlying all of the research presented in this thesis is
the accurate registration of histology to pre-operative images. However, several chal-
lenges are met in the process of finding spatial correspondence, or registration, between
resected tissue and preoperative MRI. One of the main difficulties encountered is tis-
sue deformation introduced due to the physical stresses experienced during surgery, as
well as distortions to the tissue during the histological processing (Figure 2.1). These
deformations can be divided into primary and secondary categories [1]. Primary defor-
mations can be thought of as three dimensional changes, such as mechanical distortions
This chapter is adapted from Goubran et al. “Image registration of ex-vivo MRI to sparsely sectioned
histology of hippocampal and neocortical temporal lobe specimens.” Neuroimage 2013;83:770-781
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during brain extraction once the resected specimen is detached from surrounding brain
tissue, when cutting the specimen in blocks, or non uniform shrinkage induced by for-
malin fixation. Secondary deformations are within-slice distortions which are due to
stretching of microtome cut sections on a water bath, spreading histology slices over
glass slides and staining. Breakage of histology slices, is a major manifestation of the
deformations encountered during histological processing of the tissue [2]. Specifically,
irregularities in the block surface due to different temperature and humidity can possibly
lead to loss of sections from the face of the blocks. Furthermore, differential shrinkage
of the tissue is another challenge that is due to the different intrinsic properties of white
and grey matter. Registration of histology from surgically resected brain specimens to
MRI is more challenging than registration of post-mortem or animal tissue, as the tissue
must be sparsely sectioned, in comparison to the possibility of serially sectioning the
entire specimen. This limitation is imposed by the clinical requirement of pathology
departments to retain parts of the resected specimen in tissue archives. The very differ-
ent anatomy between sparsely sectioned adjacent histology slices (several mm apart)
presents itself as another significant problem. To address the challenge of non-rigidly
registering sparsely sectioned histology slides of brain resections from epilepsy surgery
to in-vivo 3D MRI, I propose a full image registration protocol that relies on ex-vivo
imaging of the specimen, to enable accurate correlation of histopathology with MRI.
This chapter focuses on the intermediate registration of histology images to ex-vivo
imaging of hippocampal and temporal lobe resections from anterior temporal lobec-
tomies (ATL). The remaining 3D registration from ex-vivo to in-vivo MRI is dealt with
in chapter 3 and involves a set of unique challenges related to the primary deformations
occurring during brain resection and variability of the resection boundary.
A previous method has been devised to manually match histopathology of temporal
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Figure 2.1: Example of encountered deformations. Red arrows represent cortical sulci
on the pre-operative MRI and blue arrows represent the corresponding sulci on the
resected neocortex specimen. a) Photograph of surgical view before resection, b)
Volume rendering of a pre-operative MRI of the patient with a zoomed view showing
the temporal pole, c) Coronal view of the pre-operative MRI demonstrating temporal
gyri with red arrows, d) Photograph of the temporal lobe neocortex post resection, e)
Surface rendering of the resected neocortex with blue arrows showing the
corresponding sulci to part b), and f) Coronal view of the ex-vivo MRI with blue
arrows indicating sulci corresponding to part c); the small window in the top left
corner demonstrates the mesial (interior) side of the neocortex with an intersection of
the shown MRI slice.
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lobe resections to MRI using a cutting cradle to resample the MRI to the orientation
of histology [3]. However no image registration was performed and only visual assess-
ment of the correspondence between the MRI and photographs of histology slices was
accomplished. Previous studies on registration of histopathology to in-vivo imaging
were reported mostly for rodents [4, 5, 6, 7, 2] and primates [8, 9, 1, 10]. Relatively
few studies report attempts to register human brain MRI to histology, with the major-
ity being performed on whole-brain or single-hemisphere postmortem data [11, 12, 13].
These landmark-based and image-based registration algorithms, however, are not likely
to be applicable to the registration of specimens from lobectomies to full preoperative
MR images, due to the drastic change in shape and coherence when the specimen is
separated from neighbouring tissue. Other methods have been proposed that allow
co-registration of histology to other modalities through the use of stereotactic systems
using target points [14, 5], however the design of these systems is tissue-specific and
is not broadly applicable to other brain resections. To the best of our knowledge, this
is the first instance where human brain surgery specimens were registered to histology
using an image-based algorithm in a clinical setting, with a target registration error
reported and validated.
Presently, there are no automated histology to MRI image registration protocols
that could be widely applicable to focal resections of human brain, such as tissue re-
sected during epilepsy surgery. I present here a protocol to register ex-vivo scans of
hippocampal and neocortical temporal lobe resections to histology as an intermedi-
ate step that reduces the complexity of the preoperative MRI to 2D sparse histology
problem. Specifically I describe a novel landmark-free algorithm for simultaneous re-
construction and alignment of sparsely sectioned histological data to ex-vivo MRI, and
a quantitative validation for our registration method. Performing this intermediate step
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addresses most of the challenges of registration to in-vivo imaging due to the higher
resolution and reduced deformations of the ex-vivo images. Furthermore, the higher
resolution of specimen imaging is advantageous for examining the correlation between
MRI and histology. The proposed method represents a significant step towards in-vivo
MRI to histology registration in the clinical setting and can be broadly applicable to
MRI and histopathology correlations of resections other than epilepsy surgery.
2.2 Methods & Materials
2.2.1 Recruitment, surgery & specimen acquisition
Seven patients suffering from intractable temporal lobe epilepsy (TLE) were recruited
as part of an ongoing study. This project has been cleared by the Health Sciences Re-
search Ethics Board of Western University, and informed consent was obtained from
all patients prior to their participation in the study. All such patients were recom-
mended for ATL surgery by the department of clinical neurological sciences at the
University Hospital (UH) of the London Health Sciences Centre, and had preopera-
tive investigations including neuropsychological testing and 1.5T clinical MRI scans
which included T1w, T2w, FLAIR, and diffusion-weighted sequences. Patients were
monitored with scalp-based electroencephalogram (EEG) video telemetry for seizure
characterization, with three patients having to undergo monitoring with subdural place-
ment of strip electrodes. In addition to the 1.5T clinical MRI scans performed at the
hospital, patients underwent a series of scans on 3T and 7T MRI research scanners,
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including high-resolution structural imaging, diffusion-tensor imaging, relaxation map-
ping and resting-state functional imaging prior to surgery. Following surgery, the re-
sected tissue specimens were transferred to the Robarts Research Institute for ex-vivo
specimen imaging on the same 3T scanner and then to the pathology technologist for
histological processing. From the seven patients, fourteen resected specimens were
collected (7 neocortex and 7 hippocampus), whereas all 7 neocortical specimens were
fully analyzed, only 5/7 hippocampal specimens were analyzed, due to a fragmented
hippocampus specimen and missed ex-vivo hippocampus scan. All the specimens used
in this chapter were en bloc resections, however the size of the neocortex specimens
were smaller if the resection was on the language-dominant side. The mean volume
of the hippocampal specimens was 4.30 ± 0.41 mL; and the mean volumes of the neo-
cortical specimens for language-dominant side resections and non-language-dominant
resections were 12.9 ± 1.78 mL and 23.2 ± 6.41 mL respectively. It should be noted
however, that different surgeons use slightly different techniques, which could account
for the variability in the volume of specimens. Table 2.1 summarizes the patients’ de-
mographic data, as well as, their clinical MRI and histopathological findings.
2.2.2 Specimen ex-vivo MR Imaging
After resection, each specimen was placed in a large petri dish within a specialized
sealed cooler for specimen transport, and orientation labels were marked on the con-
tainer by the operating neurosurgeon, with photographs taken for future reference. MR
imaging was carried out on the specimens in two sessions: immediately following sur-
gical resection, and after overnight fixation in 10% formalin. For the initial session, re-
ferred to as the pre-fixation session, the specimens were immediately transferred from
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Subj. Sex Age Onset
age
Seizure
origin
MRI Path. Scan
Pro-
tocol
1 F 51 10 Right Normal dysplasia I
2 F 22 15 Right Normal mild MTS I
3 F 52 12 Left Non-specific mild FCD I
4? F 26 20 Right Tuberous
Sclerosis
Cortical
tubers
II
5 F 22 15 Right R. MTS MTS II
6 M 20 3 Left L. MTS MTS II
7? M 19 5 Right Normal Gliosis II
Table 2.1: Summary of demographics and clinical data, including MRI and
histopathological findings, for the seven recruited patients in the study. Registration
was performed on both hippocampus and neocortex specimens for all patients. In two
cases (denoted by ?) registration was only performed on the neocortex due to a missed
scan and a fragmented hippocampus specimen. MTS: Mesial Temporal Sclerosis.
FCD : focal cortical dysplasia.
the operating room to the scanning suite at the Robarts Research Institute and pre-
pared for imaging. Each specimen was wrapped in gauze for stabilization, transferred
to suitably-sized containers for imaging, and immersed in a fluorine-based lubricant
‘Christo-lube MCG 1046’ (Lubrication Technology, Inc) prior to imaging to avoid sus-
ceptibility artifacts at the tissue boundaries. Identical preparation was performed for
the second post-fixation session.
Specimen imaging was performed on a 3T Discovery MR750 scanner (GE Medical
Systems, Milwaukee, WI, U.S.A.). Initially, an in-house developed gradient-insert coil
was employed in the scanning setup with each specimen imaged sequentially using dif-
ferent coils. For improved time-efficiency in scanning and setup, the gradient-insert coil
was not employed in later studies, and both specimens were imaged in the same field of
view. Post-fixation T2-weighted scans were used in the subsequent image processing
and registration. Both scanning protocols are described in detail below:
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Scan Protocol I
The first protocol utilized a gradient-insert with a 4 channel TORO coil for the neo-
cortex and a solenoid coil for the hippocampus, with specimens scanned sequentially.
T2-weighted images with a multi-phase balanced SSFP FIESTA sequence with 4 cycled
phases were acquired for the neocortex (TR=3.5ms, TE=1.75ms, flip angle=40◦, N=4,
matrix=200×200, slice thickness=0.3, FOV=60mm) and the hippocampus (TR=3.97ms,
TE=1.98ms, flip angle=40◦, N=4, matrix=200×200, slice thickness=0.3, FOV=60mm).
Scan Protocol II
For the second protocol, a 6 channel coil, designed to image the carotid artery, was used
instead of the gradient-insert coil of the previous configuration. Similar T2-weighted
fast imaging employing steady state acquisition (FIESTA) images (TR=8.17ms, TE=4.08ms,
flip angle=40◦, N=2, matrix=200 × 200, slice thickness=0.4, FOV=70mm) with a res-
olution of 0.35 × 0.35 × 0.4mm, as well as, Fast gradient echo (fastGRE) scans with
sixteen echoes (TR=65.0ms, TE=38.9ms, flip angle=40◦, matrix=200×200, slice thick-
ness=0.4, FOV=70 mm) were acquired for the study for a total scan time of less than
two hours. A switch was made to the second protocol due to the significant time sav-
ings achieved during the setup and gradient shimming processes (from ∼45 min to ∼65
min) with minimal loss of image resolution. Note that similar SSFP FIESTA sequences
were used in both protocols to provide the images used in registration.
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2.2.3 Histological processing
Following pre-fixation and post-fixation MRI imaging, the specimens underwent ac-
cessioning and grossing at the Department of Pathology at the University Hospital of
London Health Sciences Centre, and were then cut into two halves midway, anterior-
posterior, through the specimen in the coronal plane. Each half of the specimen was
then embedded in agar for a stabilization effect during slicing. The half-specimens were
then sectioned parallel to the initial cut, into 4.4 mm pieces in the anterior to posterior
direction using a deli slicer (Globe Food Equipment Company, Dayton, OH, U.S.A).
Each block was embedded in paraffin and mounted on a microtome where 8 µ m thick
sections were cut from the face of each block and mounted on slides. The constraint of
cutting only one section from each block stems from two limitations. The first being
the requirement set forth by the committee governing tissue use, which requires the re-
maining part of the blocks be reserved in their tissue archive in case further analysis is
needed. The second factor is the significantly increased cost associated with acquiring
serial sections of all our blocks for both types of specimens, which would restrict the
number of subjects we could recruit for this ongoing study.
One slide from each block was stained with hematoxylin and eosin (H&E) accord-
ing to standard clinical neuropathology protocols, and additional stains or immuno-
histochemistry (IHC), mainly glial fibrillary acidic protein (GFAP) (polyclonal anti-
body) and neuronal nuclei (NeuN) (monoclonal antibody), as well as neurofilament
(NF), luxol fast blue (LFB) and cluster of differentiation antibody (CD34) were or-
dered when deemed necessary by the neuropathologist on duty. Batch IHC processing
was performed on a Dako Autostainer Link 48 (Dako Corporation, Glostrup, Denmark)
to minimize variability between slides.The median number of hippocampus (Hp) and
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neocortex (Neo) blocks was 8 and 12 respectively. For the hippocampus, on average
about a quarter of the blocks were additionally stained with GFAP. As for the neocortex,
about half of the blocks were additionally stained with a combination of the previously
mentioned stains and immunohistochemistry; while GFAP and NeuN being the two
most common additional stains. The ex-vivo subvolumes, the numbers of histological
blocks and sections, as well as NeuN and GFAP sections, are summarized in table 2.2.
The average physical size of the hippocampal histological sections (slide area (mm2ˆ))
was 96.5 ± 60.9, and 281.0 ± 168.9 for neocortical sections.
The resulting slides were digitized on a ScanScope GL (Aperio Technologies, Vista,
CA, USA) bright field slide scanning system at a maximum of 20x optical zoom, and
stitched to form full-frame multi-resolution images stored in BigTIFF file format (max-
imum pixel resolution 0.5µm).The full resolution BigTIFF histology images were re-
tained for future quantitative analysis. Since each specimen was sectioned into blocks
of 4.4mm thickness, the corresponding H&E stained images have a physical spacing
of effectively 4.4mm in the coronal (anterior-posterior) direction. Figure 2.2 shows an
overview of all these histological processing steps.
2.2.4 Image registration
To motivate our registration approach we first describe how the numerous physical pro-
cessing steps between ex-vivo MR imaging and slide digitization affect the specimen,
and how these steps could be accounted for with registration. As outlined in the previ-
ous section, after imaging, the tissue specimen is sectioned coronally, but this slicing
plane is not enforced to be along the orthogonal axes corresponding to the MRI co-
ordinate system. We therefore need to obtain a transformation between the MRI axes
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Figure 2.2: Overview of histological processing from specimen generation to
digitization. Processed performed at in a standard clinical work flow at the hospital are
included in dashed boxes.
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Subject Hp volume
(mm2)
Hp
blocks
Hp sections Neo volume
(mm2)
Neo
blocks
Neo sections
1 4808.4 9 18 (9 GFAP) 21331.0 16 20 (4 GFAP)
2 4140.3 9 11 (2 GFAP) 20363.1 10 14 (2 NeuN,
2 GFAP)
3* 3896.1 10 10 (No IHC) 14087.3 16 20 (1 NeuN,
1 GFAP)
4 - - - 32669.3 14 37 (13
NeuN, 3
GFAP)
5 3992.4 6 6 (No IHC) 18472.0 12 21 (3 NeuN,
3 GFAP)
6* 4677.0 7 8 (1 GFAP) 13830.8 12 15 (2 NeuN)
7* - - - 10885.8 9 15 (3 NeuN,
2 GFAP)
Table 2.2: Summary of ex-vivo subvolumes, the numbers of histological blocks and
sections, as well as NeuN and GFAP sections.
and tissue slicing axes. Next, when the specimen is mounted on the microtome, there
may be variability in the angle at which sections are taken and in the number of partial
sections removed before a full section is retained. This effectively leads to variability in
the angle and spacing between sections. For similar procedures carried out on prostate
specimens, Gibson et al. [15] quantified the variability to be 1.7 ± 1.1◦ and 1.0 ± 0.5
mm in angle and spacing respectively. Because of the relatively small magnitude of
variability, which presumably would be similar for brain sections, as well as the ease
of working with parallel sections, we do not explicitly account for this and and instead
assume sections are parallel and spaced by 4.4mm. The tissue being sectioned in the
microtome is highly folded after the blade is brought down, thus to mount the section
on a slide, it is first placed in a water bath to unfold, then eased onto the glass slide.
This procedure can introduce folds or tears in the mounted section, and placement on
the slide is variable. Histological processing and staining of the section can introduce
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further distortions, such as differential shrinkage or expansion of tissue. Since all these
deformations are present in the thin (8µm) section of tissue mounted on the slide, these
can be modelled as transformations and warps constrained to the 2D plane.
In summary, we require a registration approach that can model: 1) the transformation
between the 3D MRI axes to the specimen slicing axes (3D rigid transformation), and
2) the transformations and deformations of each slide-mounted section constrained to
the 2D space of the slide (2D rigid transformations and non-rigid deformations).
2.2.5 Iterative registration algorithm
In this section we outline our iterative registration approach to attain the transforma-
tions and deformations and to establish correspondence between the MRI and histology
images. Note that the registration procedures for hippocampus and neocortex images
were carried out separately in each case. Preliminary results for neocortex registration
were shown in Goubran et al. [16].
If a 3D reconstruction of the histology were given, 3D rigid image registration could
be used to align the MRI to the histology. However, to generate a 3D reconstruction
of the histology, the individual histology slices would need to be corrected, using the
registered MRI as a reference. Thus we see that obtaining the 3D rigid transformation
is dependent on having a 3D histology reconstruction, and this is in turn dependent on
the 2D histology registration with the MRI for a reference. To resolve this circularity,
we propose an iterative registration scheme that alternates between 1) finding the 3D
rigid transformations given the current histology reconstruction, and 2) finding the 2D
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rigid transformations and non-rigid deformations to reconstruct the histology volume
given the current 3D rigid transformations.
Figure 2.3 presents a block diagram overview of our overall registration algorithm.
First, the histology and MRI images are pre-processed separately to obtain image pairs
of the same resolution and field of view suitable for image registration. Then the images
are fed into an iterative registration algorithm that alternates between registration of the
MRI volume to the current estimate of the histology volume (3D Rigid Registration),
and registration of the histology slides to the reference MRI slides for histology volume
reconstruction (2D Rigid Registration and 2D Non-rigid Registration). The details of
this registration are shown in Algorithm 1.
MR image pre-processing
Prior to image registration, the images underwent a series of pre-processing steps, car-
ried out with command-line tools from the FSL image analysis suite (FSL, http:
//fsl.fmrib.ox.ac.uk) and scripts written in MATLAB (The MathWorks Inc., Nat-
ick, MA, USA). First, ex-vivo MRI images scanned with Scan Setup II, containing both
neocortex and hippocampus specimens in the same field of view, were converted from
the scanner output Dicom (dcm) format to the standard Nifti (nii) format, then bisected
to produce separate volumes. Since the orientation of these specimens in the scanner
bore did not correspond to the anatomical orientation, the orientation matrices of the
images volumes were updated to reflect the correct pose. This operation was performed
using photographs of the annotated specimens and 3D models of ex-vivo images, and
the resulting orientation matrices were applied to all the acquired images in the session.
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Input: Histology and MRI volumes: H0 = {H j} j=1...N , M
Output: Final volume and transformations: Himax , T imax3D , T
imax
2D, j=1...N ,Φ
imax
2D, j=1...N
for i = 0 to imax do
// 3D rigid registration between histology and MRI volume:
T i3D = RigidReg3D
(
Hi,M
)
// Transformed MRI volume:
MT i = T i3D ◦M
// For each histology slice:
for j = 1 to N do
// 2D rigid registration between histology and MRI
slice:
T i2D, j = RigidReg2D
(
MT
i
j ,H
i
j
)
if i > 2 then
// 2D non-rigid registration between histology and
MRI slice:
Φi2D, j = NonRigidReg2D
(
MT
i
j ,T
i
2D, j ◦ Hij
)
;
else
Φi2D, j = Id;
end
// Deformed histology slice
Hi+1j = Φ
i
2D, j ◦ T i2D, j ◦ Hij;
end
// Updated histology volume
Hi+1 = {Hi+1j } j=1...N ;
end
Algorithm 1: Iterative 3D and 2D registration of input histology volume H0 =
{H j} j=1...N and MRI volume M. Here, we represent image volumes in boldface (H)
and the corresponding slices with subscripts (H j). In the first part of each iteration,
3D registration is carried out on the current estimate of the histology volume and
the MRI volume to obtain the transformation between the MRI axes to the specimen
slicing axes. In the second part, 2D registration is carried out to obtain the transfor-
mations and deformations of each slide-mounted histology section using the current
estimate of the aligned reference MRI.
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Figure 2.3: Registration pipeline showing pre-processing steps of the data and our
iterative 2D-3D approach. The left column demonstrates the pre-processing steps
applied to the histology slides sequentially from top to bottom. Likewise, the right
column represents the pre-processing steps applied to the MRI of the specimens. The
resulting histology stack acts as a fixed image to transform the MR image in a 3D rigid
registration. The transformed image as well as the stack are split into slices 4.4 mm
apart where each histology slice has a corresponding MRI slice. These MR slices act
as fixed images to deform the histology slices rigidly then non-rigidly. The resulting
deformed histology slices are stacked and fed back into the 3D rigid registration for
the next iteration.
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The images were then background masked using a percentile threshold, resampled to
0.2 mm isotropic resolution, and cropped around the perimeter of the specimen.
Histology image pre-processing
The digitized histology images were similarly reoriented into a standard orientation,
with the origin in the top-left image corner corresponding to superior-right in anatom-
ical orientation, using the Aperio ImageScope software and the corresponding MRI as
a reference. The images were then down-sampled to 200 µm in-plane resolution and
converted into NIFTI format, where each RGB channel was represented as a slice in
a 3D volume, to match the resolution of the acquired ex-vivo MRI. We converted the
images to grayscale by extracting the green channel, since this channel was found to
possess the best gray/white matter contrast in the H&E stained slides. Finally, the im-
ages were background masked and centered in a standard 60mm field of view using the
image-based center-of-mass in each slide.
Rigid registration
Rigid registration in our iterative scheme was carried out with the flirt tool from [17]
(FSL, http://fsl.fmrib.ox.ac.uk/flirt) to perform the 3D and 2D registration.
The default multi-modal cost function (correlation ratio) was applied and the regis-
tration was constrained to a rigid transform model with 6 and 3 degrees of freedom
respectively for the 3D and 2D steps. The default correlation ratio cost function was
found to produce accurate results, and the use of normalized mutual information (NMI)
in the rigid registration was found to produce comparable results.
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Non-rigid registration
A deformable registration between corresponding histology and MRI slices was em-
ployed to account for any anisotropic tissue deformations that can occur during histo-
logical processing, sectioning, and staining. We used a fast non-rigid registration that
makes use of a B-spline deformation field and a normalized mutual information cost-
function [18, 19] (NiftyReg,http://sourceforge.net/projects/niftyreg/).
The B-spline image registration used a three-level multi-resolution image pyramid
with final control point spacing of 2 mm. This control point spacing was chosen after a
number of different control point spacings (0.1 , 0.5 ,1 , 2, 4, 6mm) were qualitatively
evaluated on representative sections on multiple specimens and the 2mm spacing was
found to perform best, as it is small enough to account for local deformations encoun-
tered and large enough to avoid noise and provide a smooth deformation. Non-rigid
registration was carried out starting at iteration 3 of the algorithm and not having been
employed in the first two iterations to ensure the sufficient convergence of the rigid reg-
istration step. Furthermore, for slices where foreground of the MRI image or histology
image were below a specified threshold, non-rigid registration was not performed and
a zero deformation was assumed for the slice. The deformation penalty term (bending
energy of the spline at a control point), was successively relaxed after each iteration to
allow for greater deformations as the alignment is improved over each iteration. Specif-
ically the sequence of bending energies employed at the iterative registration steps were
{0.5,0.025,0.01}, for iterations 3-5.
Due to histology tissue breakage and loss, a final registration step was added where
binary ‘ignore’ masks defined on the registered histology slices were included in the de-
formable registration scheme. These ignore masks were manually-defined in 3D Slicer
2.2. Methods & Materials 69
(http://www.slicer.org) using a large 2 mm radius paintbrush on regions of the
MRI image where tissue loss is readily apparent in corresponding regions of the histol-
ogy image, preventing these regions from contributing to the registration, which would
result in incorrect deformations since one-to-one tissue correspondence is unattainable.
The average percentage of sections requiring registration masks was 75% and 82.5%
for the neocortex and hippocampus respectively. An example of a registration mask for
a hippocampal section is shown on Figure 2.8-e.
Coregistration of additional staining
As noted previously additional IHC staining was performed on a subset of blocks for
clinical diagnostic purposes. To make use of these IHC stained images in future quan-
titative analysis, a supplementary registration step was carried out in order to register
the sections with additional IHC to the sections with H&E stains. This registration step
must be performed for these additional stains or IHC since additional sections were
cut, placed on slides, and processed for each stain. We performed 2D affine registration
between the H&E and the each IHC stained image with the flirt tool [17] on histology
images downsampled to 200 µm resolution and converted to grayscale. We performed
this registration for NeuN and GFAP IHC since these were the most common and rel-
evant in diagnosis or quantification of neuronal loss, cytoarchitectural abnormalities,
and gliosis.
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2.2.6 Registration validation
Landmark-based validation
To validate our registration protocol, we computed target registration error (TRE) based
on manually-identified corresponding intrinsic landmarks on MR images and histology
slices. These landmarks were used as independent targets to assess the accuracy of
the registration at each iteration of the iterative registration scheme, as well as after
deformable warping of the images. We found that micro-vasculature or micro-bleeds
that were visible on the H&E histology slides appeared as dark hypo-intense regions in
the ex-vivo T2-weighted MRI, as demonstrated in Figure 2.4. First, one rater identified
landmarks on histology slides (downsampled to 10µm per pixel), restricting selection
to vasculature with a transverse diameter of more than 35 pixels wide, assuming an
ellipsoid shape.
Figure 2.4: Example of the chosen intrinsic landmarks on histology and their localized
corresponding landmark on a neocortical ex-vivo MRI specimen. The arrows in blue
pinpoint the micro vasculature used as targets for the TLE calculations on both
histology and MRI. A zoomed in window demonstrates the targets on both modalities
with cross hairs indicating the target coordinates on MRI and a circle showing the
chosen coordinates on histology.
The most anterior and posterior histology slices in many cases of both specimens
did not contain sufficient intact tissue for reliable placement of anatomical landmarks.
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The landmarks were 20 per neocortical specimen and 12 per hippocampal specimen
on average. Figure 2.5 demonstrates the distribution of landmarks within a neocortical
specimen. Three raters then independently searched through the ex-vivo MRI to locate
corresponding landmarks in the MRI images representing the centroid of these micro-
vasculature or micro-bleeds. Since tissue contrast varies throughout the specimen, other
MR scans of the specimen were used to facilitate the localization process. To compute
the TRE the coordinates for all three raters were averaged to generate a consensus set
of MRI landmarks. A total of 215 pairs of corresponding landmarks were identified
for the TRE calculations in the twelve specimens. Note that, to ensure consistent land-
mark locations, only a single set of the histology landmarks was used. For the separate
registration between the original H&E stain and the additional IHC (NeuN, GFAP), the
target registration error of the 2D affine registration was evaluated for 2 subject neocor-
tical specimens, in a total of 5 blocks, placing a total of 40 pairs of intrinsic landmarks.
These histology intrinsic landmarks consisted of micro-vasculature or micro-bleeds vis-
ible on the different types of stains and IHC, resembling the histology landmarks used
to validate our MRI to histology registration. The 2D euclidean distance was measured
between these corresponding landmarks to compute the TRE.
Localization error and statistical analysis
Target localization incorporates human error in localizing the coordinates which com-
bines with the image registration error to produce the TRE measurements. The target
localization error (TLE) was calculated on ex-vivo MRI images as an unbiased estima-
tor of the standard deviation of repeated localizations of the same landmark by the same
rater [20], described by the equation below:
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Figure 2.5: 3D visualization revealing the wide spatial distribution of validation
landmarks (blue spheres) within an exemplar neocortical specimen in sagittal and
coronal views.
T LE =
√√
1
J
J∑
j=1
1
K − 1
K∑
K=1
||P j,k − 1K
K∑
k=1
P j,k||2
where P j,k is the k−th localization of the j−th landmark. A total of five localization
(K = 5) of twenty landmarks (J = 20) was performed.
Inter-rater variability was measured as an estimator of the standard of deviation of
repeated localization of the same landmarks by different raters, where a hundred and
twenty eight landmarks (J = 128) were placed by three different raters (K = 3). Sta-
tistical analyses were performed in Prism 5.04 (GraphPad Software, San Diego, CA).
To assess for significant differences between the several iterations of the algorithm and
across rigid and non-rigid steps , we computed a repeated-measures analysis of vari-
ance (ANOVA) of the mean TRE value of each of these steps followed by Bonferroni
multiple-comparison correction. A Bartlett’s test for equal variances was conducted
between all iterations (rigid and non-rigid) of the algorithm to verify the equal variance
assumption of the ANOVA tests.
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2.3 Results
The proposed methodology required ∼ 85 min (including setup) for ex-vivo imaging
and < 10 min for execution of both the rigid and non rigid components of the algorithm
(excluding the manual re-orientation step in the pre-processing scheme and the time for
definition of ignore masks). Evaluation of the protocol was performed by localization
of micro vasculature landmarks seen on both modalities by three raters. The localiza-
tion protocol yielded 2-4 homologous landmarks on each of 8-12 sections per neocortex
specimen and 1-3 landmarks on each of 6-8 sections per hippocampus specimen. Our
registration protocol produced a mean target registration error of 0.76 ± 0.66 for hip-
pocampal specimens, as shown in table 2.3, and 0.98 ± 0.60 for neocortical specimens.
The mean TRE was below 1.2 mm after the last step of the registration algorithm in
all cases including both specimens. The mean landmark localization error for the three
raters was 0.21 mm, relative to an MRI voxel size of 0.35×0.35×0.4 mm, while the
inter-rater reliability between the raters was 0.33 mm. Figure 2.6 shows the registration
errors across all steps of the algorithm including both rigid and non-rigid components
for both specimens. The errors are shown first along iterations 1, 3 and 5 of the rigid
component then the non-rigid steps beginning with a step using a high bending energy
regularization penalty; then a low penalty weight and finally deformable registration
utilizing ignore masks, that account for tissue breakage and differential shrinkage. The
mean error of the rigid iterations reaches a plateau around iteration 5 for both spec-
imens. The masked imaged based step outperformed the non-masked registration as
expected by avoiding tissue breakage. For the supplemental 2D affine registration be-
tween sections with the original H&E stain and sections with the additional IHC (NeuN,
GFAP), the target registration error was 0.46 ± 0.31 and 0.41 ± 0.23 for NeuN and
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GFAP respectively. This validation demonstrates our ability to accurately align, and
potentially correlate, MRI with additional stains and immunohistochemistry.
Figure 2.7 shows three neocortical slices with their corresponding MRI slices, that
represent the locations where the histology cuts were made with respect to the MRI
scans of the resections, as well as the transformations of the slices after deformable
registration. A picture of the resected specimen along with a volume rendering demon-
strating the location of these histology slices in respect to the whole specimen are also
shown in the figure. Checkerboard images of both rigid and non-rigid registration for a
hippocampal slice are displayed in figure 2.8, which also shows a rendered representa-
tion of both sides of the hippocampus where the histology slice was cut.
The Bartlett’s test confirmed the validity of the equal variance assumption for the
ANOVA analyses of both specimens (P > 0.05). The significant results of the ANOVA
analysis are shown in the ‘Mean’ row of tables 2.3 and 2.4. The ANOVA analysis,
between the first deformable registration step (High Bending Energy) and the last rigid
step (Iteration 5), failed to show a statistically significant difference of the mean TREs
for both the hippocampus (P > 0.05 , 95 % Confidence Interval [CI] of difference -
0.2666 to 1.653 ) and neocortex (P > 0.05 , 95 % CI -0.0147 to 1.54 ). However, this
test did demonstrate a significant decrease in TRE between (High Bending Energy)
and the first rigid iteration (Iteration 1) for the hippocampus and neocortex respectively
(P ≤ 0.01 , 95 % CI 0.143 to 1.69 and P ≤ 0.05, 95 % CI -0.2040 to 1.715). In compar-
ison, decreasing the bending energy weight penalty produced significantly lower mean
TRE than the final rigid iteration step (Iteration 5) for the hippocampus and neocortex
respectively (P ≤ 0.001 , 95 % CI 0.449 to 2.00 and P ≤ 0.01, 95 % CI 0.3516 to
2.271). The proposed masked non-rigid scheme (Masked NR) had as well significantly
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lower TRE (P ≤ 0.0001) than Iteration5 for both the hippocampus (95 % CI 0.590 to
2.14 mm) and neocortex (95 % CI 0.5143 - 2.434).
It.1 It.3 It.5 H.B.E L.B.E Masked
N.R
Subj
1
2.07±0.96 2.05±0.97 2.05±0.98 1.35±0.85 0.88±0.67 0.73±0.85
Subj
2
2.81±0.54 2.87±0.63 2.74±0.80 2.52±0.94 1.42±0.94 1.03±0.94
Subj
3
2.13±1.78 2.12±1.74 2.09±1.73 1.30±0.78 0.73±0.42 0.62±0.40
Subj
4
2.19±1.02 2.09±1.02 2.07±1.21 1.01±0.54 0.68±0.37 0.68±0.42
Subj
5
2.05±0.84 1.86±0.85 1.78±0.95 1.15±0.68 0.75±0.43 0.72±0.45
Mean 2.25±1.10 2.18±1.11 2.15±1.14 1.46 ±
0.77†
0.89 ±
0.61‡
0.76 ±
0.66‡
Table 2.3: TRE values for hippocampal registration across iterations. H.B.E:
Non-rigid with a High Bending Energy penalty, L.B.E: Non-rigid with a Low Bending
Energy penalty. † : P ≤ 0.01 between means registration step and Rigid Iteration 1. ‡ :
P ≤ 0.01 between means of registration step and Rigid Iteration 5.
2.4 Discussion
In this article, we have described a method to reliably register ex-vivo MRI and sparsely
sliced histology slides of neocortex and hippocampus specimens. Our protocol is a
landmark free algorithm that produced sub-millimeter accuracy for hippocampal regis-
tration and close to 1-mm of error for temporal lobe neocortical registration. Correlat-
ing MRI with histopathology is imperative in the validation of new imaging sequences,
since verification of pathological anomalies underlying signal changes is needed to
enable these sequences to ultimately gain clinical acceptance. The intrinsic higher res-
olution of ex-vivo MR images provides a superior opportunity to further examine the
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It.1 It.3 It.5 H.B.E L.B.E Masked
N.R
Subj
1
2.97±0.86 2.98±0.86 2.96±0.87 1.55±1.21 1.26±0.66 1.08±0.52
Subj
2
2.36±0.83 1.92±0.84 1.91±0.94 1.69±1.17 0.83±0.85 0.72±0.68
Subj
3
2.23±1.40 2.08±1.37 2.07±1.37 1.15±1.15 0.98±0.99 0.83±0.70
Subj
4
2.41±1.61 2.40±1.76 2.38±1.89 2.17±0.88 1.17±0.68 1.05±0.65
Subj
5
2.19±1.02 2.08±1.02 2.06±1.01 1.01±0.43 1.02±0.45 0.87±0.38
Subj
6
2.23±1.63 2.24±1.65 2.25±1.65 2.06±0.61 1.35±0.57 1.12±0.52
Subj
7
2.16±1.41 2.14±1.44 2.11±1.44 1.42±0.55 1.15±0.49 1.15±0.35
Mean 2.37±1.19 2.26±1.22 2.25±1.28 1.60 ±
1.01†
1.11 ±
0.75‡
0.98 ±
0.60‡
Table 2.4: TRE values for neocortical registration across iterations.H.BE: Non-rigid
with a High Bending Energy penalty,L. B.E: Non-rigid with a Low Bending Energy
penalty. † : P ≤ 0.01 between means registration step and Rigid Iteration 1. ‡ :
P ≤ 0.01 between means of registration step and Rigid Iteration 5.
Figure 2.6: Boxplots with 5-95% whiskers of Hippocampal and Neocortical
registration target registration errors at each stage of the iterative registration scheme.
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Figure 2.7: Example of a neocortex rigid and deformable registration showing: a)
photograph of a neocortical specimen after resected with orientation labels placed by
the operating surgeon, b) volume rendering of the MRI of the specimen showing the
location of three consecutive histology slices. c) rendering of both sides of the
specimen where the middle slice of histology was cut, d) the three histology slices
shown in b), e) the corresponding MRI slices after 3D rigid registration, and f) the
deformed histology slices after non-rigid registration to their corresponding MRI
slices.
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Figure 2.8: Example of a hippocampal rigid and deformable registration showing: a)
photograph of a hippocampus before grossing, b) volume rendering of the MRI of the
hippocampus demonstrating the location of a histology slice through the specimen, c)
rendering of both sides of the hippocampus where the histology slice was cut, and d)
three orthogonal views of the hippocampal MRI (left to right: coronal, sagittal, axial).
The bottom row depicts: e) a coronal view of the same histological slice with a
registration mask over a breakage region shown in blue, f) a checkerboard image
showing the MRI and histology before non-rigid registration, and g) a checkerboard
image showing the MRI and non-rigidly deformed histology slice.
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correlation between MRI and histology. By addressing many challenges of the in-vivo
MRI to histology registration, our protocol leaves single modality registration between
specimen and preoperative MRI scans as the remaining step. In addition, ex-vivo to
MRI registration can be used to validate specimen imaging, as it has been shown by
Madabhushi et al. [21] in prostate ex-vivo imaging examples. While using an inter-
mediate ex-vivo registration interrupts the clinical flow for specimen imaging, our al-
gorithm requires ∼9 min ±37 seconds on average (for the automated iterative 3D/2D
rigid approach plus the non-rigid steps) to register 100 µm coronally sliced (anterior to
posterior) histology slices to ex-vivo MRI images.
The vast majority of previous attempts at registering MRI and histology using a
combination of 2D and 3D transformations, or alternating between 2D and 3D registra-
tion, were performed with a reconstructed 3D histology volume from serially sectioned
brain specimens at < 700µm [22, 5, 1, 7, 23]. This technique, while producing accurate
results, is not compatible with the clinical work flow of pathology departments, where
the tissue is sparsely sectioned at a thickness of more than a few mm. Previous regis-
tration work flow with sparsely sectioned histology focused on non-brain tissue such
as the prostate [24, 25]. Brain tissue has different mechanical characteristics than other
tissue in the body, and is more susceptible to deformation as compared to non-brain
tissue, such as the prostate. These characteristics cause the brain to deform signif-
icantly during surgery and histological processing, increasing the complexity of the
registration and the need for deformable registration. For example, it has been shown
that sub-millimeter accuracy for registering ex-vivo prostate MRI with histology could
be achieved using only affine transformations [24]. This finding is very unlikely to
be reproduced in brain tissue. In addition, sparsely sectioned brain tissue shows high
anatomical variability between consecutive histology slices which may not be true for
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other tissue due to the tissue overall shape. This difference in anatomy adds another
layer to the complexity of the histology reconstruction and in turn the registration as a
whole.
To achieve correlation of MRI and histology at a voxel-wise level, where the highest
resolution of the pre-operative MRI is 1-mm isotropic, the registration error would
ideally be less than 1mm. This required registration accuracy depends on the physical
scale of the pathology being correlated, and in turn the scale at which the image analysis
is being performed. However, detection of pathology at single voxels is impractical and
thus voxel-based analysis techniques typically involve the use of a smoothing kernel to
improve signal-to-noise and be reduce sensitivity to registration error. Recent studies
of voxel-based analysis in temporal lobe epilepsy have used smoothing kernels from
4-8 mm (FWHM) [26, 27], thus the overall pre-operative MRI to histology error should
be in this range.
The measurement of TRE requires the identification of homologous landmarks on
images of both modalities used for registration and is frequently lacking in analyses
of these methods. A few articles have quantified and reported TRE in brain histology
to MRI. Jacobs et al. [4] reported a registration residual root-mean square (RMS) er-
ror of 0.83 mm between histological sections and MRI of ischemic rats and Humm
et al. [5] obtained a 0.25 mm registration error for tumor xenografts of one mice us-
ing stereotactic fiduciary markers. Both studies could not be extrapolated or compared
to human cases due to the methodological differences between these protocols and re-
sected human specimens, as well as the mechanical differences between excised human
and whole primate brain. Singh et al. [13] reported a 5.1 mm TRE computed as 3D co-
ordinates of centroid of marked lesions in both modalities, which exceeds the desired
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error range for correlation between histopathology and MRI in focal epilepsy as under-
lying pathologies may be found on the scale of millimeters. Our method produced a
mean TRE of 0.76 ± 0.66 and 0.98 ± 0.60 for hippocampal and neocortical specimens
respectively, which is sufficient for exploring underlying pathologies of focal epilepsy.
For a very small FCD with a volume of 128mm3 [28], the mean TRE obtained from our
algorithm is able to achieve a 70% overlap of the FCD, assuming it is a sphere. Our
mean TLE of 0.21 mm is indicative that the localization variability is not dominating
in the TRE measurements. The significantly lower mean TRE for the latter deformable
registration found by our ANOVA analysis motivates the use of the hierarchal bending
energies as well as the incorporation of ignore masks. It should be noted however that
the variability in orientation and depth of the actual section relative to the block face in
section is not specifically accounted for in our registration procedure and thus would
contribute in part to our target registration error.
A previous method proposed visual comparison of photographs of temporal lobe
neocortex tissue slices to MRI, and reported a < 2 mm difference between two ob-
servers in most cases [3]. This manual matching technique suffers from a major lim-
itation that is the lack of image registration between the histology and MRI, which in
turn dictates the use of region of interest (ROI) based analysis in further studies of cor-
relation [26, 29, 27]. This operator-based method incorporates human bias in locating
the corresponding slice of MRI, which explains the 4-mm difference between raters in
their last case. Only two ROIs in temporal lobe neocortical specimen were assessed in
Lockwood-Estrin’s and Eriksson’s work to analyze histopathology to MRI correlation.
In one instance a negative correlation was seen between grey matter T2 values of fast
Flair (fFT2) and NeuN field fraction [26], and another no correlation was found be-
tween normalized FLAIR signal intensity (nFSI) and NeuN field fraction within these
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ROIs [27]. While the differences between fFT2 and nFSI may not necessarily explain
this discrepancy, averaging across the whole area of the ROI may mask signal changes
of pathologies smaller than the size of the ROI. Moreover, unlike our protocol, Eriksson
et al. [3] focused on matching temporal lobe neocortical specimen and no hippocampal
correspondence was performed. Registration of the hippocampus is very challenging
due to the smaller size of the resection and the higher susceptibility of the tissue to de-
form and the histology slices to break apart. Furthermore, performing an image-based
registration allows exploratory hypothesis-free analysis at a voxel-wise level and does
not require ROI definition, which may be more sensitive to subtle pathologies. Our
protocol will be complemented with 3D in-vivo to ex-vivo MR registration in order
to explore the correlations between MRI and histology at greater depth, and provide
histopathological validation of multi-modal MRI analysis techniques.
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Chapter 3
Registration of Ex-vivo to In-vivo MRI
3.1 Introduction
MRI to histology registration is far from trivial due to the significant deformations un-
dergone by the brain tissue during surgery, handling, and histological processing. As
mentioned in chapter 2, these deformations can be split into two main categories, those
occurring during surgical resection and those during histological processing [1]. Those
due to surgical resection, are three dimensional mechanical deformations that take place
once brain tissue is resected, due to its tendency to deform when separated from neigh-
bouring tissue. The histological processing deformations are three dimensional, occur-
ring during sectioning or due to non uniform shrinkage induced by formalin fixation,
as well as two dimensional (within-slice) distortions due to stretching of microtome
This chapter is adapted from Goubran et al. “Registration of pre-operative to it ex-vivo MRI of
resected specimens: a pipeline for histology to pre-op registration.” Journal of neuroscience methods.
Under-review
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cut sections on a water bath, spreading histology slices over glass slides and staining.
The deformations induced during histological processing can be isolated from those
from surgery and handling by employing an intermediary MRI image of the specimen
or using blockface images for histological reconstruction, splitting the in-vivo MRI to
histology registration procedure into two distinct problems (in-vivo to reference and
reference to histology). As described in chapter 2, which focused on registering ex-
vivo MRI to sparsely sectioned histology hippocampal and neocortical temporal lobe
specimens, the intermediate ex-vivo MRI or blockface stack can function as an anatom-
ical reference with which the 2D histological slices can be corrected against [2]. In
this chapter, however, I focus on the first problem of registering the in-vivo MRI to
the intermediate ex-vivo MRI, and completing a pipeline for histology to in-vivo MRI
registration in temporal lobe epilepsy.
There have been many attempts in the literature to register in-vivo MR images of
many organs, such as the prostate [3, 4], to histology slices. Extrapolating these reg-
istration techniques to the brain may not be practical since the brain has very differ-
ent biomechanical properties than other organs and is prone to deformation. More-
over, algorithms optimized for registering other resected organs generally do not deal
with part-to-whole registration, and thus may not be applicable in our problem. In the
past two decades, there have also been many studies specifically dealing with in-vivo
brain MRI to post-mortem histology. The majority of these studies focused on primates
[5, 6, 1, 7, 8] or rodents [9, 10, 11, 12, 13, 14]. The few studies that registered human
brain MRI to histology were performed on whole-brain [15, 16, 17], or single hemi-
sphere [18, 19] postmortem serially sectioned data. Amunts et al. [20] created a 3D
model of single subject’s brain using post-mortem histological sections reconstructed
at 20 µm isotropic resolution and registered it to a T1 average atlas created from 24
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subjects. [21] reported registering histology of neocortical specimens from anterior
temporal lobectomies to in-vivo MRI, however, their approach only involved visually
selecting the closest coronal MRI slice for each histology slide, and did not attempt to
find a dense correspondence between each histology slide and the corresponding MRI
slice. Table 3.1 presents a summary of the studies reporting algorithms for in-vivo MRI
to histology of the brain in the last 15 years.
The registration approach for in-vivo to ex-vivo MRI registration uses an automated
initialization as well as a landmark-based rigid registration, followed by a landmark de-
formable registration for hippocampal specimens and an image-based non-rigid warp-
ing for neocortical specimens. Using anatomical landmarks is a reliable technique for
registration that exploits the operator’s anatomical expertise and enforces registration
constraints based on the placed landmarks.
3.2 Methods & Materials
3.2.1 Recruitment, surgery & specimen acquisition
Temporal lobe epilepsy patients who were candidates for anterior temporal lobectomy
(ATL) surgery were recruited for this study. Patients had preoperative investigations in-
cluding neuropsychological testing and 1.5T clinical MRI scans which included T1w,
T2w, FLAIR, and diffusion-weighted sequences. Patients were monitored with scalp-
based electroencephalogram (EEG) video telemetry for seizure characterization, with
three patients requiring subdural electrodes placement. In addition to the 1.5T clinical
MRI scans performed at the hospital, patients underwent a series of scans on 3T and
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Table 3.1: Overview of the studies reporting algorithms for in-vivo MRI to histology
of the brain in the last 15 years.
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7T MRI research scanners, described in the in-vivo MRI subsection. The study cohort
included 10 temporal lobe patients who underwent epilepsy surgery and the resection
of two specimens, temporal lobe neocortex and hippocampus, as part of an ongoing
project at the Robarts Research Institute. Two hippocampal specimens were not ob-
tained en-bloc due to the use of the cavitron ultrasonic surgical aspirator (CUSA) device
during surgery, and were thus excluded from this study. This project was cleared by the
Health Sciences Research Ethics Board of Western University, and informed consent
was obtained from all patients prior to their participation in the study. Table 3.2 sum-
marizes the age, sex, onset age, seizure origin as well as clinical MRI and pathology
findings for our patient cohort.
3.2.2 Patient in-vivo MR imaging & map generation
All patients underwent pre-operative imaging on a 3 Tesla Discovery MR750 scanner
(General Electric , Milwaukee, WI, U.S.A.) with a 32 channel head coil and consisted
of relaxation mapping, diffusion-tensor imaging and resting-state functional imaging.
For T1 mapping the ‘DESPOT1-HIFI’ approach [22] was employed and involved ac-
quisition of two 3D SPGR sagittal T1-weighted images (TR=8.36ms, TE=3.712ms,
flip angles =4◦ & 18◦, matrix=220 × 220, slice thickness=1, FOV=220 mm), as well
as an additional inversion-prepared SPGR for B1 mapping (TR = 6.46ms, TE = 3.1ms,
flip angle = 5◦, matrix = 220 × 128, slice thickness = 0.5, FOV = 220 mm). For
T2 mapping the ‘DESPOT2-FM’ approach [23], whereby five balanced steady-state
free precession (bSSFP) images were acquired with flip angles 5◦, 35◦ and 68◦ with
phase cycling patterns θRF = 0◦ and 180◦ (TR = 4.608ms, TE = 2.356ms, matrix =
220 × 220, slice thickness = 1, FOV = 220 mm). Images were co-registered to the
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first T1-weighted scan in the session using the Flirt tool from [24] of the FSL image
analysis suite (FSL, http://fsl.fmrib.ox.ac.uk) oﬄine to correct for motion be-
tween scans. Subsequently, T1 and T2 quantitative maps were reconstructed from their
respective weighted images using their signal equations as described in Deoni [22, 23].
The T1 map was subsequently used for the registration protocol for all the patients. Dif-
fusion tensor imaging (DTI), though not used to guide the registration, was performed
using an axial spin-echo echo-planar imaging (EPI) sequence with 41 diffusion direc-
tions and a b-value of 1000 (TR = 1100ms, TE = 63.2ms, flip angle = 90◦, matrix =
96 × 96, slice thickness = 2.5, FOV = 240 mm). Eddy-current correction and diffusion
tensor estimation were performed using FMRIB’s Diffusion Toolbox (FDT) and maps
of fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD) and axial
diffusivity (AD) were computed after tensor estimation, transformed and resampled to
the coordinate system defined by the 1mm isotropic T1 map.
Patients also underwent high resolution structural imaging at 7T (Agilent Technolo-
gies, Santa Clara, CA, U.S.A/ Siemens, Erlangen, Germany), and are also shown in
conjunction with the histology for a qualitative comparison. The 7T imaging protocol
comprised a T1-weighted magnetization prepared rapid gradient echo (MPRAGE) se-
quence with a 0.75 mm isotropic resolution (TR = 8.42ms, TE = 3.9ms, flip angles =
11◦, matrix = 220 × 294 × 230, FOV = 150 × 220 × 172 mm) and a T2-w turbo spin
echo (TSE) sequence with a 0.6 mm isotropic resolution (TR = 3750ms, Effective TE
= 470.83ms, Echo spacing=4.73ms, flip angles = 90◦, matrix = 260 × 366 × 266, FOV
= 156 × 220 × 160 mm, echo train length(ETL) = 199, n.avg = 4)
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Patient Sex Age Onset
age
Seizure
origin
MRI Path. Scan
Pro-
tocol
1? F 26 20 Right TS Cortical
tubers
3T
2 F 22 15 Right R. HS HS 3T
3 M 20 3 Left L. HS HS 3T
4? M 19 5 Right Normal Gliosis 3T
5 M 49 13 Left Normal mild HS 3T
6 F 21 13 Right Non-specific mild FCD 3T
7 F 47 8 Right Normal dysplasia 9.4T
8 M 19 5 Right L. HS HS 9.4T
9 F 43 3 Right R. HS HS 9.4T
10 M 34 15 Left L. HS HS 9.4T
Table 3.2: Summary of demographics and clinical data, including MRI and
histopathological findings, for the ten recruited patients in the study. Registration was
performed on both hippocampus and neocortex specimens eight patients. Registration
was only performed on the neocortex for cases denoted by ?. HS: Hippocampal
Sclerosis. FCD : Focal Cortical Dysplasia. TS: Tuberous Sclerosis.
3.2.3 Specimen ex-vivo MR imaging
Following surgery, the resected tissue specimens were transferred to the Robarts Re-
search Institute for ex-vivo specimen imaging followed by processing in Pathology. Af-
ter resection, each specimen was oriented by the operating neurosurgeon, photographed
and transported on ice to the imaging lab. The ex-vivo scanning was performed after
overnight fixation in 10% formalin. We have initially tested specimen imaging before
and after overnight fixation and found that post-fixation provided superior gray matter-
white matter contrast to the pre-fixation images. Each specimen was wrapped in gauze
for stabilization, transferred to suitably-sized containers for imaging, and immersed in a
fluorine-based lubricant ‘Christo-lube MCG 1046’ (Lubrication Technology, Inc) prior
to imaging to avoid susceptibility artifacts at the tissue boundaries. The specimen scan-
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ning was performed on the 3 T scanner used for patient imaging with both hippocampal
and neocortical specimens imaged in the same field of view using a 6 channel coil de-
signed to image the carotid artery. The protocol sequences and imaging parameters are
described under ‘Scan Protocol II’ in chapter 2, and included T2-weighted FIESTA im-
ages with a resolution of 0.35 × 0.35 × 0.4mm, as well as, fastGRE scans with sixteen
echoes.
For cases where overnight imaging was feasible and not disruptive to the clinical
work flow (N=4), scanning was performed on a 9.4T small bore Varian MR mag-
net (Varian, Palo Alto, CA, U.S.A) for improved image resolution and signal-to-noise
(SNR), as an alternative to the 3T scan. Each specimen was imaged separately us-
ing different coils for a total time of sixteen hours per specimen. The hippocampal
specimens were imaged in a millipede birdcage MP30 coil (Agilent, Santa Clara, CA,
U.S.A) and the neocortical specimens were scanned with an in-house developed coil.
True fast imaging with steady state precession (TrueFisp) images (TR = 7.6 ms, TE =
3.8 ms, flip angle = 30◦) were acquired with a resolution of 0.1 mm isotropic, a FOV of
38. × 25.6 × 19.2 mm; and a resolution of 0.2 mm isotropic (FOV of 50 × 26 × 44), for
hippocampal and neocortical specimens respectively. Spin-echo diffusion sequences
were also acquired (TR = 7.6 ms, TE = 3.8 ms, slice thickness = 0.4mm) with an in-
plane resolution of 0.1× 0.1 mm and FOV of 38.× 25.6 mm, and an in-plane resolution
of 0.2 × 0.2 mm and FOV of 50 × 26, for hippocampal and neocortical specimens re-
spectively. The T2-weighted images from either protocol were used in the registration
pipeline.
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3.2.4 Histological processing
Following ex-vivo imaging, the specimens underwent histological processing as de-
scribed in chapter 2. Briefly, the specimens were accessioned and examined prior to
coronal blocking every 4.4 mm. Each block was embedded in paraffin and mounted
on a microtome where 8 µm thick sections were cut from the face of each block and
mounted on slides. One slide from each block was stained with hematoxylin and eosin
(H&E) and select blocks processed for immunohistochemistry (IHC) as determined
on clinical grounds. The resulting slides were digitized on a ScanScope GL (Aperio
Technologies, Vista, CA, USA) bright field slide scanning system at a maximum of
20x optical zoom, and stitched to form full-frame multi-resolution images stored in
BigTIFF file format (maximum pixel resolution 0.5 µm). The ex-vivo subvolumes, the
numbers of histological blocks and sections, as well as NeuN and GFAP sections, are
summarized in Table 3.3.
3.2.5 Image registration
The goal of the image registration for a given specimen is to find correspondence be-
tween the 3D in-vivo MRI, denoted as Iin, and the set of N 2D histology slides, denoted
as {Iih2D}i=1...N . We divide this process into two distinct steps through the use of an in-
termediate 3D ex-vivo MRI of the specimen, Iex. Chapter 2 [2] described and validated
methodology for generating a 3D reconstruction of the histology slides, Ih3D, with an
iterative approach that alternates between aligning Iex to Ih3D, and correcting for within-
slices deformations using the aligned Iex as a reference. The registration detailed in this
work relates to finding the transformations between Iin and Iex, thus connecting images
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Subject Hp vol
(mm3)
Hp
blocks
Hp sections Neo vol
(mm3)
Neo
blocks
Neo sections
1? - - - 32669.3 14 37 (13
NeuN, 3
GFAP)
2 3992.4 6 6 (No IHC) 18472.0 12 21 (3 NeuN,
3 GFAP)
3 4677.0 7 8 (1 GFAP) 13830.8 12 15 (2 NeuN)
4? - - - 10885.8 9 15 (3 NeuN,
2 GFAP)
5 3705.1 9 13 (4 GFAP) 20371.0 14 18 (4 GFAP)
6 4373.2 9 11 (2 GFAP) 20896.6 11 15 (2 NeuN,
2 GFAP)
7 3748.6 8 8 (No IHC) 16067.5 15 22 (1 NeuN,
1 GFAP)
8 4588.4 7 8 (1 NeuN) 22719.9 12 14 (1 NeuN,
1 GFAP)
9 3545.0 8 13 (2 GFAP,
3 NeuN)
17225.5 13 28 (8 NeuN,
7 GFAP)
10 3147.5 8 10 (2 GFAP) 19368.6 12 22 (5 NeuN,
5 GFAP)
Mean 3972.2 7 9 19126.2 12 19
Table 3.3: Summary of ex-vivo subvolumes, the numbers of histological blocks and
sections, as well as NeuN and GFAP sections. In two cases (denoted by ∗) registration
was only performed on the neocortex
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obtained in-vivo with histological slides, as depicted in Figure 3.1. These transforma-
tions are obtained in a hierarchical fashion, beginning with an initial translation, Ttransex,in ,
a landmark-based similarity transformation, Tsimex,in, and finally a non-rigid deformation,
φex,in. To avoid oblique resampling of the highly anisotropic histology images for the
purposes of visualization and analysis, the in-vivo and ex-vivo images are ultimately
transformed to the space of the 3D reconstructed histology, Hist3D, where the recon-
structed coronal histology slides are stacked parallel to the anterior-posterior axis.
Initialization
Prior to image registration, the images underwent a series of pre-processing steps, car-
ried out with command-line tools from the FSL image analysis suite (FSL, http:
//fsl.fmrib.ox.ac.uk) and scripts written in MATLAB (The MathWorks Inc., Nat-
ick, MA, USA). First, all MR images were converted from the scanner output Dicom
(dcm) format to the standard Nifti (nii) format. Since the anatomical orientation of
the ex-vivo specimens in the scanner bore may not correspond to the head-based scan-
ner orientation, we first updated the orientation matrices of Iex to encode the actual
anatomical orientation. We used photographs of the anatomical specimens labeled in
the operating room along with 3D models to assist in this process and to obtain the
correct pose. The same orientation correction was applied to all images in the same
ex-vivo scan session.
The goal of the first transformation obtained between Iex and Iin, as depicted in
Figure 3.1, is to translate the resected specimen into in-vivo space, in close proximity to
the relevant anatomical structures in the anterior temporal lobe. We performed this step
in an automated fashion by computing a translation matrix, Ttransex,in between standardized
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Figure 3.1: In-vivo MRI to histology registration scheme depicting the
transformations obtained through each registration step and the resulting images.
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coordinates in Iin (anterior temporal lobe, hippocampus) and the center of mass in a
foreground mask obtained from Iex, generating the ex-vivo image Itransex . The in-vivo
coordinates were found through linear registration to the montreal neurological institute
(MNI) 152 brain atlas, where the center of the anterior temporal lobe and hippocampus
in each respective hemisphere were labeled with MNI152 coordinates of (25,−14,−19)
and (40,−2,−30) for the right hippocampus and temporal lobe respectively (left side
coordinates had the x negated). The images, Itransex and Iin, were then resampled to an
isotropic voxel size of 0.4mm, and both cropped to the extents of Itransex . This initial
translation, along with the pose correction, allows for visualization of the ex-vivo and
in-vivo images in the same space and greatly facilitates placement of landmarks for the
following step.
Landmark-based similarity transformation
After the initial translation, alignment of the images was further refined using landmark-
based registration. Landmarks were placed on the initialized ex-vivo and in-vivo images
Itransex and Iin in the open source software 3D Slicer, http://www.slicer.org, version
4.2.1. For the hippocampal specimens, on average up to 10 anatomical landmarks were
chosen on orthogonal image planes within the hippocampus proper and the hippocam-
pal subfields, specifically the dentate gyrus, with the guidance of the hippocampal sul-
cus, as well as the parahippocampal gyrus depending on the extents of the resection.
For the neocortical specimens, the anatomical landmarks were chosen on the surface of
both the in-vivo brain and ex-vivo specimen using 3D surface models and photographs
from pathological grossing of the specimen. A surface-based approach was chosen
since the rich set of cortical surface features visible on both images was amenable
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to localization of corresponding landmarks. Surface visualization of the in-vivo brain
was accomplished with volume-rendering of the skull-stripped and bias-corrected T1-
weighted SPGR image (flip angle 18◦). An average of 15 landmarks were placed on the
surface of each neocortical specimen. The mean number of placed landmarks on the
surface of the neocortical specimens was 15 landmarks per specimen. Figures 3.2 and
3.3 demonstrate an example of corresponding anatomical landmarks on both the in-vivo
T1 map and the ex-vivo hippocampi and neocortices, and their distribution within each
specimen, respectively.
After placement of landmarks the optimal transformation, Tsimex,in (7 dof rigid trans-
form plus scaling), aligning the ex-vivo to the in-vivo set was found. The scale factor
was employed to allow more flexibility than a rigid transformation to account for physi-
cal contraction of the tissue, while restricting unrealistic shearing that would be present
in an affine transformation. The similarity transformation was estimated with the Fidu-
cial Registration module in Slicer 4 and applied to the translated ex-vivo images Itransex
to produce, I simex .
Non-rigid registration: Hippocampus
A non-rigid transformation, φex,in, is required to account for deformations of the hip-
pocampi during and after surgery. We chose a user-guided landmark-based approach to
account for these deformations since there is a great deal of variability in how much of
the anterior hippocampus and the proximal mesial structures is retrieved from case to
case, in part due to the fact that some of the tissue is lost through aspiration. Subsequent
to the landmark-based similarity transform, we performed a deformable landmark-
based registration for our hippocampal specimens using radial basis functions (RBF)
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Figure 3.2: Landmark placement for in-vivo to ex-vivo registration of hippocampal
specimens. a) An example hippocampus before grossing. b) Surface rendering of the
ex-vivo MR of the specimen. c) Distribution of landmarks (green) within the volume
of the specimen. d) Three pairs of corresponding landmarks chosen on orthogonal
planes of in-vivo (blue) and ex-vivo (red) images.
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Figure 3.3: Landmark placement for rigid registration of neocortical specimens. The
white arrows point to homologous points and their corresponding gyri. a) Neocortex
specimen before grossing. b) Volume rendering of the in-vivo MR image of the patient
with registration landmarks overlaid on top (red). c) Surface rendering of the ex-vivo
MR image of the specimen with registration landmarks overlaid on top (blue).
for local corrections as implemented in the Plasti match plug-in [25] in 3D Slicer. Two
new sets of corresponding landmarks were placed, on I simex and Iin, in coronal MR slices
to match the coronally slice histology. Applying the similarity transform before choos-
ing a second set of landmarks for non-rigid registration helps identify landmarks more
readily since the anatomy is better aligned at this stage and thus the search space is
restricted. After testing a range of parameters and visual analysis of the results, we
performed the deformable landmark-based registration using a Gaussian RBF radius of
50 mm and a regularization weight of 0.1. In some cases the regularization parameter
was increased, by 0.1 increments, to ensure smoothness of the resulting deformation in
regions where errors in landmarks correspondence might warp the images inappropri-
ately. A average of 12 landmarks were used per specimen to perform the registration.
Since the Hist3D space was chosen as the target space for bringing in-vivo MRI and
histology into alignment, the inverse deformation field φ−1ex,in was computed using the
Inverse warp tool in FSL. This inverse warp was afterwards composed with the inverse
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transforms, Tsimex,in and T
trans
ex,in , generated in the previous sections, as well as T
rig
ex,h3D to
bring the in-vivo image, Iin, to the Hist3D space, as depicted in Figure 3.1. The re-
sulting composite deformation was applied to the T2 quantitative map, the FA and MD
diffusion maps and structural images acquired at 7T as well as clinical 1.5T scans, if
available, to warp them to the Hist3D space for visualization and analysis.
Non-rigid registration: Neocortex
Since the neocortex specimens are larger in size, deform more regularly, and contain
many salient features in the cortical folding patterns, a more automated image-based
approach was chosen to provide the analogous non-rigid deformation. We performed a
fast non-rigid registration on the rigidly aligned images, I simex and Iin, that makes use of a
B-spline deformation field, and a normalized mutual information (NMI) cost-function
[26, 27] (NiftyReg,http://sourceforge.net/projects/niftyreg/). The algo-
rithm estimates the transformation, φex,in, that maps the ex-vivo image to the in-vivo im-
ages such that the NMI cost function is minimized, with a regularization term based on
the bending energy at each control point. A symmetric implementation was employed
that also generates an inverse warp, φinvex,in, for warping images in the opposite direction.
The B-spline registration employed a three-level multi-resolution image pyramid with
final control point spacing of 7 voxels or 2.8 mm, small enough to account for local
deformations encountered and sufficiently large to avoid noise and provide a smooth
deformation. We set the deformation penalty term (bending energy of the spline at a
control point) as 1e−4. As employed for the hippocampal specimens, a composite defor-
mation field, generated by combining φex,in and the transformations described in previ-
ous sections, was applied to our 3T quantitative maps, the 7T high resolution anatomical
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scans, if available, and clinical 1.5T scans to warp them to the Hist3D space.
In-vivo MRI to Histology registration
Transformations obtained via the methodology outlined in chapter 2 [2] were used to
reconstruct a 3D histology stack and register the ex-vivo MRI to this stack. This work
also described a supplementary co-registration to bring additional immunohistochem-
istry (IHC) stains, such as neuronal nuclei (NeuN) and glial fibrillary acidic protein
(GFAP), into alignment with the H&E stains used for registration with the MRI. We re-
constructed three dimensional RGB histology volumes from downsampled two dimen-
sional sections (20 µm and 100 µm) and warped them using the previously described
deformation fields to the intermediate Hist3D space, as shown in Figure 3.8(c).
3.2.6 Registration validation & statistical analysis
Validation of our registration protocol, was achieved by computing target registration
error (TRE) based on manually-identified corresponding intrinsic landmarks on in-vivo
and ex-vivo MR images. A set of landmarks, different from those used in the regis-
tration steps, was employed to validate our target registration accuracy to assess the
accuracy of the registration at both the rigid and deformable stages of the protocol.
Matching point landmarks were chosen throughout the hippocampus and neocortex
using anatomical structures on the three orthogonal imaging planes. All validation
landmarks were placed on the MR images in their original space. To assess significant
differences between the rigid and deformable registrations, we computed a Wilcoxon
matched-pairs signed-rank test with a two-tailed α value of 0.05 between the mean
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TRE values of both registrations. Statistical analyses were performed in Prism 5.04
(GraphPad Software, San Diego, CA).
We also assessed the sensitivity of our registration protocol to using different sets
of landmarks for computing the rigid and non-rigid transformations, by performing the
registration on three hippocampal specimens, using two independent landmark sets.
The two resulting transformations for each specimen were applied to a single set of
validation landmarks to assess the differences between TRE.
There is also human error associated with placement of the landmarks used for vali-
dation, and this error effectively contributes to the TRE. To quantify this target localiza-
tion error (TLE) we evaluated the reproducibility of landmark placement on the in-vivo
MRI given a single set of ex-vivo landmarks. TLE was calculated as an unbiased esti-
mator of the standard deviation of repeated localizations of the same landmark by the
same rater [28], or the intra-rater variability, described by (1) below:
T LE =
√√
1
J
J∑
j=1
1
K − 1
K∑
K=1
||P j,k − 1K
K∑
k=1
P j,k||2 (3.1)
where P j,k is the k−th localization of the j−th landmark. A total of three localization
(K = 3) of fifteen landmarks (J = 15) was performed.
In addition to the landmark-based validation of registration errors, we performed re-
gion based by employing the Dice similarity coefficient, between delineated regions of
interests (ROIs) on the histology and MRI, to further validate the registration accuracy.
The cortical gray matter crown and adjacent white matter were chosen as ROIs for
neocortical specimens, whereas the entorhinal cortex and combined cornu Ammonis
(CA) subfields were chosen as targets for hippocampal specimens. Root mean square
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error (RMSE) was computed as well for the chosen ROIs in all the specimens. The two
dimensional Dice coefficient and RMSE results are summarized in table A.1.
Table 3.4: Summary of Dice similarity metric coefficient and root mean squared error
(RMSE) for both tissue types (GM & WM)
Neocortex Hippocampus
GM WM GM WM
Dice 0.875 ± 0.009 0.851 ± 0.038 0.854 ± 0.027 0.838 ± 0.039
RMSE (mm) 0.335 ± 0.118 0.405 ± 0.239 0.338 ± 0.175 0.375 ± 0.296
3.3 Results
Our registration protocol produced a mean TRE of 1.46±0.30 mm and 1.35±0.11 mm
for rigid and non-rigid registrations of neocortical specimens respectively, as shown
in Figure 3.4. Similarly, we computed a TRE of 1.71 ± 0.36 mm and 1.41 ± 0.33
mm for rigid and non-rigid registrations of hippocampal specimens respectively. The
mean landmark localization error was 0.23 mm, which is small relative to an isotropic
1 mm voxel size of our T1 maps, Iin, while the mean difference of TRE for our re-
peatability experiment of two independent landmark sets was 7% and %11 deviation
form previous mean for rigid and non-rigid registrations respectively. The Wilcoxon
matched-pairs signed-rank test confirmed that the deformable registration significantly
improved the registration accuracy for the neocortex (Pneo = 0.0019, 95% CI of dif-
ference [−0.20,−0.027]) and the hippocampus. (Php = 0.0011, 95% CI of difference
[−0.54,−0.038]).
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Figure 3.4: Boxplots with standard deviation of Hippocampal and Neocortical
registration target registration errors at rigid and non-rigid registration stages.
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The results of the landmark-based rigid and non-rigid registrations for the hip-
pocampi are depicted on an example specimen in Figure 3.5. Purple (Figure 3.5(b))
and red (Figure 3.5(c)) represent rigidly and non-rigidly registered hippocampi re-
spectively. The white arrows in the figure show areas were deformable registration
outperformed rigid registration. The last row (Figure 3.5(f)) depicts the difference in
shape and volume between the hippocampus specimen after rigid transformation and
deformable warping. Figure 3.6 shows a comparison between the results of the rigid
landmark-based and deformable image-based neocortical registration on an example
specimen. As with the hippocampus, the white arrows highlight regions were the non-
rigid registration produced a more optimal fit between the images. The figure highlights
the high specimen deformations that occur during surgery and thus motivates the use of
a free-form deformation model within the registration protocol.
This complete registration pipeline, allows in-vivo MR images to be registered to
histology of surgically resected specimens, and brings both modalities to an interme-
diate reference space, based on ex-vivo MR images. After generating the deforma-
tion fields that bring pre-operative images to the ex-vivo space, we warped all the pre-
operative scans acquired in the 3 Tesla MRI scanning session, as well as those acquired
using the 7T scanner if available. Figure 3.7 presents 7T, 3T, as well as clinical 1.5T
scans from a single subject registered to the excised neocortical sample. Registered
histological slices of a coronal section of the neocortex are also shown. The figure
highlights the effect of signal-to-noise (SNR) and image resolution on the quality of
registration. It also highlights the potential of warping quantitative T1 and T2, as well as
diffusion maps to histology for use in region of interest (ROI) or voxel-based analysis.
A warped, reconstructed 3D stack of consecutive H&E stained slices of a neocortical
specimen is shown registered to the ex-vivo MRI in Figure 3.8(c). This figure highlights
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Figure 3.5: Comparison of landmark-based rigid and non-rigid registrations for the
hippocampus. The white arrows depict areas where deformable registration
outperformed rigid registration. a) Cropped in-vivo MR image, Ic, b) Rigidly
registered ex-vivo specimen (purple), c) Merged view of rigidly registered ex-vivo to
in-vivo image, d) Non-rigidly registered ex-vivo specimen (red), e) Merged view of
non-rigidly registered ex-vivo to in-vivo image, f) Difference in shape and volume
between the hippocampus specimen after rigid transformation and deformable
warping.
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Figure 3.6: Comparison of landmark-based rigid and non-rigid registrations for the
neocortex. The white arrows depict areas where deformable registration outperformed
rigid registration. a) Cropped in-vivo MR image, Ic, b) Rigidly registered ex-vivo
specimen, c) Merged view of rigidly registered ex-vivo to in-vivo image, d)
Non-rigidly registered ex-vivo specimen, e) Merged view of non-rigidly registered
ex-vivo to in-vivo image.
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as well the 2D affine registration between H&E and other IHC stained sections (f-i).
3.4 Discussion
The presented in-vivo to ex-vivo MR registration protocol resulted in a target regis-
tration error (TRE) of 1.35 ± 0.11mm and 1.41 ± 0.33mm for neocortical and hip-
pocampal specimens respectively. We have previously demonstrated [2] that the errors
for the intermediate ex-vivo to histology registration were 0.98 ± 0.60mm and 0.76 ±
0.66mm for neocortical and hippocampal specimens respectively, resulting in a cumu-
lative total error close to 2.33 mm and 2.17 mm for the in-vivo to histology registration.
Performing voxel-based registration allows for spatially-local comparison of MRI and
histology, and the scale of this analysis is dependent on the achievable registration ac-
curacy. Many previous studies in MRI and histology registration (see Table 1) did not
report accuracy or TRE [15, 29, 5, 11, 18, 1, 12, 19], and furthermore many previ-
ous studies were proof-of-concept works that included evaluation on only one dataset
[16, 15, 29, 30, 5, 11, 18, 19, 8]. Of the studies that did report accuracy on more than
one dataset, TRE ranged from sub-millimeter [7, 9, 13] to 3-5mm [14, 17]. Techniques
that reported sub-millimeter TRE were applied on either whole brain sections of rodents
or serially sectioned histology of primates, thus the smaller scale of anatomy and lack
of variable resection boundaries can explain the lower TRE relative to this work. For
a more relevant comparison, Singh et al. [17] performed registration of human in-vivo
and post-mortem whole brain specimens and reported a TRE of 5.1mm. The only exist-
ing work that dealt with resected temporal lobe specimens was [21], however they only
aimed to find corresponding slices between MRI and histology, and reported inter- and
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intra-observer variability (< 2mm) instead of an accuracy measure. This work builds
upon these efforts and provides a means to perform voxel-based MRI and histology
studies in both neocortical and hippocampal specimens.
Figure 3.7: Mapping of in-vivo MR images to the aligned space for a neocortical
specimen. The spatial resolution decreases vertically (top to bottom) in the figure. The
top row depicts the ex-vivo MR (left) and three stains of a histological section (right).
The 2nd, 3rd and 4th rows show warped images taken at 7, 3 and 1.5 Tesla respectively.
The last row demonstrates warped diffusion maps (FA= fractional anisotropy, MD=
mean diffusivity).
There has been a recurring theme of using registration features as segmented con-
tours or surfaces [9, 18, 7, 13], as well as landmarks [30, 19, 8, 14] to find similari-
ties between the images to aid the registration algorithm. Although, manual landmark
placement can be time consuming and user-dependent, user anatomical expertise can
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enforce registration constraints with placed landmarks when similarity metrics fail to
find sufficient correspondences between both modalities. I have also shown that the
landmark registration protocols are reproducible across different attempts using two
independent sets for the same hippocampal specimens. An implementation of a fully
automated deformable registration algorithm based on image features would have de-
creased the amount of time required for performing the registration tasks; however,
it may not have improved the registration accuracy specifically for smaller highly de-
formed specimens.
Many studies correlating MRI and histology have been done without the use of
computational methods for 3D image registration [21, 31, 32]. These rely on visual
matching of anatomy or lesions, usually on a slice by slice basis, and are suitable if
the tissue of interest (lesion, or anatomy) can be reliably identified in both modalities.
However, this is not possible in cases where the visibility or boundaries of the lesion
in MRI are different than in histology, or if there is no apparent lesion (as is the case
in paradoxical TLE). It is in these cases where MRI-histology registration is crucial,
since allows for quantitative investigation of imaging correlates in these lesions that
can ultimately improve MRI-based detection and delineation. Another drawback of
visual matching is that it becomes more challenging to find corresponding slices when
there are 3D deformations present, as the anatomy in a histology slice may not be
fully present in a single MRI slice, even if obliquely resampled. Registration methods
that can deal with, and compensate for, 3D deformations take the guesswork out of
the inherently 2-dimensional visual matching task by using the salient features in the
images to define the 3D transformations. Many registration protocols, including ours,
also employ specialized tissue handling and slicing protocols designed to minimize
deformations and maximize consistency; these are helpful in many cases but do not
3.4. Discussion 115
Figure 3.8: 3D histological reconstruction and registration to MR. a) A resected
temporal lobe neocortical specimen from epilepsy surgery. b) Rendering of the
specimen from a 9.4T MR image registered to histological slices. c) 3D consecutive
histology slices in the MR space. d) Rendering of both sides of the specimen where a
histology slice was cut. e) Registered MRI slice to the cut histology slice. Four
different immunohistochemistry and staining techniques are shown as well for the cut
histology section: f) Hematoxylin & Eosin (H&E), g) Neuronal Nuclei (NeuN), h)
Microtubule associated protein (MAP)2 and i) Luxol fast blue (LFB).
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preclude the use of further image-based or landmark-based registration to obtain greater
accuracy.
We have presented and evaluated a detailed protocol for relating in-vivo MRI and
histology, however, a true test of its generalizability would be to implement and validate
this protocol in another clinical research setting. There are several limitations which
could make translation of this technique difficult. For one, this protocol requires close
co-operation with both neurosurgery and pathology departments. En-bloc resections
are not always performed for temporal lobectomies, and the use of ultrasonic aspirators
results in fragmented tissue that is difficult or impossible to deal with in histology cor-
relation studies. A final issue is the reliance on sophisticated imaging resources, such as
high-field and ultra-high field magnets for pre-operative and ex-vivo imaging. Despite
these limitations, the deployment of this protocol in our unique clinical and research
environment allows us to investigate specific clinical questions that can significantly
influence our understanding and treatment of temporal lobe epilepsy. The histological
basis of focal alterations of relaxometry and diffusion in epilepsy, both proximal and
distal to the seizure focus, are important questions that have yet to be resolved [33, 34]
and could also impact the clinical use of such sequences in assessing laterality or local-
ization of epileptogenicity. Future work will involve a registration-based correlation of
MRI and histology whereby spatial clusters of abnormal T1, T2, fractional anisotropy,
or mean diffusivity, could be compared against histological measures such as neuronal
density, gliosis, and myelination. The investigation of HS and its sub-types is another
area of research which may impact clinical treatment and prediction of surgical out-
comes [35]. The presented registration of hippocampal specimens is a critical step in
the exploration of imaging and histology correlates in sub-regions of the hippocam-
pus and could lead to better pre-operative assessment of hippocampal sub-types and
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perhaps greater sensitivity to subtle changes in early stages of HS.
Bibliography
[1] Julien Dauguet, Thierry Delzescaux, Franc¸oise Conde´, Jean-Franc¸ois Mangin,
Nicholas Ayache, Philippe Hantraye, and Vincent Frouin. Three-dimensional
reconstruction of stained histological slices and 3D non-linear registration with
in-vivo MRI for whole baboon brain. Journal of neuroscience methods, 164(1):
191–204, 2007.
[2] Maged Goubran, Cathie Crukley, Sandrine de Ribaupierre, Terence M Peters, and
Ali R Khan. Image registration of ex-vivo MRI to sparsely sectioned histology of
hippocampal and neocortical temporal lobe specimens. Neuroimage, 83:770–781,
2013.
[3] A Ward, C Crukley, C McKenzie, J Montreuil, E Gibson, J Gomez, M Moussa,
G Bauman, and A Fenster. Registration of in vivo prostate magnetic resonance
images to digital histopathology images. Prostate Cancer Imaging. Computer-
Aided Diagnosis, Prognosis, and Intervention, pages 66–76, 2010.
[4] Jonathan Chappelow, B. Nicolas Bloch, Neil Rofsky, Elizabeth Genega, Robert
Lenkinski, William DeWolf, and Anant Madabhushi. Elastic registration of mul-
timodal prostate mri and histology via multiattribute combined mutual informa-
tion. Medical Physics, 38(4):2005, February 2011. doi: 10.1118/1.3560879. URL
http://link.aip.org/link/MPHYA6/v38/i4/p2005/s1{&}Agg=doi.
118 Chapter 3. III Registration of Ex-vivo to In-vivo MRI
[5] Gre´goire Malandain, Eric Bardinet, Koen Nelissen, and Wim Vanduffel. Fusion
of autoradiographs with an MR volume using 2-D and 3-D linear transformations.
Neuroimage, 23(1):111–27, 2004.
[6] Michael S Breen, Tanya L Lancaster, and David L Wilson. Correcting spatial
distortion in histological images. Comput Med Imaging Graph, 29(6):405–17,
2005.
[7] Can Ceritoglu, Lei Wang, Lynn D Selemon, John G Csernansky, Michael I Miller,
and J Tilak Ratnanather. Large Deformation Diffeomorphic Metric Mapping Reg-
istration of Reconstructed 3D Histological Section Images and in vivo MR Im-
ages. Front Hum Neurosci, 4:43, 2010.
[8] Ann S Choe, Yurui Gao, Xia Li, Keegan B Compton, Iwona Stepniewska, and
Adam W Anderson. Accuracy of image registration between mri and light mi-
croscopy in the ex vivo brain. Magnetic resonance imaging, 29(5):683–692, 2011.
[9] M A Jacobs, J P Windham, H Soltanian-Zadeh, D J Peck, and R A Knight. Reg-
istration and warping of magnetic resonance images to histological sections. Med
Phys, 26(8):1568–78, 1999.
[10] J L Humm, D Ballon, Y C Hu, S Ruan, C Chui, P K Tulipano, A Erdi, J Koutcher,
K Zakian, M Urano, P Zanzonico, C Mattis, J Dyke, Y Chen, P Harrington, J A
O’Donoghue, and C C Ling. A stereotactic method for the three-dimensional
registration of multi-modality biologic images in animals: NMR, PET, histology,
and autoradiography. Med Phys, 30(9):2303–14, 2003.
[11] Charles R Meyer, Bradford A Moffat, Kyle K Kuszpit, Peyton L Bland, Paul E
Mckeever, Timothy D Johnson, Thomas L Chenevert, Alnawaz Rehemtulla, and
BIBLIOGRAPHY 119
Brian D Ross. A methodology for registration of a histological slide and in vivo
MRI volume based on optimizing mutual information. Mol Imaging, 5(1):16–23,
2006.
[12] J Lebenberg, A S He´rard, A Dubois, J Dauguet, V Frouin, M Dhenain, P Hantraye,
and T Delzescaux. Validation of MRI-based 3D digital atlas registration with his-
tological and autoradiographic volumes: An anatomofunctional transgenic mouse
brain imaging study. Neuroimage, 51(3):1037–1046, 2010.
[13] Zhengyi Yang, Kay Richards, Nyoman D Kurniawan, Steven Petrou, and David C
Reutens. Mri-guided volume reconstruction of mouse brain from histological
sections. Journal of neuroscience methods, 211(2):210–217, 2012.
[14] Yutong Liu, Balasrinivasa R Sajja, Mariano G Uberti, Howard E Gendelman,
Tammy Kielian, and Michael D Boska. Landmark optimization using local curva-
ture for point-based nonlinear rodent brain image registration. Journal of Biomed-
ical Imaging, 2012:1, 2012.
[15] T Schormann, A Dabringhaus, and K Zilles. Statistics of deformations in his-
tology and application to improved alignment with MRI. IEEE Transactions on
Medical Imaging, 14(1):25–35, 1995.
[16] T.S Kim, M Singh, W Sungkarat, C Zarow, and H Chui. Automatic registration
of postmortem brain slices to MRI reference volume. Nuclear Science, IEEE
Transactions on, 47(4):1607–1613, 2000.
[17] M Singh, A Rajagopalan, T-S Kim, D Hwang, H Chui, X-L Zhang, A-Y Lee, and
C Zarow. Co-registration of In-Vivo Human MRI Brain Images to Postmortem
120 Chapter 3. III Registration of Ex-vivo to In-vivo MRI
Histological Microscopic Images. Int. J. Imaging Syst. Technol., 18(5-6):325–
335, 2008.
[18] J Yelnik, E Bardinet, D Dormont, G Malandain, S Ourselin, D Tande´, C Karachi,
N Ayache, P Cornu, and Y Agid. A three-dimensional, histological and de-
formable atlas of the human basal ganglia. I. Atlas construction based on im-
munohistochemical and MRI data. Neuroimage, 34(2):618–638, 2007.
[19] Sergey Osechinskiy and Frithjof Kruggel. Slice-to-Volume Nonrigid Registration
of Histological Sections to MR Images of the Human Brain. Anatomy Research
International, 2011, 2010.
[20] Katrin Amunts, Claude Lepage, Louis Borgeat, Hartmut Mohlberg, Timo
Dickscheid, Marc-E´tienne Rousseau, Sebastian Bludau, Pierre-Louis Bazin,
Lindsay B Lewis, Ana-Maria Oros-Peusquens, et al. Bigbrain: an ultrahigh-
resolution 3d human brain model. Science, 340(6139):1472–1475, 2013.
[21] Sofia H Eriksson, Samantha L Free, Maria Thom, William Harkness, Sanjay M
Sisodiya, and John S Duncan. Reliable registration of preoperative MRI with
histopathology after temporal lobe resections. Epilepsia, 46(10):1646–53, 2005.
[22] Sean C L Deoni. High-resolution T1 mapping of the brain at 3T with driven
equilibrium single pulse observation of T1 with high-speed incorporation of RF
field inhomogeneities (DESPOT1-HIFI). J Magn Reson Imaging, 26(4):1106–11,
2007.
[23] Sean C L Deoni. Transverse relaxation time (T2) mapping in the brain with off-
resonance correction using phase-cycled steady-state free precession imaging. J
Magn Reson Imaging, 30(2):411–7, 2009.
BIBLIOGRAPHY 121
[24] M Jenkinson and S Smith. A global optimisation method for robust affine regis-
tration of brain images. Medical Image Analysis, 5(2):143–56, 2001.
[25] Csaba Pinter, Andras Lasso, An Wang, David Jaffray, and Gabor Fichtinger.
Slicerrt: Radiation therapy research toolkit for 3d slicer. Medical physics, 39
(10):6332–6338, 2012.
[26] D Rueckert, L I Sonoda, C Hayes, D L Hill, M O Leach, and D J Hawkes. Non-
rigid registration using free-form deformations: application to breast MR images.
IEEE Transactions on Medical Imaging, 18(8):712–21, 1999.
[27] Marc Modat, Gerard R Ridgway, Zeike A Taylor, Manja Lehmann, Josephine
Barnes, David J Hawkes, Nick C Fox, and Se´bastien Ourselin. Fast free-form
deformation using graphics processing units. Computer methods and programs in
biomedicine, 98(3):278–84, 2010.
[28] J M Fitzpatrick, J B West, and C R Maurer. Predicting error in rigid-body point-
based registration. IEEE Trans Med Imaging, 17(5):694–702, 1998.
[29] E Bardinet, S Ourselin, D Dormont, G Malandain, D Tande´, K Parain, N Ayache,
and J Yelnik. Co-registration of histological, optical and mr data of the human
brain. Medical Image Computing and Computer-Assisted Intervention—MICCAI
2002, pages 548–555, 2002.
[30] Roee S Lazebnik, Tanya L Lancaster, Michael S Breen, Jonathan S Lewin, and
David L Wilson. Volume registration using needle paths and point landmarks
for evaluation of interventional MRI treatments. IEEE Transactions on Medical
Imaging, 22(5):653–60, 2003.
122 Chapter 3. III Registration of Ex-vivo to In-vivo MRI
[31] Georgia Lockwood-Estrin, Maria Thom, Niels K Focke, Mark R Symms, Lillian
Martinian, Sanjay M Sisodiya, John S Duncan, and Sofia H Eriksson. Correlating
3T MRI and histopathology in patients undergoing epilepsy surgery. Journal of
Neuroscience Methods, 205(1):182–9, 2012.
[32] Rita Garbelli, Gloria Milesi, Valentina Medici, Flavio Villani, Giuseppe Didato,
Francesco Deleo, Ludovico D’Incerti, Michela Morbin, Giulia Mazzoleni,
Anna Rita Giovagnoli, Annalisa Parente, Ileana Zucca, Alfonso Mastropietro,
and Roberto Spreafico. Blurring in patients with temporal lobe epilepsy: clini-
cal, high-field imaging and ultrastructural study. Brain, 135(Pt 8):2337–49, 2012.
[33] Fergus J Rugg-Gunn, Sofia H Eriksson, Mark R Symms, Gareth J Barker, Maria
Thom, William Harkness, and John S Duncan. Diffusion tensor imaging in re-
fractory epilepsy. Lancet, 359(9319):1748–51, 2002.
[34] G D Jackson, A Connelly, J S Duncan, R A Gru¨newald, and D G Gadian. Detec-
tion of hippocampal pathology in intractable partial epilepsy: increased sensitivity
with quantitative magnetic resonance T2 relaxometry. Neurology, 43(9):1793–9,
1993.
[35] Ingmar Blu¨mcke, Roland Coras, Hajime Miyata, and Cigdem Ozkara. Defin-
ing clinico-neuropathological subtypes of mesial temporal lobe epilepsy with hip-
pocampal sclerosis. Brain Pathol, 22(3):402–11, 2012.
Chapter 4
Correlation of Neocortical MRI and
histology
4.1 Introduction
The registration protocol described in chapters 2 & 3 between histology - currently
considered as the ground truth - and in-vivo MRI of resected tissue is a key compo-
nent towards achieving MRI and histology correlation by bringing together information
from both domains. Studies involving MRI and histology correlation from neocortical
specimens in TLE have been used to better understand the relationships between the
two. Garbelli et al. [1] investigated blurred cortical boundaries in the temporal pole
with immunohistochemistry (IHC), and found it to be related to degeneration of fiber
bundles. With visually-matched GM and WM ROIs in the middle temporal gyrus,
This chapter is adapted from Goubran et al. “MRI and histology correlation in the neocortex of
temporal lobe epilepsy.” Annals of neurology. Under-review
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Eriksson et al. [2] found a significant negative correlation between GM fast FLAIR T2
(FFT2) and neuronal nuclear antigen (NeuN). A follow-up study [3] investigating GM
probability maps with NeuN and glial fibrillary acidic protein (GFAP) did not find any
correlations. Similarly, Lockwood-Estrin et al. [4] also incorporating FLAIR (normal-
ized intensities) and DTI still failed to find any correlations. Such data suggest that the
pathological basis of abnormal MRI signals is still poorly understood in focal epilepsy.
There may be several reasons why the studies at higher field strength with a larger
number of subjects failed to reveal significant correlations between MRI and histology.
One potential factor is that errors in the visual matching of slices and regions between
MRI and histology, induced by rater error and non-rigid tissue deformations, could
have led to different tissue being sampled in MRI and histology ROIs. Another factor
could be the use of pseudo-quantitative MRI parameters, such as normalized FLAIR
intensities, instead of quantitative relaxometry, since these approaches are more likely
to include variability specific to the scan session and scan parameters, and may not
precisely represent the intrinsic tissue parameters.
The objective of this chapter is to investigate the histopathological correlates of
quantitative relaxometry and DTI from neocortical specimens of intractable TLE pa-
tients, while directly addressing these potential confounding issues. I make use of
a validated non-rigid image registration protocol to obtain accurate correspondences
between quantitative in-vivo MRI and histology images. Quantitative histology param-
eters from the grey and white matter in each NeuN (representing neuron integrity) and
GFAP (representing gliosis) IHC slide are sampled, and then image registration is em-
ployed to obtain the corresponding MRI parameters from high-resolution quantitative
T1 and T2 maps along with DTI.
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4.2 Materials & Methods
4.2.1 Patients and Samples
Our study cohort included 13 TLE (5 males, 8 females, age: 34 ± 15 (range: 18-56))
who underwent anterior temporal lobectomy (ATL) surgery. This project, part of an
ongoing research study at the Robarts Research Institute, was cleared by the Health
Sciences Research Ethics Board of Western University, and informed consent was ob-
tained from all patients prior to their participation in the study. Patients had preoper-
ative investigations including neuropsychological testing and 1.5T clinical MRI scans,
which included T1-weighted, T2-weighted, FLAIR, and diffusion-weighted sequences.
Patients were monitored with video-scalp EEG telemetry for seizure characterization,
with three patients requiring subdural electrodes placement. In addition to the 1.5T
clinical MRI scans performed as part of their clinical diagnosis, patients underwent a
series of scans on a 3T MRI research scanner as described in the in-vivo MRI imaging
subsection. Table 4.1 summarizes the age at the time of the last consultation prior to
surgery, gender, age at seizure onset, electrographic seizure origin as well as clinical
MRI and pathology findings for our patient cohort.
4.2.2 In-vivo Magnetic Resonance Imaging
All patients underwent pre-operative imaging, comprising relaxation mapping and DTI,
on a 3 Tesla Discovery MR750 scanner (General Electric, Milwaukee, WI, U.S.A.)
with a 32 channel head coil. In-vivo image acquisition sequences and scanning pa-
rameters are described in details in chapter 3. Briefly, the imaging protocol comprises:
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Table 4.1: Patient demographics and clinical information including age, gender, onset
age, seizure origin as well as clinical MRI and pathology findings for our patient
cohort. MTS = mesial temporal sclerosis, MAA= minor architectural abnormalities,
Neo. Path. = Neocortical Pathology, Hp. Path. = Hippocampal Pathology,† Previous
resection of left temporal lobe tumour (DNET), * not enough tissue to make diagnosis
of MTS
ID Sex Age Age
of
On-
set
Sz
Ori-
gin
Sz
Freq.
MRI Neo.
Path.
Hp. Path Engel
out-
come
Yrs
since
surgery
1 F 25 17 L 2 Normal † Gliosis,
Ki67-
positive
cells in
WM
Gliosis 3 2
2 M 20 3 L 16 MTS Gliosis,
MAA
MTS 2 2.1
3 M 18 14 R 32 Possible
MTS
Gliosis,
MAA
Gliosis* 1 2.1
4 F 48 36 L 28 MTS Gliosis MTS 1 1.7
5 F 50 47 L 20 GM/WM
blurring
Gliosis Gliosis* 1 1.6
6 M 31 28 R 2 Normal Mild
gliosis,
MAA
Negligible
gliosis
1 1.3
7 F 32 19 L 2 MTS Gliosis MTS 1 1.2
8 F 43 3 R 4 MTS Gliosis MTS 2 1.4
9 F 26 19 R 12 Cortical
tubers
Dysplastic
lesion,
cortical
tuber
Gliosis 2 2.5
10 M 34 15 L 2 MTS Gliosis,
focal
MAA
MTS 3 1.2
11 F 40 7 R 20 MTS,
Poren-
cephaly
Gliosis,
MAA
MTS 2 2.5
12 F 56 15 R 8 Normal Gliosis,
arte-
rioscle-
rosis
Gliosis* 1 1
13 M 23 18 L 12 Normal Gliosis,
MAA,
possible
FCD
type 1a
Gliosis 1 1
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1) the DESPOT1-HIFI technique [5] for T1 mapping whereby two SPGR sagittal T1-
weighted scans and an inversion-prepared SPGR for B1 mapping are acquired, 2) the
DESPOT2-FM approach [6] which relies on five bSSFP scans with different flip angles
and phase cycling patterns and 3) an axial SE EPI to obtain DTI. Quantitative T1 and
T2 maps were then reconstructed from the weighted images using their signal equations
as described in Deoni [5], Deoni et al. [7], and FMRIB’s Diffusion Toolbox (FDT) was
used for diffusion tensor estimation, Eddy-current correction (EPI distortion) and com-
putation of diffusion indices. We subsequently transformed and resampled the resulting
diffusion maps (FA & MD) to the coordinate system defined by the 1mm isotropic T1
map.
4.2.3 Histological processing and quantitative histology
The specimens underwent histological processing (grossing, slicing, embedding, sec-
tioning and digitization) according to the protocol described in chapter 2. Field fraction
estimates (proportion of all pixels in the field that were positively-stained) were used
to quantify the NeuN and GFAP IHC. These estimates been used in previous studies
to represent neuronal integrity and gliosis [2, 3, 4] and is sensitive to the packing den-
sity and cell-size of neuronal cell bodies and processes (NeuN) or astrocytes (GFAP).
The positive pixel count algorithm (Aperio Technologies, Vista, CA, USA) was em-
ployed for this purpose and employs color-based thresholding for hue, saturation, and
intensity to determine whether or not a pixel is immuno-positive. Slides were batch
processed using scripts written in MATLAB (The MathWorks Inc., Natick, MA, USA),
processing the full resolution images in blocks of 100 µm x 100 µm. Hue and satura-
tion thresholds were fixed (Hue value = 0.1, Hue width = 0.2 and saturation = 4x10-2)
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and the intensity threshold was chosen for each case to visualize the immuno-positive
pixels and account for staining variability between slides.
Field fraction measurements involving dysplastic cortex could be less sensitive when
reductions in packing density are accompanied by cyto-morphological size changes,
since each would affect the field fraction in opposing directions. To better decouple
these factors, we developed a method for segmenting the neuronal cell bodies to pro-
vide local estimates of neuron density and size. This procedure first employs colour
deconvolution [8] to extract the colour component related to immuno-positive stain-
ing, then performs a watershed-based segmentation procedure [9] for splitting joined
or connected neurons, removes objects smaller than a predefined area defined as noise
(less than 14 µm2). This provides a segmentation of each individual neuron cell body
that can be used to determine the neuron density in this field (# of neurons/field) and
the mean size of neuron cell bodies in the field. To further discriminate between neu-
rons, we also categorized them as either small-calibre (granular cells) or large-calibre
(pyramidal cells) using an area threshold of 125 µm2 and reported the density of each
of these in the field. This procedure inherently allows analysis for laminar specificity
since larger neurons are typically found in layers 3 and 5, and smaller neurons in layer
2 and 4. NeuN slides were batch-processed with scripts written in MATLAB, to ex-
tract the neuron-specific quantitative features in each 100 µm x 100 µm field. Figure
4.1 illustrates this procedure and demonstrates the six different quantitative histological
features: NeuN field fraction, neuron density, mean neuron size, small neuron density,
large neuron density, and GFAP field fraction.
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Figure 4.1: Histological processing and semi-quantitative features extraction, for both
NeuN and GFAP IHC stains.
4.2.4 ROI Placement and Image Registration
To quantitatively correlate in-vivo MRI parameters and corresponding histological fea-
tures, we relied on region of interest (ROI) analysis as a means of extracting the desired
parameters and features from homologous regions. Histology ROIs were delineated on
100 µm downsampled H&E histology slices using ITKsnap [10]. Since the middle tem-
poral gyrus was present in all available resections, ROIs were defined on the histology
slides at the crown of the gyrus comprising grey matter (GM) and white matter (WM)
sub-regions (Figure 4.2), as was also done by Eriksson et al. [2]. The edges of the WM
ROIs were constrained to be 2 mm from the grey/white boundary and were not delin-
eated inside the high curvature regions of the gyrus. The boundaries of the GM ROI
were limited to a distance of 1mm from the pia to avoid partial volume effects on the
in-vivo MRI images. A total of 55 ROIs: 29 GM and 26 WM (one patient had no WM
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ROIs as the resection did not include sufficient tissue), were segmented on histology
slices.
To ensure that equivalent ROIs were analyzed in each modality, we employed non-
rigid image registration to map the H&E defined histology ROIs to the IHC slides
and the in-vivo MRI. Non-rigid image registration was performed between the in-vivo
MRI and histology images, using an ex-vivo MRI scan of the specimen as an interme-
diate reference image to effectively split the registration in two steps. After surgical
resection, each specimen was oriented by the operating neurosurgeon, photographed
and transported on ice to the imaging lab for ex-vivo scanning, which was performed
after overnight fixation in 10% formalin. Each specimen was wrapped in gauze for
stabilization, transferred to suitably-sized containers for imaging, and immersed in a
fluorine-based ‘fluid Christo-lube MCG 1046T M’ (Lubrication Technology, Inc) prior
to imaging to avoid susceptibility artifacts at the tissue boundaries. The specimen scan-
ning was performed on the same 3 T MR scanner employed for patient imaging, using a
6 channel coil designed to image the carotid artery. The sequences used for images that
are part of the registration pipeline are described in detail below. The T2-weighted im-
ages were acquired with the fast imaging employing steady state acquisition (FIESTA)
sequence (TR = 8.17ms, TE = 4.08ms, flip angle = 40circ, N = 2, matrix = 200 × 200,
slice thickness = 0.4, FOV = 70 mm) with a resolution of 0.35 × 0.35 × 0.4mm. For
cases where overnight imaging was feasible and not disruptive to the clinical work
flow (N=4), scanning was performed on a 9.4T small bore Agilent MR magnet (Agi-
lent, Santa Clara, CA, U.S.A) for improved image resolution and signal-to-noise ratio
(SNR), as an alternative to the 3T scan. The specimens were scanned with an in-house
developed coil for a total time of sixteen hours. For this protocol, images were acquired
with the TrueFisp sequence (TR = 7.6 ms, TE = 3.8 ms, flip angle = 30circ) with an
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isotropic resolution of 0.2 mm and a FOV of (50 × 26 × 44) voxels.
First, we aligned the histology images from each specimen to the corresponding
slice within the 3D ex-vivo MRI volume [11]. Next, the in-vivo and ex-vivo MR images
were aligned using a combination of image-based and landmark-based 3D deformable
registration. The image-based registration made use of a B-spline deformation field
and a normalized mutual information (NMI) cost-function [12], while the landmark
registration relied on Gaussian radial basis functions [13].Validation of our registration
protocol was achieved by computing target registration error (TRE) based on manually-
identified corresponding intrinsic anatomical landmarks, demonstrating registration er-
rors of 0.98 ± 0.60 mm and 1.35 ± 0.11 mm for histology to ex-vivo and ex-vivo to
in-vivo registrations respectively [11]. The IHC slides (NeuN and GFAP) were linearly
co-registered to the H&E slides using downsampled grayscale images of each slide,
with registration accuracy better than 0.5 mm [11]. To avoid oblique resampling of the
anisotropic histology images, for the purposes of visualization and analysis, the in-vivo
and ex-vivo images were ultimately transformed to the space of the 3D reconstructed
histology, Hist3D, where the reconstructed coronal histology slides are stacked parallel
to the anterior-posterior axis. Figure 4.3 illustrates the four different spaces of MRI and
histology, and registration results to bring both modalities in alignment. All in-vivo
quantitative maps (T1, T2, FA, MD, AD and RD) were warped to the Hist3D space
using the resultant deformation fields. Similarly, the histology ROIs were mapped to
the IHC slides and the intermediate space, and underwent a final step of manual cor-
rection, if needed, to account for potential registration errors and to circumvent partial
volume effects. ROIs transformed to in-vivo MRI space were used to obtain estimates
of the mean MRI parameter T1, T2, FA, MD, AD, and RD at each location in the plane
corresponding to the histology slides.
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Figure 4.2: ROI placement and MRI parameters extraction. A) Grey matter and white
ROI on 100um H&E histology slice in histology native space. B) Registered ex-vivo
MRI slice corresponding to the histology slice in Hist3D space. C) Warped ROIs
overlaid on the registered and obliquely resampled T1 map in Hist3D space where
MRI parameters extraction is performed. The registered histology slice is shown in the
top left corner. D) Warped ROIs in the native in-vivo MRI space overlaid on three
consecutive slices of the T1 map for illustration purposes.
Figure 4.3: Overview of our registration pipeline depicting registration results and the
four different spaces of MRI and histology including the intermediate Hist 3D space
where reconstructed histology slices are stacked parallel to the A-P axis.
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4.2.5 Statistical analysis
To assess the Gaussianity of the distribution of MRI samples, we employed the D’agostino
& Pearson omnibus normality test. Linear mixed effects with random effects were em-
ployed to test for relationships between MRI parameters and histological features. For
these analyses the histological features (stain field fraction, neuron size and neuron
counts) were entered as dependent variables and MRI parameters (T1, T2, FA, MD)
from patients and slices as the independent variables, whereas variables for both pa-
tient and slice were entered as repeated measures. In addition, a random effect for
subject was included to account for lower variance of MRI parameters within a single
(across slices) subject as compared to between subjects. For fixed effects, we first fitted
a model that included all MRI parameters as explanatory variables. We employed Wald
statistics for covariance structure selection. In addition, we assessed the correlations
between each of the above variables as well as seizure frequency, age at the time of the
last consultation prior to surgery, age of seizure onset, duration of epilepsy, and side of
onset/resection. We also looked at correlations between each MRI parameter and every
other MRI parameter, as well as those between histological features.
To investigate whether white matter MRI abnormalities are related to adjacent cor-
tical histology, we also employed linear mixed models between MRI parameters from
each WM ROI with histology features from its neighbouring GM ROI. Statistical anal-
yses were performed in IBM SPSS statistics 20 (IBM, Armonk, NY). To test whether
combining multiple MRI parameters leads to better prediction of histological features,
multi-parametric models were compared against simpler univariate models using like-
lihood ratio tests.
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4.3 Results
4.3.1 MRI parameters-Histology features correlation
The registration protocol enabled us to determine precise correspondences between MR
and histology slices, and hence parameters from each slice were not averaged per pa-
tient and were instead employed as unique data points in the analysis. P-values from
the linear mixed effects model analysis for the following histological features: neu-
ron density, density (big neurons), density (small neurons), NeuN field fraction, are
summarized in Table 4.2. T1 was found to be a significant predictor of total neuronal
density in GM (Figure 4.4), as well as NeuN field fraction in the GM. Moreover, when
assessing different sub-types of neurons, T1 and FA were both found to be predictors
of neuronal density of large-caliber neurons (pyramidal cells) in the GM. Furthermore,
only T1 was found to be a predictor of small-caliber neurons (granular cells) in the
GM. There were no significant associations between the GFAP field fraction and any
MRI parameter in either GM or WM. Similarly, no significant associations were seen
between histology and MRI parameters in the white matter.
4.3.2 Multivariate vs. univariate MRI
To test whether combining multiple MRI parameters leads to better prediction of histo-
logical features, multi-parametric mixed effects models were compared against nested
univariate models using likelihood ratio tests and the chi-squared distribution. Multiple
linear regression analysis demonstrated that combining T1 and FA values predicted GM
neuronal density of large-caliber neurons with a better fit than T1 or FA on their own
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Figure 4.4: Relationships between quantitative MRI parameters (T1 and FA) and
neuronal density in GM (Top left: Total neuronal density, Top right: Neuronal density
for small-caliber neurons, Bottom: Neuronal density for large-caliber neurons).
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Table 4.2: Results of the linear mixed-effects models with random effects for subjects,
showing parameter estimates (β), standard error (SE) and p-values for all variables.
Density (L.N)= Large Neurons, Density (S.N) = Small Neurons, NeuN F.F = Field
Fraction. * Variable with fixed effect significant at p < 0.05, ** Variable with fixed
effect significant at p < 0.01
Total density Density (L.N) Density (S.N) NEUN F.F
Grey β p β p β p β p
matter (SE) (SE) (SE) (SE)
T1 -0.427 0.008 -0.387 0.021 -0.517 0.004 -0.531 0.003
(0.064) (0.066) (0.122) (0.137)
T2 0.038 0.733 0.085 0.227 -0.101 0.422 -.118 0.526
(0.112) (0.062) (0.122) (0.113)
FA -0.091 0.101 -0.446 0.009 -0.022 0.209 -0.282 0.089
(0.077) (0.031) (0.087) (0.048)
MD -0.049 0.649 0.065 0.243 0.044 0.722 -0.067 0.549
(0.107) (0.050) (0.123) (0.108)
( -2 log likelihood difference: 12.06, p < 0.001). Other multi-parametric combinations
however failed to demonstrate similar predictive improvements. Figure 4.5 plots the
samples in the space spanned by T1 and FA, revealing that combining both parame-
ters provides better discrimination of density of large neurons in neocortical GM. Each
dot in this plot refers to a grey matter ROI on a histology slide, with representative
dots being labeled with patient IDs from Table 4.1. It is clear from the figure that low
and high neuron densities are not well separated when using T1 or FA (see projections
on horizontal and vertical axes), but in the two-dimensional space the data demonstrate
are more clearly separable (demonstrated by the dashed line), suggesting that multivari-
ate or multi-parametric analysis would be more beneficial in predicting or classifying
pathology in-vivo. Since the presented ROIs are extracted from sparsely sectioned his-
tology slices (4 mm apart), this figure highlights the potential of imaging parameters in
detecting local pathology within the neocortex.
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Figure 4.5: Representation of T1-FA multi-parametric space, revealing that combining
T1 and FA provides better discrimination of normal and abnormal neuron density in
neocortical grey matter. Each dot in this plot refers to a grey matter ROI on a histology
slide, with representative dots being labeled with patient IDs from Table 1. It is clear
from the figure that low and high neuron densities are not well separated when using
T1 or FA (see projections on horizontal and vertical axes), but in the two-dimensional
space the data demonstrate are more clearly separable (demonstrated by the dashed
line), suggesting that multivariate or multi-parametric analysis would be more
beneficial in predicting or classifying pathology in-vivo. Since the presented ROIs are
extracted from sparsely sectioned histology slices (4 mm apart), this figure highlights
the potential of imaging parameters in detecting local pathology within the neocortex.
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4.3.3 Correlation with clinical variables
Correlations with clinical variables revealed significant positive correlations between
neuronal density and age (rs = 0.726, pfwe = 0.021). Finally there were significant
correlations with side of seizure onset, with left TLE patients exhibiting increased GM
T1 (rs = 0.671, pfwe = 0.042). Clinical variables did not correlate with either the MRI
parameters or histological features in white matter.
4.3.4 MRI-MRI parameters correlation
Table 4.3 summarizes the correlations between all MRI parameters within both tissue
types (GM and WM). When assessing the relationships between diffusion and relaxom-
etry parameters, there was a negative correlation between T1 and FA in WM, as well as
a positive correlation between T1 values and MD in WM. When assessing the relation-
ships between diffusion parameters (FA vs. MD) and also relaxation parameters (T1 vs.
T2) no significant correlations were found after multiple comparison correction. Figure
4.6 demonstrates the significant relationships between diffusion and relaxometry MRI
parameters.
4.3.5 Histology-Histology features correlation
As for the histological features, we found a positive correlation between neuronal den-
sity and NeuN field fraction in GM (rs = 0.929, p = 4.0x10-09), as shown in Figure 4.6.
Similarly, neuronal density was positively correlated with densities of both large and
small neurons in GM when analyzed separately (rs = 0.93, p = 1.4x10-09 and rs = 0.95,
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Table 4.3: Significance of Spearman Rho correlations between MR parameters. All
p-values were corrected for family wise error.
Grey matter parameters T1 T2 FA MD
T1 r = 0.323 r = 0.207 r = 0.129
P = 0.428 P = 0.515 P = 0.843
T2 r = 0.316 r = 0.036
P = 0.463 P = 0.931
FA r = 0.188
P = 0.612
MD
White matter parameters T1 T2 FA MD
T1 r = 0.464 r = 0.806 r = 0.643
P = 0.144 P = 1.73e-04* P = 0.032
T2 r = 0.229 r = 0.381
P = 0.639 P = 0.241
FA r = 0.527
P = 0.147
MD
p = 1.4x10-10). In addition, a slightly higher correlation was detected between NeuN
field fraction and density of larger neurons in GM (rs = 0.96, p = 1.5x10-11), than with
density of smaller neurons in GM (rs = 0.83, p = 1.8x10-05). Finally, the association
between both measurements of densities proved positively correlated as well in GM (rs
= 0.80, p = 1.1x10-04).
4.4 Discussion
4.4.1 Neurobiological interpretations and considerations
A significant finding of this chapter was the negative association between T1 values
and neuronal integrity measures (NeuN field fraction, neuronal density) in the grey
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Figure 4.6: Significant relationships between diffusion and relaxometry MRI
parameters, as well as the association between neuronal density and NeuN field
fraction.
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matter. T1 relaxation is related to many factors in the tissue, including macromolecular
integrity and the relationship between free and bound water. Neuronal loss will likely
result in an overall loss of macromolecules and an increase in the extra-cellular space
(thus increased amount of extra-cellular water and decreased amount of intra-cellular
water), all of which would act to increase T1 [14]. A similar relationship between ex-
vivo GM T1 values and neuronal density has been described in patients with multiple
sclerosis [15]. Our study is the first to observe this relationship with in-vivo quantitative
T1 mapping and in temporal lobe resections. Eriksson et al. [2] found correlations
between T2 and grey matter NeuN field fraction, employing a dual-echo fast FLAIR
T2 (FFT2) mapping at 1.5T with a 5 mm slice thickness. One possible explanation
why we did not observe this trend with our T2 maps could be because of differences
in the mapping protocols; our protocol is at 3T, has significantly thinner slices, and did
not use a fluid-attenuated inversion recovery (FLAIR) sequence. We plan to compare
the relationship between our T1 and T2 maps and FLAIR sequences in future work to
better understand the effectiveness of each technique in assessing pathology.
We also found that FA was a predictor of neuronal density of large-calibre (layer
3/5) neurons in the cortical gray matter. While this seems counterintuitive to our ex-
pectations in white matter, where a decrease in FA is usually associated with pathology,
the cyto- and myelo-architecture in the cortex is considerably different from that in
the white matter. Moreover, an increase in anisotropy was previously reported [16]
within the dentate gyrus in an animal model of seizing rats, as compared to naive con-
trols. Diffusion anisotropy is low and not typically examined in the cortical grey matter,
with some exceptions [17]. However high-resolution diffusion studies on post-mortem
brains have shown that the fiber configuration can be complex, with both fibers parallel
and perpendicular to the cortical surface observed, along with areas of fiber crossings
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[18]. In a region of low anisotropy due to fiber-crossing, such as the cortex, selective
loss of one type of fibers would lead to an increase in anisotropy (i.e. a shift to a sim-
pler fiber configuration). This phenomenon has been observed previously in a region of
white matter fiber-crossing, where Douaud et al. [19] demonstrated an increase of FA
could be explained by a relative preservation of motor-related projection fibers crossing
the association fibers of the superior longitudinal fasciculus in mild cognitive impair-
ment subjects. Thus, the increase in FA we observed, coinciding with a loss of only
large-calibre neurons, could be explained by the selective loss of fibers running either
parallel or perpendicular to the cortical surface), as depicted in the simplified schematic
representation in Figure 4.7. Given the limitations of in-vivo DTI data we cannot pre-
cisely assess the nature of the architectural changes related to FA, however we hope
to explore these issues further using high-resolution ex-vivo DTI of the resected speci-
mens.
In the white matter, increases in T1 were positively correlated with MD and nega-
tively with FA. This agrees with previous studies that have also demonstrated reduced
FA and increased MD in the ipsilateral white matter in TLE [20, 21, 22, 23, 24, 25].
These changes may be due to degeneration of axons, reduced packing, or demyeli-
nation [26] which may facilitate isotropic diffusion and accumulation of free water
in the extracellular space, which would lengthen T1 as well. A similar trend of pro-
longed T1 times and decreased FA was reported in white matter hyperintense regions
of Alzheimer’s patients [27], where they showed that increased T1 reflected a range of
pathological findings including axon and myelin loss and microglial activation, whereas
the strongest predictor of decreased FA was axonal loss. In addition to affecting relax-
ation and diffusion parameters, reactive gliosis has also been previously associated with
neuronal loss [28]; however we did not observe any significant correlations with GFAP
4.4. Discussion 143
Figure 4.7: Summary of MRI parameters and histological features correlations in both
tissues of the temporal lobe neocortex, along with possible neurobiological
explanations for the highlighted relations.
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IHC in either GM or WM.
The positive correlation reported between age and neuronal density has been shown
previously in a healthy aging population [29], and was attributed to atrophy (volume
loss) without accompanied neuronal loss. This has potential implications on the detec-
tion of neuronal integrity, since if age-related atrophy (density increases) and neuron
loss (density decreases) occur simultaneously, there may be no net change in density,
and thus no change in MRI signal. Finally, we found significant differences in left-onset
TLE patients, who demonstrated had increased T1 and decreased FA in the grey matter.
Asymmetry has also been found in other recent DTI studies [30, 31] with left-onset pa-
tients having more significant and widespread abnormalities and greater hippocampal
atrophy [32], and have been speculated to be due to the greater vulnerability to early
injury and the progressive effect of seizures on the left hemisphere. These asymmet-
ric structural differences could also be related to the inherent functional lateralization,
including language dominance [33].
4.4.2 Benefit of registration-based correlation
Many studies correlating MRI and histology have been performed without the use of
computational methods for 3D image registration, relying instead on visual matching of
ROIs. However, this is difficult in cases where the visibility or boundaries of the lesion
in MRI and histology differ and where no definitive lesion is apparent (as in paradoxical
TLE). Another drawback of visual matching is that it becomes more challenging to find
corresponding slices when there are 3D deformations present, as the anatomy in a his-
tology slice may not be fully present in a single MRI slice, even if obliquely resampled.
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If no registration is employed and the tissue is subjected to non-rigid deformations,
the samples from both modalities may represent different parts of the same anatomical
region, which could potentially lead to abnormal sub-regions of one modality being
correlated with normal elements of the other. When image registration is employed,
the degree of mismatch between regions of both modalities becomes dependent on the
registration error. For example, an image registration error between in-vivo MRI and
histology of 1 mm would produce an overlap of 70% between two regions of interests
with a volume of 140 mm3 on each modalities, (roughly the size of a very small FCD)
[34].
4.4.3 Limitations and future work
The current study is limited to the investigation of neuronal integrity and gliosis through
field fractions and measurements of neuronal size and density. Since focal neuronal loss
and gliosis are thought to be related to epileptogenicity, correlation of these measures
with MRI is an important step in validating quantitative imaging techniques. Additional
insight might also be gained through the use of myelin-specific stains (Luxol fast blue,
or myelin basic protein), since their relationship with both T1 [35] and T2 [15] has
been previously demonstrated. Another limitation of this preliminary work is the lack
of normative control data for histology, which we plan to address in future studies
with tissue obtained from post-mortem specimens. The lack of control non-epileptic
specimens makes it difficult to validate that the observed pathological changes directly
relate to seizure generation.
In addition to histopathology, correlation with electrophysiology obtained with in-
tracranial EEG (iEEG) could be used to further validate these techniques and better
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understand the relationship with epileptogenicity, imaging, and histology. However,
there are some issues with using iEEG as a gold-standard for validating imaging meth-
ods, since localization is limited to placement of the electrodes and abnormal iEEG
may not actually have an altered structural substrate that can be detected. For these
reasons, it may still be more beneficial to investigate the histopathological correlates in-
stead of iEEG, specifically of cortical dysplasia, which often go undetected and have a
higher risk for seizure recurrence [36]. We intend as well to correlate our imaging find-
ings (specifically abnormalities found on T1 and FA maps) with long-term seizure out-
comes, and investigate whether the absence of such lesions provides more favourable
outcomes for patients undergoing surgery due to hippocampal sclerosis. Future work
should as well investigate whether these neocortical abnormalities are related to the
epileptogenicity in those patients, possibly though correlation of the imaging abnor-
malities with depth electrode recordings. Better quantification and characterization of
these lesions in histology, based on neuronal- and laminar-centric analysis, could be
used to improve detection and precise delineation with MRI, and could improve surgi-
cal outcomes through more complete resection of the underlying pathology [37]. Our
future work in this direction will build upon histological image processing techniques
and ex-vivo MR microscopy to accurately quantify and characterize these lesions for
correlation with MRI.
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Chapter 5
Correlation of Hippocampal MRI and
histology
5.1 Introduction
Chapter 4 focused on correlating pathology from neocortical TLE with imaging find-
ings. Although the landscape of epilepsy surgery is changing with more neocortical
lesions and FCD resections being performed, patients with hippocampal sclerosis (HS)
still compromise the majority of surgical patients. In this chapter I focus on analyz-
ing imaging findings within the hippocampal subfields for patients with TLE due to
HS. Since the early 1990s HS has been detectable on pre-operative MRI [1], where
its classic hallmark is reduced hippocampal volume and increased signal intensity on
T2-weighted scans and T2 relaxometry maps. A large body of research has established
This chapter is in-preparation for submission to the journal ‘Annals of neurology’
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the reliability of hippocampal volumetry and/or T2 signal increases in reflecting hip-
pocampal atrophy [1, 2, 3, 4, 5, 6, 7, 8, 9, 10], and psychological functioning such
as memory performance [11, 12] Subfield hippocampal volume changes in intractable
TLE have also been previously described in the epilepsy literature [12, 13, 14]. More-
over, previous studies investigated diffusion changes in patients with HS and demon-
strated increased MD as well as decreased FA in the ipsilateral hippocampi and white
matter [15, 16, 17, 18, 19]. However, these studies lacked histological validation and
the exact causal relationship between structural changes and epileptogenesis in the hip-
pocampus is still unclear. Moreover, because of limited image resolution, as well as
the lack of sensitivity of standard clinical sequences to detect hippocampal subfield at-
rophy, the current radiological clinical practice is to report the presence or absence of
HS without mention of the subtypes or subfield atrophy and pathology. Quantitative
MRI sequences such as high-resolution T2 relaxometry mapping and diffusion tensor
imaging (DTI) can reveal subtle pathologies undetected on conventional or routine MRI
[20, 21, 22].
To this end, there are three primary objectives of this current study. We first seek
to establish the pathological substrates of hippocampal volume and intensity changes
in TLE, by correlating quantitative MRI parameters including relaxation, diffusion and
volumetry measures with histological features such as neuronal loss and gliosis within
the subfields. We then investigate the efficacy of these quantitative MRI measures in
predicting neuronal loss from in-vivo imaging, and finally compare the influence and
importance of each subfield in classifying hippocampal sclerosis subtypes from pre-
operative MRI.
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5.2 Materials & Methods
5.2.1 Patients and Samples
15 TLE (6 males, 9 females, age: 34 ± 11 (range: 20-56)), who underwent anterior
temporal lobectomy (ATL) surgery, were included in this study. It should be noted
that while there is overlap between the patient cohorts of this chapter and Chapter 4,
the patients groups are not identical across both chapters and their inclusion criteria
depended on clinical MRI and histology reports of the studied pathology (whether
neocortical or hippocampal). In the ATL procedure, the mesial structures, the hip-
pocampus and amygdala, and up to 3-5 cm of the temporal neocortex are removed.
Informed consent was collected from all participants prior to their participation in the
study. This project was cleared by the Health Sciences Research Ethics Board of West-
ern University. All patients had preoperative investigations including 1.5T clinical MRI
scans (T1-weighted, T2-weighted, FLAIR, and diffusion-weighted sequences) and neu-
ropsychological testing, as part of their clinical diagnostic workup. Video-scalp EEG
telemetry was employed to monitor patients for seizure characterization, with four pa-
tients needing subdural electrodes placement to better localize the seizures. In addition
to the 1.5T conventional MRI sequences, patients underwent a series of scans on a 3T
MRI research scanner as described in the in-vivo MRI imaging subsection. Table 5.1
summarizes the age at the time of the last consultation prior to surgery, gender, age at
seizure onset, electrographic seizure origin, Engel outcome as well as clinical MRI and
pathology findings for our patient cohort.
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5.2.2 In-vivo MRI and Qualitative classification
All patients underwent in-vivo imaging, including relaxation (T1 & T2) mapping and
DTI, on a 3T Discovery MR750 scanner (General Electric, Milwaukee, WI, U.S.A.)
using a 32 channel head coil. In-vivo image acquisition sequences and scanning pa-
rameters are described in details in Chapters 3 & 4. In addition to the T2 relaxometry
map, we computed normalized T2 intensity (normalized in respect to the lateral ven-
tricle ipsilateral to the hippocampus) from one of the ssfp scans (flip angle 35). A
three-level clinical hippocampal sclerosis classification of the patients was performed
employing MRI and histology reports. The degree of sclerosis was stratified with no
HS being scored as 1, moderate 2 and severe HS 3. This clinical classification will
henceforth be referred to as ‘Qualitative HS subtypes’.
5.2.3 Histological processing and quantitative histology
Two of the 15 specimens were discarded from the analysis as the hippocampi were
fragmented and there was insufficient tissue to clinically assess HS or perform au-
tomated neuron analysis. The resected hippocampal specimens underwent grossing
and accessioning at the Department of Pathology of the University Hospital of London
Health Sciences Centre. There are numerous challenges, particularly the high com-
plexity of en-bloc resection, as well as preservation of very small sclerotic hippocampi
throughout histological processing, encountered in our pipeline to perform quantitative
histology on surgical hippocampal specimens. Other technical challenges comprise the
tendency of the tissue to deform and presentation of histological breakage (partially due
to the differential shrinkage of gray and white matter) across the specimens. To better
158 Chapter 5. V Correlation of Hippocampal MRI and histology
Table 5.1: Patient demographics and clinical information including age, gender, onset
age, seizure origin as well as clinical MRI and pathology findings for our patient
cohort. HS = mesial temporal sclerosis, MAA= minor architectural abnormalities,
Neo. Path. = Neocortical Pathology, Hp. Path. = Hippocampal Pathology † Previous
resection of left temporal lobe tumour (DNET), ‡ not enough tissue to make diagnosis
of HS
ID Sex Age Onset Sz Origin SzFreq. MRI Hp. Path.
Engel Yrs
/month outcome since
surgery
1 F 22 15 R 8 Normal Early
stage
HS
2 3.52
2 M 52 45 L 2 Tumour Gliosis 2 3.37
3 F 40 7 R 20 HS,
Poren-
cephaly
HS 2 2.5
4 M 20 3 L 16 HS HS 2 2.1
5 F 48 36 L 28 HS HS 1 1.7
6 M 30 2 L 4 HS HS 1 1.87
7 M 31 28 R 2 Normal Negligible
gliosis
1 1.3
8 F 32 19 L 2 HS HS 1 1.2
9 F 43 3 R 4 HS HS 2 1.4
10 M 39 22 R 2 CD Gliosis 1 0.94
11 M 23 18 L 12 Normal Gliosis 1 1
12 M 34 15 L 2 HS HS 3 1.2
13 F 25 17 L 2 Normal
†
Gliosis 3 2
14 F 56 15 R 8 Normal Gliosis
‡
1 1.12
15 M 39 13 R 12 DNET
or CD
Gliosis
‡
2 1.16
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preserve the specimen, they were cut in half in the coronal plane and each half was
embedded in agar for stabilization as well as support during slicing. The histological
processing pipeline (slicing, embedding, sectioning and digitization) was identical to
that described in chapter 2. Similarly, the GFAP field fraction estimation was identical
to the protocol described in chapter 4.
To provide local estimates of neuron density and size we developed a method for
segmenting cell bodies of pyramidal and granular neurons. This technique first extracts
the colour component related to immuno-positive staining using colour deconvolution
[23] preceding a watershed-based segmentation procedure [24] for splitting joined or
connected neurons, and removes objects smaller than a predefined area defined as noise
(less than 14 µm2). The resulting neuron segmentations provide the neuronal density
(number of neurons) per field, as well as the mean area (size) of cell bodies, within
the field. To further discriminate between pyramidal neurons of the CA subfields and
granular neurons of the dentate gyrus, we used area thresholds (125 µm2 and 50 µm2
respectively) to categorize them. NeuN slides were batch-processed with scripts written
in MATLAB, to extract the neuron-specific quantitative features in each 100 µm × 100
µm field. Manual counts taken from random fields within the CA subfields as well as the
dentate gyrus were employed to validate our automated cell segmentation procedure for
pyramidal and granular neuron quantification. Figure 5.1 illustrates this procedure and
demonstrates some of the quantitative histological features: neuron density (for both
CA and DG), mean neuron size, and GFAP field fraction. Neuronal counts from the
least sclerotic specimens per subfield were used as references to compute percent cell
loss for each patient. A second HS subtype classification was performed based on the
computed percent cell loss employing guidelines (thresholds for percent cell loss per
subtype and subfield) from the new clinico-pathological classification of the different
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subtypes [25]. This classification will be referred to as ‘Quantitative HS subtypes’
throughout the manuscript. It should be noted that five patients out of the 13 that were
classified as having different grades of sclerosis, based on clinical reports, compared to
that identified via histological cell loss, as shown in Table 5.2.
Figure 5.1: Overview of some of the quantitative histological features including:
neuron density (for both CA and DG), mean neuron size, and GFAP field fraction.
5.2.4 Histology subfields segmentation
The hippocampal subfields were subsequently manually delineated on 20 µm downsam-
pled histology slices, using the open-software tool ITKSNAP [26] and were checked
by a pathologist (R.H). This segmentation protocol is similar to that described in Ap-
pendix A [27] and is based on previous protocols proposed by Wisse et al. [28] at 7T
and the Duvernoy hippocampus atlas [29]. The key difference between our previous,
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Table 5.2: Percent neuron loss per subfield and qualitative and Quantitative HS
subtype classifications.
Patient CA1 CA2 CA3 CA4 Qual.
HS
subtype
Quant.
HS
subtype
1 29.1951 11.9081 27.6011 0 1 1
2 0 0 32.936 29.5362 1 1
3 67.3426 91.7395 96.1312 95.1284 3 3
4 48.4765 29.357 84.0857 97.598 2 2
5 66.3895 40.7307 88.6651 96.063 3 3
6 80.3388 39.1261 92.3729 95.5111 2 3
7 64.5315 9.96929 28.3791 15.5876 1 2
8 67.0925 52.5966 95.2398 93.5412 3 3
9 69.9437 51.275 75.3959 87.3308 2 3
10 16.7605 39.1261 0 19.9012 1 1
11 32.0994 52.1615 50.5222 44.4942 1 2
12 72.2818 53.2529 80.6291 88.398 2 3
13 69.7113 4.0401 50.6483 64.1137 3 3
and current MRI delineation protocols employing higher resolution histology images,
is that a distinction was made between CA2 and CA3, as well as CA4 and dentate
gyrus in the newer protocol. The marking scheme and border definitions are as fol-
lows: The border between the subiculum and CA1 was defined as a horizontal line at
the edge of the subiculum extending from the inferior border of the dentate gyrus and
the hippocampal sulcus. The CA1/CA2 boundary was designated as the point at which
a noticeable decrease in width of the CA1 subfield was observed, following the most
lateral point of the DG. The CA2/CA3 boundary was defined at the most medial point
of the superior curve of the dentate gyrus where a gradient of pyramidal cells density
is observed between the subfields. The opening of subfields into the globular region of
the hippocampal formation formed the CA3/CA4 border. The remaining globular re-
gion of the hippocampal formation was marked as the CA4 subfield. The dentate gyrus
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was divided into two labels, one encompassing the granular layer and another combin-
ing both molecular and polymorphic layers surrounding the granular cells. Figure 5.2
shows examples of subfield delineation on histology slices from three patients from our
cohort with mild, moderate and severe sclerosis.
5.2.5 MRI subfields segmentation
The standard methodological convention, employed in previous correction studies of
hippocampal histology and MRI, is to correlate pathology findings on one or a few
histology slices with MRI findings extracted from the entire hippocampus. Work from
previous chapters focusing on an image registration pipeline between both modalities
provides us with the MRI slice corresponding (or registered) to the cut histology slice.
Hence, instead of relying on imaging parameters from segmented subfields along the
entire length of the hippocampus, I extract parameters from a selective, patient-specific,
target region around the corresponding MRI slice (within the hippocampal body). Fig-
ure 5.3 presents a schematic overview of the MRI parameters extraction pipeline. A
region was chosen for parameter extraction, instead of relying only on parameters from
the corresponding MRI slice to incorporate registration and histological sectioning er-
rors. The target registration error for my pipeline was previously quantified to be
around 2 mm, moreover, Gibson et al. [30] quantified the variance in sectioning his-
tology slices from the face of blocks to be 1 mm. Thus, a 3 mm radius was chosen
for the target region either side in the sagittal plane from the corresponding MRI slice.
In addition, instead of averaging parameters across all the slices of the target region, I
took a weighted average of the parameters whereby slices closer to the corresponding
MRI slice in the sagittal plane had higher weighting, in order to model the registration
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uncertainty. The weighting kernel employed was sync function with a full width half
maximum (FWHM) of 3 mm.
Figure 5.2: Subfield delineation on histology slices from three patients from our
cohort (Top: Mild sclerosis, Middle: Moderate sclerosis, Bottom: Severe sclerosis).
The labeling scheme (colour representing each subfield) is described at the bottom of
the figure.
To ensure that the MRI subfields within the target region mirror those segmented
on histology slices, I first initialized the labels using the automated Freesurfer sub-
fields segmentation technique [31], then manually segmented the subfields within the
chosen target region. Three main subfields were delineated using the segmentation
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technique, including CA1, CA2/3 and CA4/DG. To employ the Freesurfer segmen-
tation algorithm, I first created a synthetic T1-weighted image from the T1 map for
each patient. The signal equation for the SPGR images that are employed in T1 map
generation is denoted by: where E1= exp(−TR/T1) and k is a constant proportional
to the longitudinal magnetization equilibrium [32]. Synthetic T1-weighted images
(SynT1) were reconstructed by substituting the calculated values back into the SPGR
signal equation and using a nominal value of k = 1000 [32]. These SynT1 images
(1mm isotropic) were first submitted to the automated FreeSurfer processing stream
(http://surfer.nmr.mgh.harvard.edu/). The hippocampal subfield segmenta-
tion technique [31] was then performed on the FreeSurfer-processed images after up-
sampling their voxel size to 0.5 mm isotropic. This technique uses a statistical model
with Markov random field priors to delineate subfield boundaries based on T1-weighted
MPRAGE MR sequences [8]. It should be noted that MRI parameter extraction was
performed in the intrinsic in-vivo space (1 mm isotropic) and not the upsampled space
to avoid resampling the quantitative maps.
5.2.6 Statistical analysis
Our statistical analysis was stratified into three distinct experiments comprising differ-
ent tests to tackle the three key objectives of the study. Firstly, we employed correlation
analysis to investigate non-parametric (Spearman Rho) univariate associations between
neuronal density and size vs. subfield volume, T1 and DTI, as well as between GFAP
field fraction vs. T2 and DTI. This analysis was first performed using whole hippocam-
pus MRI parameters, then employing subfield-specific parameters where only MRI and
histological features from the corresponding subfield are correlated. Internal z-scores
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Figure 5.3: In-vivo MRI parameter extraction scheme. A target region was chosen
around the corresponding (registered) MRI slice to the cut histology slice for
parameter extraction. Manual segmentation of the subfields was employed within the
target region and a sagittal weighting kernel was applied, whereby slices closer to the
corresponding MRI slice in the sagittal plane had higher weighting.
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were generated for the parameters and features and employed in the statistical analy-
sis. We corrected for multiple comparisons in our correlation analysis with family-wise
error rate (FWER) control using permutation tests [33].
To the test the efficacy of quantitative MRI parameters in pre-operatively predicting
neuronal loss per subfield, multiple linear regression analysis was performed between
all MRI parameters and percent loss of neurons for each subfield. Similarly to the
previous experiment, regression analysis was first performed employing whole hip-
pocampus, and then subfield parameters. We employed a forward stepwise selection
procedure where variables were added sequentially to the model only if they improve
the fit and the process was repeated until the addition of further variables was no longer
necessary.
Finally we employed linear discriminant functional analysis to investigate the effec-
tiveness of each subfield in accurately classifying the patients according to the quanti-
tative HS subtype classification. The classification algorithm was performed using first
the volumetric and all other quantitative parameters for whole hippocampal measures,
then the same parameters for each subfield (CA1, CA2/3 and CA4 separately). Statisti-
cal analyses were performed in IBM SPSS statistics 20 (IBM, Armonk, NY) and JMP
statistical software 10 (SAS, Cary, NC).
5.3 Results
Our manual count experiment to validate the automated neuron segmentation produced
98% and 96% agreements for computation of pyramidal and granular cell counts re-
spectively. A summary of the volumetry, relaxometry and diffusion MRI data as well
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as histological neuronal density, categorized by the qualitative HS subtype classifica-
tion, is presented in Figure 5.4.
5.3.1 MRI-histology correlation analysis
A significant positive Spearman Rho correlation was found between whole hippocam-
pal volume and neuronal density in CA1. A significant negative Spearman Rho cor-
relation was also found between whole hippocampus MD on pre-operative MRI and
pyramidal cell density and size of the CA2/3 and CA4 subfields. In addition, whole
hippocampus T1 positively correlated with neuronal size of CA4. As for subfield-
specific correlations, there was a significant positive correlation between volume on
MRI and neuronal density as well as size on histology in all subfields. MD within the
CA4/DG subfields was negatively correlated with pyramidal cell density. Moreover,
T1 in CA4/DG was negatively correlated with neuronal size and density of the CA4
subfield. Finally, CA1 normalized T2 intensity correlated with GFAP field fraction
(r=0.835, p ¡ 0.001), as shown in Figure 5.5, and CA2/3 FA was negatively correlated
with GFAP field fraction. Table 5.3 summarizes the Spearman Rho correlation results
for whole hippocampus as well as subfield-specific analyses respectively.
5.3.2 Correlations with clinical variables
Whole hippocampus volume negatively correlated with both qualitative and quantita-
tive HS subtype classifications (r = -0.917, p = 0.01 and r = -0.781, p = 0.02), where
higher grades indicated increased sclerosis. In addition, whole hippocampus MD cor-
related with the clinical qualitative HS subtype classification (r = -0.781, p = 0.04). In
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Figure 5.4: Boxplots of in-vivo MRI parameters (Volume, T1, T2, FA and MD) as
well as histological neuronal density categorized by the qualitative HS subtype
classification.
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Table 5.3: Significance of Spearman’s correlations between MR parameters and
histological features for whole hippocampus and subfield-specific analyses.
Whole hippocampus MRI parameters
H
is
to
lo
gy
fe
at
ur
es
CA1 Volume T1 T2 FA MD
Density r = 0.839 ns ns ns ns
p = 0.001
CA2/3 Volume T1 T2 FA MD
Density r = 0.586 ns ns ns r = -0.786
p = 0.035 p = 0.001
Size ns ns ns ns r = -0.835
p = 0.002
CA4 Volume T1 T2 FA MD
Density r= 0.611 ns ns ns r =- 0.857
p = 0.027 p = 0.001
Size r = 0.602 r = -0.703 ns ns r = - 0.758
p = 0.017 p = 0.007 p = 0.003
Subfield-specific MRI parameters
H
is
to
lo
gy
fe
at
ur
es
CA1 CA1Volume T1 T2 FA MD
Density r = 0.910 ns ns ns ns
p < 0.001
Size r = 0.731 ns ns ns ns
p = 0.005
CA2/3 CA2/3
Volume T1 T2 FA MD
Density r = 0.811 ns ns ns ns
p = 0.001
GFAP F.F ns ns ns r=-
0.489
ns
p=0.048
CA4 CA4/DGVolume T1 T2 FA MD
Density r=0.731 r=-0.781 ns ns r = -0.833
p = 0.005 p = 0.002 p < 0.001
Size r=0.749 r = -0.830 ns ns r = -0.841
p = 0.003 p < 0.001 p = 0.039
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the subfield-specific correlation analysis, both qualitative and quantitative HS subtypes
negatively correlated with volume of all the subfields. CA4 MD correlated as well with
both classifications (r = 0.847, p = 0.01 and r = 0.708, p = 0.03) and CA2/3 MD corre-
lated with the qualitative HS subtypes (r = -0.781, p = 0.04). When correlated against
histological features, the qualitative HS subtype classification correlated with neuronal
density in all subfields except for DG. It should be noted as well that neither qualitative
nor quantitative classification of HS subtypes correlated with Engel outcomes.
5.3.3 Multiple linear regressions
A multiple linear regression analysis was performed to predict percentage neuron loss
per subfield from quantitative and volumetric whole hippocampus MRI parameters.
Whole hippocampus volume and T2 predicted percent pyramidal cell loss in CA1 with
meager accuracy (adjusted R2 = 0.433). Only hippocampal volume added significantly
to the prediction. Whole hippocampus MD and T2 predicted percent pyramidal cell
loss in CA2/3 with high accuracy (adjusted R2 = 0.853). Only hippocampal MD added
significantly to the prediction. Similarly, MD, T2 and volume accurately predicted
percent pyramidal cell loss in CA4 (adjusted R2 = 0.853). Both MD and T2 added
significantly to the prediction. Table 5.4 summarizes the multiple linear regression fit
for predicting percent neuron loss from whole hippocampus parameters.
In the subfield-specific experiment, CA4/DG volume as well as CA1 T1 and FA,
predicted CA1 percent neuronal loss with high accuracy (adjusted R2 = 0.904). Only
volume added significantly to the model with standardized coefficients. Volume and
T1 parameters from CA2/3 as well as CA4/DG MD and T2 predicted CA2/3 percent
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Figure 5.5: Most significant associations from Spearman’s correlation analysis for
subfield-specific MRI parameters with histological features.
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Table 5.4: Model fit of multiple linear regression analysis for predicting percent
neuron loss per subfield using whole hippocampus MRI parameters.
Dependent
variable
Independent
variables
Standardized
coefficient
(β)
p F R2 Adjusted
R2
Prob
> F
% cell loss
CA1
5.588 0.528 0.433 0.023
Volume -0.586 0.022*
T2 -0.402 0.094
% cell loss
CA2/3
13.7250.795 0.649 0.023
MD 0.466 0.001**
T2 -0.395 0.043*
% cell loss
CA4
24.202 0.89 0.853 0.003
MD -0.537 0.001**
T2 -0.353 0.011*
Volume -0.288 0.066
loss with very high accuracy (adjusted R2 = 0.958). All four parameters from CA2/3
added significantly to the prediction. Finally, loss in CA4 was predicted with equivalent
accuracy using CA4/DG and CA2/3 volume and MD (adjusted R2 = 0.971). Table 5.5
summarizes the multiple linear regression results for the subfield-specific experiment.
The model fit for the prediction of neuronal loss of the four analyzed subfields from
subfield-specific parameters is demonstrated in Figure 5.6.
5.3.4 Discriminant function analysis
The quantitative HS subtypes categorization was employed as the grouping variable
for the discriminant function analysis. We performed three classification experiments
each using the volumetry and quantitative MRI parameters of each of the three pre-
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Figure 5.6: Multiple linear regression results for subfield-specific parameters depicting
predicted vs. actual percent neuron loss for each of the four CA subfields.
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Table 5.5: Model fit of multiple linear regression analysis for predicting percent
neuron loss per subfield using subfield-specific MRI parameters.
Dependent
variable
Independent
variables
Estimate
(β)
p F R2 Adjusted
R2
Prob
> F
% cell loss
CA1
39.0 0.929 0.905 <0.001
CA4/DG
Vol
-25.211 <0.001**
CA1 FA -6.714 0.039*
CA1 T1 -5.707 0.094
% cell loss
CA2/3
56.5 0.976 0.958 <0.001
CA2/3 Vol -22.754 <0.001**
CA 2/3 T1 -22.754 <0.001**
CA4/DG
MD
15.316 0.006**
CA4/DG
T2
-8.24 0.023*
% cell loss
CA4
102.8 0.980 0.971 <0.001
CA4/DG
MD
17.239 0.0008**
CA2/3 Vol -40.529 <0.001**
CA2/3 MD 3.828 0.389
CA1 Vol 10.605 0.003*
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operatively segmented subfields (CA1, CA2/3 and CA4/DG) as independents. Leave-
one-out cross-validation was employed whereby each patient was classified based on
the functions from all other subjects. CA2/3 outperformed CA1 and CA4/DG with
92.3% (all but one) of cross-validated grouped patients correctly classified, as compared
to a 84.6% (CA4/DG) and a 61.5% (CA1) accurately predicted classification.
5.4 Discussion
Numerous studies previously correlated T2 relaxometry with pathology in the context
of hippocampal sclerosis. However, they only focused on whole hippocampus MRI pa-
rameters and employed relaxometry maps with low out-of-plane resolution (> 3 mm)
[6, 3, 4, 5, 9, 10, 11]. This work is the first to investigate quantitative multi-modal relax-
ometry (T1 and T2) as well as diffusion metrics within the hippocampal subfields while
employing high resolution in-vivo maps at 3T. A comprehensive protocol that validates
high-resolution MRI maps with quantitative histology was employed to better under-
stand the pathological substrates of our imaging findings. An automated quantitative
histology procedure for quantification of neuronal density, size and NeuN and GFAP
field fractions was also developed and validated. These features maybe more sensitive
to neuronal degeneration as compared to qualitative assessment or quantitative grading
of neuronal loss as they provide a continuous measurement of pathologies.
5.4.1 Biological Interpretations
In our correlation analysis, whole hippocampus volumetry was correlated with neu-
ronal density in all subfields. Similarly, pre-operative subfield volumetry was found
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to be highly correlated with subfield density (specifically in CA1). Moreover whole
hippocampal volume, as well as all subfield-specific volumes correlated with the quan-
titative HS subtypes, which can be thought of as a global measure of neuron loss in
the subfields (since it is entirely based on percent loss). Numerous studies have re-
ported that neuronal density within the subfield may directly relate to volume atrophy
[1, 2, 3, 8, 34]. The presented subfield-specific and whole hippocampus correlation
analyses confirmed these previous findings.
Mean diffusivity was the most prominent MRI metric (having the most associations)
in the MRI-histology correlation analysis, whether whole hippocampus or subfield-
specific within CA4. In our subfield correlation analysis, MD was negatively corre-
lated with neuronal density and size of CA4. In addition, whole hippocampus, CA2/3
and CA4/DG MD correlated with the qualitative classification and only CA4/DG MD
correlated with the quantitative HS subtypes. Such correlations demonstrate the impor-
tance of this MRI parameter in determining subtypes pre-operatively. A previous study
analyzing relationships between diffusion maps and cell density in malignant brain tu-
mours described an analogous association between MD and tumour core cell density
[35]. The loss of neurons in the hippocampal subfields may lead to less restricted,
or hindered, water diffusion and thus higher diffusivity. A similar interpretation can
be described for the relationship between MD and neuronal size, since as neuronal cell
bodies shrink water diffuses more freely and diffusivity increases. Given the limitations
of in-vivo DTI data, we cannot precisely assess the nature of the architectural changes
related to MD, however we hope to explore these issues further using high-resolution
ex-vivo DTI of the resected specimens.
T1 and FA were also negatively correlated with neuronal density/size and GFAP
field fractions respectively in CA2/3. An analogous relationship between ex-vivo GM
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T1 values and neuronal density has been described in patients with multiple sclero-
sis [36]. Cell loss will likely result in an increase in the extra-cellular space, thus the
intra-cellular water will decrease as extra-cellular water increases, which in turn would
increase T1 [37]. A previous study demonstrated as well the negative correlation be-
tween FA and GFAP in a rat model of hydrocephalus pathology [38]. FA is a marker
of tissue microstructure and axonal integrity and reduced FA is often accompanying
neuronal degeneration [38]. Similarly, increased GFAP field fraction expression rep-
resents astrocytic and microglial proliferation of the subfields and increased reactive
gliosis is observed with neuronal loss. T2 anomalies have been previously suggested
to reflect gliotic changes in the dentate gyrus [34]. This relationship was not observed
in our analysis, and the discrepancy in the results may be attributed to methodological
differences since we relied on GFAP field fraction whereas glial cell counts (astrocytes
and oligodendroglial cells) were used in that study.
5.4.2 Clinical findings and insights
Multiple linear regression analysis revealed that volume and MD are the most promi-
nent parameters in predicting neuronal loss. This observation mirrors the correlation
analysis where MD and volume were the parameters with the highest number of as-
sociations with histological features. T1 was also correlated with neuronal size and
density, but a larger cohort may be needed to observe its predictive validity on neuronal
density. Hippocampal neuronal loss has been previously shown to be a predictor of
patient outcomes [39] and memory deficits [40]. Predicting subfield loss from in-vivo
quantitative MRI has the potential to non-invasively localize pathology and determine
the extent of hippocampal atrophy, with a precision so far unachievable. It may also
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help classify patients into different HS subtypes and decide on the merit of their surgical
candidacy. Both multiple linear regression and discriminant function analyses demon-
strated, as expected, that subfield-specific analysis is more sensitive towards subfield
pathology as compared to whole hippocampus measurements. Specifically, subfield-
specific parameters produced more accurate prediction of percent loss in all subfields
(mainly CA1 and CA2). Classifying HS subtypes revealed that MRI parameters from
CA2/3 and CA4/DG act as more effective discriminating variables as compared to CA1
parameters. This effect could be due to the extent of atrophy within the subfields; the
most sclerotic CA1 subfields are almost depleted of neurons by the time of surgery,
while a more balanced distribution of the subtypes is observed in other subfields.
The association between the qualitative HS subtype classification and neuronal den-
sity within the CA subfields validates the accuracy of our automated neuron quantifi-
cation procedure. Hippocampal sclerosis subtypes have previously been shown to have
different post-operative outcomes; those with CA4 atrophy have more favourable out-
comes than others [41, 42] and correlate with seizure duration and onset [43]. There-
fore, the task of determining HS subtypes from in-vivo images is of great importance
for pre-operative investigation of intractable TLE patients. The Engel outcomes pre-
sented in this study are reported in the short-term follow up with the average time since
surgery for our cohort being just under two years (22 months). The lack of correlations
between the HS subtype classification and Engel outcomes in our analysis maybe due
to the small number of subjects.
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5.4.3 Limitations and technical considerations
There are two steps in our processing pipeline where mis-registration between images
could affect the accuracy of the results. The first is the multi-modal registration be-
tween the different quantitative maps, and the second is the registration of our quan-
titative maps to the Freesurfer template for subfield segmentation (part of the labeling
scheme). The former should not account for significant error, as the employed correla-
tion ratio similarity metric is robust to multi-modal registration of the same subject. The
latter is mitigated by the generation of SynT1 images which have analogous intensities
to T1-weighted images upon which the algorithm is optimized. Although our maps are
of higher spatial resolution than standard clinical scans, a higher intrinsic resolution
(sub-millimeter) is preferred to achieve superior delineation and extraction of relax-
ation times or diffusion signal within the subfields. Another limitation of this work,
is the lack of normative control data for histology, and hence the least sclerotic speci-
mens were used as reference for computation of percent cell loss. We also employed
histological measurements from one optimal slide per subject, due to the large variabil-
ity in specimen sizes, as well as effects of tissue breakage and fragmentations of the
specimens, which may have biased the results. Another way to correlate pre-operative
MRI and pathology is through direct registration of both modalities [44] and warping
of regions of interest from histology to in-vivo space. However, for this technique to
be effective, image resolution of pre-operative volumes needs to be sub-millimeter. For
example, if in-vivo maps have a 1 mm isotropic resolution, smaller subfields (i.e CA2
and CA3) warped from histology would only occupy 2 or 3 voxels on a slice in the
in-vivo space, which would challenge the accuracy of the results.
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Chapter 6
Conclusions and future work
The focus of this thesis is the correlation of quantitative MRI parameters with quanti-
tative histological features within both the hippocampus and temporal lobe neocortex
of patients suffering from drug-resistant epilepsy. These correlations relied on image
registration and a comprehensive pipeline to bring both modalities together and merge
information from both, macro and micro, domains. Correlating MRI and histology
validates novel MRI sequences and aids in better understanding the pathological sub-
strates of our imaging findings. More importantly, I demonstrated that quantitative MRI
parameters can predict pathology and neuron integrity pre-operatively, which -with fur-
ther studies- can have an impact on pre-operative evaluation, patient stratification and
outcome prediction. Predicting subfield loss from in-vivo quantitative MRI has the po-
tential to non-invasively localize pathology and determine the extent of hippocampal
atrophy. It may also help classify patients into different HS subtypes and decide on
the merit of their surgical candidacy. These in-vivo quantitative maps can be extended
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as well as a marker for degeneration of hippocampal subfields in neurodegenerative
diseases such as Alzheimer’s.
Chapter 2 presents a protocol for registration of ex-vivo specimen MRI to histopathol-
ogy, specifically hippocampal and neocortical temporal lobe sections. Sub-millimeter
errors have been shown for ex-vivo MRI to histology registration on twelve collected
specimens from seven patients. A successful registration between histology - currently
considered as the ground truth - and post-operative MRI of resected tissue is impera-
tive for better understanding of focal epilepsy at both the micro and macro levels. This
correspondence is a key component towards achieving MRI and histology correlation
by bringing together information from both domains.
Accordingly, I implemented and validated a protocol for registration of in-vivo to
ex-vivo brain MRI specimens, allowing for the first time a dense correspondence of in-
vivo MR with temporal lobe histology. Image registration of surgically resected brain
specimens is a unique application which presents a number of technical challenges
that have not been fully addressed in previous literature. The registration accuracy
reported is within an acceptable range and allows for the spatially-local and quantitative
assessment of pathological correlates in MRI by the fusion of information from both
modalities.
In chapter 4, I demonstrated that alterations of in-vivo T1 and FA, in the temporal
lobe cortex and white matter, are predictive of neuronal integrity (density and size) that
serve to delineate an epileptogenic lesion. This work is the first to quantitatively assess
the relationship between MRI and histopathological features using correspondences
based on image registration in focal epilepsy, and to relate in-vivo T1 and FA values
to the proportion of neurons, specifically large-caliber neurons, in the neocortical gray
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matter. Our registration and correlation pipeline allows for a quantitative assessment of
the pathological correlates of MRI by bringing information from both modalities, and
the potential prediction of pathology from in-vivo MRI.
Finally, I investigated, for the first time, quantitative multi-modal in-vivo relaxome-
try and diffusion parameters within the hippocampal subfields for intractable TLE pa-
tients, and also developed and validated an automated quantitative histology procedure
for quantification of neuronal density, size and NeuN and GFAP field fractions. This
analysis demonstrates that MD correlates with neuronal density and size, and can act
as a marker for neuron integrity. More importantly, this thesis is the first to highlight
the potential of subfield relaxometry and diffusion parameters (mainly T2 and MD) as
well as volumetry in predicting patterns of neuronal loss and the extent of cell loss
per hippocampal subfield, with a precision that has not been achieved previously, bet-
ter characterizing different HS subtypes pre-operatively. These in-vivo maps provide a
non-invasive means of localizing pathology and determining the degree of hippocampal
subfield atrophy, which has the potential to impact pre-operative evaluation and predic-
tion of surgical outcomes. Our results suggest that high-resolution quantitative MRI
sequences could have a role in routine clinical practice for pre-operative evaluation of
drug-resistant focal epilepsy.
6.0.4 Current Limitations & Future Directions
The global hypothesis of this thesis is that the signatures provided by quantitative multi-
parametric MRI are able to predict pathology and ultimately provide vital guidance to
the neurosurgeon during surgery. There are numerous future directions needed for this
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work to achieve the ultimate goal of assisting the surgeons in localizing/resecting the
seizure focus and predicting outcomes. For in-vivo maps to accurately predict pathol-
ogy, many more patients need to be recruited to build a database of associated MRI
parameters and pathology across different pathological substrates and sclerosis grades.
Data from this large cohort would be fed into a machine learning algorithm such as a
support vector machine (SVM) classifier that determines the set MR parameters most
likely to represent each histological feature. Such algorithms will learn, or train for,
the optimal set of features from all but the tested (new) subject in a cross-validated
manner to predict pre-operatively. The resulting ‘predictive’ histology maps would be
presented to the surgeons for minimally invasive pre-operative planning. Such maps
could also be employed in an augmented reality setting as an interactive display for
surgical guidance during the operation. Our imaging-histology protocol allows the de-
velopment of a workflow from in-vivo imaging to the operating room that incorporates
these ’predictive’ maps and eventually their validation through histological analysis.
Furthermore, this work only focused on correlating structural substrates extracted
from histopathology with MRI. Whether predicted structural pathology is directly re-
lated to the epileptogenicity of the tissue, and whether histopathological findings are
more extensive than the epileptogenic cortex, are questions that still need to be ad-
dressed. Correlation with functional data such as electrophysiology acquired using
either scalp or intracranial EEG could be used to validate the link between imaging
findings and epileptogenicity and better understand the relationship between imaging,
histology and seizure generation/propagation. With the moderate, current long-term
success of surgery, outcome prediction and patient stratification into perspective Engel
outcomes is a vital task for clinicians. Hence, it is of great importance to correlate the
presented imaging findings with long-term seizure outcomes, and investigate whether
192 Chapter 6. VI Conclusions and future work
the absence of such lesions provides more favourable outcomes. Similarly, a larger set
of truly negative TLE patients (where clinical MRI fails to find hippocampal, neocorti-
cal or whole-brain anomalies) needs to be examined with multi-parametric quantitative
MRI to validate the effectiveness of these techniques in lesion detection for this subset
of patients.
Appendix A presented a quantitative normative atlas of the hippocampal subfields
using R2* and quantitative susceptibility at 7T. We aim as well to investigate these
high field quantitative parameters within the subfields, in both HS-positive and neg-
ative patients, against volunteers to better understand and characterize hippocampal
pathology. Another limitation of this work was the follow-up times and short-term out-
comes employed for analysis. Since surgical outcomes is a major factor for these pa-
tients, performing the presented analyses/correlations between multi-parametric MRI
and long-term outcomes is required for the translation of these techniques to clinical
protocols. Moreover, employing control histological specimens would validate the pre-
sented histological findings and aid in interpreting whether these pathological substrates
are linked to epileptogenicity of the temporal lobe in these patients.
Image resolution of in-vivo maps, whether structural or diffusion maps, is a major
limiting factor for understanding pathological substrates of MRI. We plan to explore
high field imaging, whether in-vivo 7T or ex-vivo 9.4T, for morphometry and diffusion
changes not readily detectable at lower field strengths, which will help optimize in-vivo
sequences at 1.5 and 3T. Furthermore, as advances in MRI hardware and software re-
construction continue, in-vivo scans with higher resolution and/or signal-to-noise will
become available, which will allow more accurate and confident automated image reg-
istration between in-vivo MRI and histology of the hippocampus. This would in-turn
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provide the opportunity to investigate MRI-histology associations employing voxel-
based instead of ROI-based, or subfield-based analysis. Voxel-based analysis is supe-
rior to ROIs as it samples much more data in a bias-free manner without any priors.
This technique will rely on a data-driven partitioning of the specimens, which can be
compared to anatomical knowledge such as subfields in the hippocampus or cortical
layers in the neocortex.
Bibliography
Appendix A
In vivo atlas of the hippocampal
subfields
A.1 Introduction
The human hippocampus is the most frequently studied structure in the temporal lobe,
due to its role in formation of memory and learning, among other functions. Struc-
tural abnormalities of the whole hippocampus, as assessed by volume measurements,
have been studied extensively in diseases such as epilepsy [1], Alzheimer’s disease
(AD) [2], schizophrenia [3], depression [4] and post traumatic disorder [5]. The hip-
pocampal formation is a compound structure. comprising the dentate gyrus (fascia
dentata), the hippocampus proper and the subiculum (parahippocampal gyrus), located
in the temporal lobe of the brain [6]. The hippocampus proper is further divided into
This chapter is adapted from Goubran et al. “In vivo normative atlas of the hippocampal subfields
using multi-echo susceptibility imaging at 7 Tesla.” Human Brain Mapping 2014;35(8):3588-3601
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three subfields, Cornu Ammonis (CA) 1-3, with the fourth CA subfield or the hilus
frequently considered as part of the dentate gyrus. Both pre-clinical and postmortem
studies suggest that these morphologically and functionally distinct subfields are se-
lectively affected throughout the progression of different neurological diseases. West
et al. [7] for instance, demonstrated that the most distinctive neuronal loss associated
with Alzheimer’s disease (AD) was seen in CA1. Comparatively, Ro¨ssler et al. [8]
showed that CA1 and the subiculum (SUB) are both involved in the stage-dependent
neuronal loss of the disease. Pathologic stress has also been associated with atrophy
in the CA3 [9]. Changes in the hippocampal subfields have also been linked to tem-
poral lobe epilepsy (TLE). For instance, mesial temporal sclerosis (MTS), the most
common underlying pathology in TLE, can be characterized according to changes in
the hippocampal subfields. According to the existing literature, three types of changes
can occur: type 1 (associated with sclerosis in CA1 and CA4), type 2 (defined by CA1
sclerosis), and type 3 (associated with end folium sclerosis) [10]. Since epilepsy surgi-
cal outcomes differ significantly for each of these MTS types, and because of the clear
importance of the subfields in epilepsy monitoring and surgical planning, we believe
that analysis of each subfield independently will lead to more accurate TLE diagnosis
and improved surgical planning.
Imaging the hippocampal subfields in-vivo at 1.5 or 3.0 T is challenging due to the
limited spatial resolution and signal-to-noise afforded by clinical 1.5 or 3.0 T scanners
[11]. However, recent advances in ultra-high-field imaging have provided the oppor-
tunity to study the hippocampal internal architecture in-vivo at high resolution. Previ-
ous studies at 3-4.7 T [12, 13, 14] or 7T [15] have focused on standard T2-weighted
sequences to attain the necessary contrast and resolution to delineate the hippocam-
pal subfields and investigate morphometric properties. Gradient-echo MRI sequences,
196 Chapter A. App. A - In vivo atlas of the hippocampal subfields
such as those employed for quantitative susceptibility mapping (QSM) [16] may of-
fer improved delineation of the hippocampus and its associated subfields. Specifically,
multi-echo gradient echo sequences have the added benefit of providing additional in-
formation, such as T2* relaxation time and quantitative volume magnetic susceptibility.
These quantitative metrics can be employed to better characterize structures of interest
while still permitting the use of traditional volumetric and morphometric analyses. For
example, T2* imaging has been employed at 7 Tesla in multiple previous reports to
study the normal anatomy of the hippocampus [11, 17]. It has also been employed to
analyze diseased populations as in temporal lobe epilepsy [18] or Alzheimer’s disease
[19].
In this appendix we investigated the potential of the high-field, susceptibility related
contrast to better characterize the subfields of the hippocampus. Presently, there are no
reports of QS values in the hippocampal subfields at higher fields in-vivo, and only one
study quantifying R2* (1/T2*) at 7T [20]. This study presents the first attempt at in
vivo quantification of susceptibility values within the subfields at 7T, and our quantita-
tive MRI measurements provide a useful starting point for more advanced analyses of
subfield composition in both healthy control and diseased populations.
Anatomical atlases derived from group-wise registration of a cohort of subjects, can
provide enhanced localization and visualization for structural and functional imaging
studies, as well as enable voxel-based or morphometric analysis in a broad set of ap-
plications. The objective of the work reported here was to enhance our understanding
of the hippocampal subfields through the development of a high resolution normative
atlas using 7 T quantitative susceptibility imaging. To this end we first developed and
validated a manual labeling protocol for the hippocampal subfields to assess how well
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they could be identified with our proposed imaging sequence. We then applied a group-
wise registration technique to align images from seventeen healthy subjects and gen-
erated a anatomical atlas of the hippocampus and its subfields, assessing accuracy of
the alignment using the manually-labeled subfields. R2* and QS maps from each sub-
ject were subsequently warped to generate R2* and QS atlases, and we evaluated these
quantitative metrics both within the hippocampal subfields and in the basal ganglia for
comparative purposes.
A.2 Methods
A.2.1 Materials & Imaging
The subject cohort enrolled in this study included seventeen healthy controls (10 Males,
7 Females, mean age 31.3 ± 8.7). All data were acquired on a 7 Tesla neuroimaging op-
timized MRI scanner (Agilent, Santa Clara, CA, U.S.A/ Siemens, Erlangen, Germany)
using a 16 channel transmit-receive head coil array constructed in-house. The imaging
sequence used for this study was a multi-echo gradient-echo sequence with six echoes
acquired with a 0.5 mm in-plane resolution (TR=40 ms, TE1=4.57 ms, Echo spac-
ing= 4.89 ms, flip angle=13o, N=1, matrix=256x360x80, slice thickness= 1.5 mm,
FOV=128x180x120 mm, total time=12 minutes), with slices acquired perpendicular
to the long axis of the hippocampus in a coronal oblique orientation. Quantitative
maps of the apparent transverse relaxation rate, R2* = 1/T2*, were calculated using
a Levenberg-Marquardt, least-squares fitting routine for non-linear equations. Specifi-
cally, the following mono-exponential decay function:
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S (T E) = S 0 × exp(−T E × R∗2)
was fit to the magnitude data on a voxel-by voxel basis. In equation [1], TE rep-
resents the echo time in ms and S the signal intensity at TE = 0. A magnitude im-
age derived from the average of all six echoes was employed for subfield labeling and
groupwise registration for atlas building. This study has been approved by the office of
research and ethics of Western University, and informed consent was obtained from all
volunteers prior to their recruitment in the study.
A.2.2 MRI Phase Processing
From the gradient echo data, susceptibility-weighted images (SWI), local frequency
shift (LFS) and quantitative susceptibility (QS) maps were reconstructed using the fol-
lowing multi-step procedure. Removal of channel dependent phase offsets and channel
combination was performed simultaneously by calculating the hermitian inner product
between all later echoes and the first, then summing the complex data across channels.
This is a customary approach for simultaneously removing the influence of channel
specific and B1-induced phase errors and combining multi-channel MRI data [21]. The
resulting raw phase images were then unwrapped in three-dimensions using a region-
growing algorithm [22]. The phase image for each echo was then divided by its corre-
sponding echo time to produce a local frequency shift maps and a weighted average lo-
cal frequency shift map was calculated using the phase noise variances as the weights.
To remove slowly-varying background field caused by tissue-air interfaces, we have
implemented and applied the projection onto dipole fields (PDF) [23], as well as the
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sophisticated harmonic artifact reduction on phase data (SHARP) filtering technique
[24] to the Fourier transform of the unwrapped phase data. We tried a variety of mul-
tiple kernel sizes to acquire the optimal results for our application, and we obtained
the best results by applying a SHARP filter with a spherical convolution kernel of size
3 mm. For edge pixels, binary erosion using a spherical structuring element with the
same size as the convolution kernel was performed prior to the SHARP deconvolution
operation to eliminate artifacts at the edge of the brain volume. The SHARP filter size
was chosen to minimize artifacts in the hippocampal region and may not be ideal for
maximizing contrast in other areas of the brain such as the basal ganglia.
A.2.3 Susceptibility Weighted Image Calculation
Susceptibility weighted images (SWI), which are preferentially sensitive to subtle tis-
sue boundaries arising from differences in the T2* and frequency, were generated using
a frequency mask (FM) derived from the MR phase information. Specifically, the un-
wrapped phase image was filtered using the Fourier-domain, Gaussian high-pass filter
described in the previous section. The filtered phase images (one for each echo) were
then combined into a single local frequency shift (LFS) map using a weighted linear
regression [25]. The resulting LFS map was used to calculate a frequency mask (FM)
according to the following non-linear, Hann window function:
FM(x) =
0 i f x < −X
1
2
[
1 + cospixX
]
i f − X ≤ x ≤ 0
1 i f x > 0
200 Chapter A. App. A - In vivo atlas of the hippocampal subfields
where x denotes the frequency shift of a voxel in the LFS map and X is the cutoff
frequency of the Hann window function. The cutoff frequency was set to 20 Hz for
this work. To acquire a susceptibility weighted contrast, the magnitude image must be
multiplied by the frequency mask, an effect that is accentuated by repeated this mul-
tiplication several times. We multiplied the frequency mask by the magnitude image
four times to generate the SWI maps.
A.2.4 Quantitative Susceptibility Maps
Quantitative susceptibility mapping measures the apparent magnetic susceptibility of
the tissue using MR phase images, which unfortunately is an ill-conditioned inverse
problem (i.e. one that does not necessarily have a unique solution). Recent research
suggests that the incorporation of spatial prior information, generated from the mag-
nitude image data, can be used to identify a meaningful solution to this problem [26].
In this recent work, computation of quantitative susceptibility from local Larmor fre-
quency shift maps was performed using quadratic minimization of a regularized least-
squares objective function. The QS minimization problem can be written in a weighted
least-squares form with spatial priors as described by de Rochefort et al. [26]:
mixx ‖W(CX − δ)‖22 + α ‖W0X‖22 + β2 ‖W1GX‖22 ,
where X denotes the k-space local frequency shift, C the Fourier domain dipole
convolution kernel and X the Fourier domain susceptibility distribution of interest. W,
W0 and W1 are weighting matrices (spatial prior information) defined as: the magnitude
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image itself (W), a binary mask of the brain of the magnitude image (W0), and the
gradient norm of the magnitude image (W1). The matrix denotes the gradient operator,
while and are the associated regularization constants. In our numerical implementation
of QSM, a minimum quadratic form of Eq. 3 was solved using the conjugate gradient
normal residual (CGNR) method [26]:
C?W?WCX + α2W?0 W0X + β
2G?W?1 W1GX = C
?W?Wδ,
In principle, a compromise must be selected for the values of α2 and β2 to achieve
low streaking artifact, while preserving accuracy of the maps [26, 25]. We have chosen
values of α2 and β2 equal to 1 x 104, since they resulted in the smallest log residual at
the transition point in the L-curve (log-log plot of the norm of a regularized solution
and the norm of the corresponding residual norm) and produced realistic values of
susceptibility over a range of iterative steps in the CGNR algorithm. Larger values
resulted in increased smoothing and reduced streaking artifact. The CGNR algorithm
outlined above was implemented in Matlab (R2012b, The MathWorks, Natick, MA,
USA).
To ensure reproducibility, values of quantitative magnetic susceptibility must be re-
ported relative to a common reference structure. Previous studies have used either CSF
or frontal white matter as a reference. In this study, we employed a bilateral region of
interest (ROI) in the frontal white matter, to avoid phase-related artifacts due to flow
and partial volume related effects relating to reference ROIs within the CSF. All QS
values in this study are reported relative to the reference susceptibility of the bilateral
frontal white matter ROI.
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A.2.5 Subfield Labeling
A magnitude image derived from the average of all six echoes was used to perform
the subfield labeling using the ITKsnap software [27]. The hippocampus, including the
hippocampus proper and subiculum, was outlined and subdivided into different fields
of cornu ammonis (CA) and dentate gyrus (DG) based on an adaptation of the man-
ual delineation protocol proposed by Mueller et al. [28], as well as the Duvernoy HM
(2005) atlas. The Mueller et al. [28] protocol at 4T was extended, using the higher field
advantage; by including anatomical definitions obtained from the protocol described
by Wisse et al. (2012) at 7T. We did not include the entorhinal cortex (ERC), alveus
and fimbria. The hippocampus was partitioned into anterior (head), posterior (tail),
and mid-region (body) segments, with no further subdivision of the head and tail since
the additional folds (digitations of the head) from medial bending of the hippocampus
in these regions caused differentiation between subfields to be unreliable. The parti-
tioning of hippocampal head and tail followed definitions by Yushkevich et al. (2010)
and the remaining slices between them were defined as the hippocampal body and sub-
ject to further subfield delineation. For the body of the hippocampus, the following
sub-regions were segmented; subiculum (SUB), Amun’s horn (CA1, CA2+CA3), and
CA4+dentate gyrus (DG).The border between the SUB and ERC was formed follow-
ing the uncal sulcus from its fundus to the medial surface (Wisse et al., 2012). As
the ERC can be found in the hippocampal fissure (Insausti et al., 1987), our SUB la-
bel may have sometimes incorporated part of the ERC. The border of the SUB with
CA1 was defined as a vertical line at the edge of the SUB touching the most medial
border of the DG+CA4 region, in imitation to the protocol by Mueller et al. (2007).
The CA1/CA2 boundary was designated as the point at which a noticeable decrease in
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width of the CA1 subfield was observed, following the most lateral point of the DG.
No distinction was made between CA2 and CA3 since our images showed no visible
boundary between them. Similarly, in line with the debate in histological literature as
to whether CA4 belongs to the CA [6] or the DG, CA4 and DG were combined. The
opening of subfields into the globular region of the hippocampal formation formed the
CA2+CA3/DG+CA4 border, which was specifically identified by the continuation of
a clear consistent hypointense line representing the stratum lacunosum-moleculare of
CA and dendrites of the molecular layer of DG, as described by Wisse et al. [15]. The
remaining globular region of the hippocampal formation was marked as CA4+DG.
A single rater applied the described manual segmentation protocol to the set of sev-
enteen subjects. To assess the accuracy and reproducibility of our segmentation proto-
col, images from five volunteers were segmented a second time by an additional opera-
tor, and the resulting labels compared to the first segmentation using the Dice similarity
coefficient (DSC), defined as:
DS C =
2(RA ∩ RB)
RA + RB
as well as the absolute percentage volume error (
∣∣∣δVp∣∣∣), defined as:
∣∣∣δVp∣∣∣ = |(VA − VB)|VB
The intraclass correlation coefficient (ICC) was also computed for inter-rater relia-
bility analysis with values near unity indicating consistent volume measurements. Re-
ported subfield volumes were normalized by the intracranial volume (ICV) as estimated
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by the Freesurfer software (Buckner, 2004), using the formula: normalized volume =
(raw volume / ICV) × 1000 mm3.
A.2.6 Average Atlas construction
To construct an atlas of the hippocampal subfields, we used an iterative groupwise dif-
feomorphic registration as implemented in the ANTS software [29]. The atlas was
created using the iterative procedure of 1) registering each image to an estimate of
the average, then 2) updating the average estimate using the warped images. All im-
ages were first corrected for bias field inhomogeneities using the non-uniform intensity
normalization (N3) algorithm [30] and each registration step involved affine registra-
tion followed by diffeomorphic registration. The affine initialization employed a his-
togram matched mutual information similarity metric to align all images to one subject
of the data set, which was chosen arbitrarily. The diffeomorphic registration was per-
formed using a cross correlation similarity metric with a window radius of 5 voxels and
used a greedy symmetric transformation (greedy SyN) with Gaussian regularization
(sigma=3). Each optimization was performed over three resolutions with a maximum
of 30 iterations at the coarsest level (one quarter of the full resolution), 90 at the next
coarsest (one half of the full resolution) and 20 at the full resolution. The average atlas
construction, alternating between the registration phase and average update phase, was
performed in 4 iterations, with a shape update performed at each iteration to maintain
stability of the average. This shape update consisted of warping the atlas a small step
size (epsilon=0.25) towards the mean of the inverse warps. After the template construc-
tion, the R2*, SWI and QS maps were warped to the atlas space, upsampled to 0.5 mm
isotropic resolution and averaged. The segmented labels of each subject were warped
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in the same manner and fused using a majority vote (for each voxel the label that ap-
peared the most across subjects was chosen). To validate accuracy of the group-wise
registration, we evaluated the alignment of the whole hippocampus for all subjects in
the average atlas space by computing the pair-wise Dice similarity metric between the
warped hippocampus labels for every pair of subjects in atlas space.
A.2.7 R2* validation
To validate our R2* values, we performed an ex-vivo scan on a resected hippocam-
pal specimen after a surgical operation: anterior temporal lobectomy. The specimen
was part of an ongoing temporal lobe epilepsy study at our center, and the hippocam-
pus was confirmed as sclerotic by both clinical imaging and histology. The scanning
was performed on a ultra-high-field 9.4T MRI scanner (Varian, Palo Alto, CA, U.S.A)
using a millepede birdcage coil (Agilent, Santa Clara, CA, U.S.A.) with a multi-echo
gradient-echo sequence. The specimen was imaged at a resolution of 0.1 mm isotropic.
The resulting R2* values were compared with the R2* values from the patient’s 7T pre-
operative scan within the subfields. The subfields were delineated on a representative
coronal slice of the ex-vivo scan, shown in Figure A.3. This figure summarizes the pre-
op, ex-vivo comparison. To further evaluate our R2* maps we compared values of the
basal ganglia structures with those reported in Deistung et al. [31] at 7T. Manual ROI
labels for the thalamus, putamen, caudate nucleus and globus pallidus were delineated
on a representative coronal slice of our atlas.
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A.2.8 Quantitative susceptibility validation
Since QS values of the hippocampal subfields have not been previously reported at
7 Tesla, to evaluate our quantitative maps, we compared values of the basal ganglia
structures with those reported in Deistung et al. [31] and [32] at 7T. Five normal controls
were scanned according to the previously described imaging protocol, with the in-plane
orientation being axial instead of coronal. The phase images were filtered using SHARP
with a 7 mm kernel size, otherwise the processing and susceptibility quantification
was identical to our previous cohort. Manual ROI labels for the thalamus, putamen,
caudate nucleus and globus pallidus were delineated on a representative axial slice of
each subject. Manual segmentation was preferred to atlas-based segmentation, to avoid
miss registration and partial voluming effects. The validation experiment is summarized
in Figure A.4.
A.2.9 Statistical comparison
To investigate the differences between magnitude, R2* and QS maps, we performed a
one-way analysis of variance (ANOVA) using the mean value over each subfield label
in each subject’s native-space scan. These tests were corrected using Tukey’s multiple
comparisons method and the alpha (p) value was set to 0.05. The magnitude images
were intensity normalized with 100 being the mean intensity. The statistical analysis
was performed using Prism (GraphPad, La Jolla, USA) statistical software. Table 4
summarizes the significant results found between subfields for the three different imag-
ing techniques.
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A.3 Results
Figure A.1 displays representative coronal slices of our atlas-based maps for (i) the
average magnitude image across all echoes (top left), (ii) R2* (top right), (iii) SWI
(bottom left) and (iv) QS (bottom right). As well, the average magnitude image for
all echoes for a single subject is displayed in the center of figure A.1 to illustrate the
difference between the atlas-based images and the single subject case. Magnified repre-
sentations of the left hippocampus are shown for visual comparison and assessment of
the contrast and sharpness of the average maps. Since inter-subject anatomical variabil-
ity was accounted for using a deformable registration, it was possible to generate these
group-averaged atlases (average of all 17 subjects) which serve to effectively increase
the signal to noise ratio and contrast to noise ratio in the hippocampal subfields. The
sharp anatomical definition in these images is evidence of the accuracy of the groupwise
registration within the hippocampus and in the subcortical regions. The cortical regions
do not possess the same level of alignment because of the higher variability in cortical
folding patterns, which is expected, and is difficult to account for with image-based
registration.
The inter-rater reliability results measured by the Dice similarity metric and volume
difference (in mm3) between the labels are summarized in Table A.1. The Dice metric
demonstrates good agreement between both raters across the subfields, with the Dice
coefficient for the total hippocampus being 0.844 for the right side and 0.839 for the
left side. The highest Dice coefficient between all subfields was 0.847 for the right side
and 0.801 for the left, both representing the CA4+DG label, while the lowest was for
the CA2+CA3 label, being 0.682 and 0.638 for the right and left sides respectively.
Similarly, the volume difference measures outlined in Table 1 showed good agreement,
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Figure A.1: Single subject (Middle) as well as atlas-based images of average
magnitude across echoes (Top Left), R2* (Top Right), qualitative SWI (Bottom Left)
and QS maps (Bottom Right). The adjacent image to each map shows a zoomed-in
representation of a hippocampal slice in the coronal view. The same slice is chosen for
all maps to compare CNR and SNR across the different maps.
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on average, which validates the repeatability of our protocol. The volume of the CA1
label had showed the most agreement between the raters with a volume percentage
difference of 6%. In addition, Table A.1 also displays the intraclass correlation (ICC)
analysis for inter and intra-rater reliability. High consistency was observed between our
raters for most of the subfields (ICC > 0.75), as well as for the repeated datasets our first
rater which demonstrates the reliability of our protocol. Segmentation of the CA2+CA3
label was the least reliable with an ICC between raters of 0.624. The volumes of the
subfields resulting from our manual delineation protocol were reported in Table A.2.
Table A.1: Table I: Dice similarity coefficient, absolute percentage volume error and
Intra-class correlation coefficient metrics in conducted patient space
Sub CA1 CA2+CA3 CA4+DG Hp
tail
Hp
head
Total
DSC
L 0.605 0.714 0.638 0.801 0.692 0.768 0.839
R 0.734 0.796 0.682 0.847 0.706 0.814 0.844
9.6 6 11.3 11.2 15.4 6.7 6.5
ICC Rater 1 0.949 0.973 0.781 0.966 0.813 0.984 -
ICC (between raters) 0.833 0.834 0.624 0.881 0.727 0.906 -
Table A.2: Table II: Hippocampal subfield volumes normalized by intracranial volume
(ICV), reported in mm3.
Sub CA1 CA2+3 CA4+DG Hp tail Hp
head
Total
Hp
Left 222.5 249.2 71.9 214.2 428.9 1263.8 2450.3
Right 233 248.4 73.4 216.5 469.8 1312.1 2553.2
Mean 227.8 248.8 72.7 215.3 449.3 1287.9 2501.8
(sd) (-61.2) (54.2) (-7.9) (47.2) (146.3) (196.3) (251.2)
Figure A.2 displays coronal views of selected slices running through hippocampal
body for the three major image contrasts employed in this study: the magnitude image
averaged across echoes, R2* and quantitative susceptibility maps. Two sets of three
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consecutive slices (Fig. 2a and 2b) are shown. The segmentation labels for the sub-
fields are overlaid on the images. The segmentation protocol was performed using the
magnitude images only. For the slices corresponding to figure A.2a (the left side of
the figure), both R2* and QS showed improved delineation of the subiculum/CA1 and
CA1/(CA2+CA3) boundaries compared to the magnitude image. Furthermore, the QS
map defined the (CA2+CA3) subfield more clearly compared both the R2* and mag-
nitude images based on the reduced susceptibility in this region of the hippocampus.
Accuracy of the group-wise registration and the resulting average atlas was evaluated
both qualitatively and quantitatively. The mean Dice metric between the hippocampus
labels in the atlas space was 0.69 0.03 and ranged from 0.69 to 0.77.
Table A.3 summarizes the quantitative, intrinsic MRI measures of the hippocam-
pal subfields, specifically R2* and quantitative susceptibility (QS). The values in table
A.3 represent mean values averaged across all subjects. QS values demonstrated rel-
atively high standard deviations within each subfield, which did not correlate with the
size of the subfield. As for our R2* ex-vivo validation using a resected hippocampus
from epilepsy surgery, Figure A.3 shows a very good agreement within the subfields
between the pre-operative 7T scan and the 9.4T image. In addition, the R2* values for
basal ganglia structures in our study are as follows (in units of s-1): thalamus (38.8),
putamen (49.5), caudate nucleus (43.1) and globus pallidus (72.7). Comparatively,
Deistung et al. [31] reported the following values: thalamus (41.4), putamen (49.4),
caudate nucleus (42.3) and globus pallidus (83.4). Similarly, the QS validation on five
normal volunteers scanned axially showed that our values (in parts-per-million of the
main magnetic field, ppm) for these structures (0.0395, 0.0586, 0.0599 and 0.117) are
within range of those reported in Deistung et al. [31]’s study (0.0261, 0.0380, 0.0440
and 0.131) and those reported in Wharton and Bowtell [32] at 7T (0.020, 0.060, 0.060,
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Figure A.2: Two sets of three consecutive coronal slices as seen in atlas space in the
magnitude across echoes, R2* and QS maps, with the top row of each block showing
segmentation labels overlaid on the images. The location of the slices is indicated on a
sagittal view of the hippocampus at the top of the figure.
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0.160). These values are graphed in Figure A.4 to demonstrate the agreement between
our values and those reported in the literature. The ANOVA analysis showed that R2*
resulted in the highest number of significant comparisons between the subfields, fol-
lowed by QS; and that normalized magnitude images showed no significance for all
subfield comparisons. Table A.4 summarizes all the significant comparisons for R2*
and QS.
Table A.3: Table III: Subfield volumes, R2* and QS values as a mean across all
subject in subject space
Sub CA1 CA2 +
CA3
CA4+DG Hp tail Hp
head
Volume (mm3)µ 227.8 248.8 72.7 215.3 449.3 1287.9
(σ) (61.2) (54.2) (-7.9) (47.2) (146.3) (196.3)
R2* (1/s) µ 32.2 25.5 30 30.4 28.2 28.1
(σ) (2.3) (2.0) (-4.2) (-3.3) (-1.9) (-2.1)
QS (ppm) µ -0.0216 -0.0187 -0.0376 -0.0237 -0.0134 -0.0164
(σ) (0.013) (0.008) (0.016) (0.009) (0.005) (0.011)
A.4 Discussion & conclusion
Quantitative R2* maps have shown great potential as a diagnostic tool for numerous
diseases affecting the hippocampus both because of the improved contrast, and through
the use of voxel-based studies. Similarly, the quantitative atlas-based QS map demon-
strates a unique contrast driven by the underlying magnetic susceptibility of the tissue
and vasculature, which cannot be obtained using standard GRE/T2* weighted images.
In-vivo susceptibility mapping can also resolve substructures of deep grey matter (GM)
nuclei consistent with histological sections of post mortem brains [31]. The low vari-
ability of the R2* values within small structures as the subfields (8.5% of the mean on
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Table A.4: Table IV: One-way analysis of variance (ANOVA) between all subfields for
R2* and QS maps
Imaging Subfields Mean
diff.
95% CI of diff. Level of
significance
R2* CA4-DG vs. CA1 5.152 3.043 to 7.260 P ≤ 0.0001
CA4-DG vs. Hp
tail
2.376 0.2673 to 4.485 P ≤ 0.05
CA4-DG vs. Hp
head
2.556 0.4472 to 4.665 P ≤ 0.01
Sub vs. CA1 6.806 4.697 to 8.914 P ≤ 0.0001
Sub vs. Hp tail 4.03 1.921 to 6.139 P ≤ 0.0001
Sub vs. Hp head 4.21 2.101 to 6.319 P ≤ 0.0001
CA1 vs. CA2-CA3 -4.774 -6.882 to -2.665 P ≤ 0.0001
CA1 vs. Hp tail -2.776 -4.884 to -0.6671 P ≤ 0.01
CA1 vs. Hp head -2.596 -4.705 to -0.4872 P ≤ 0.01
CA2-CA3 vs. Hp
head
2.178 0.06928 to 4.287 P ≤ 0.05
QS
map
CA4-DG vs.
CA2-CA3
0.01383 0.004786 to
0.02288
P ≤ 0.001
CA4-DG vs. Hp
tail
-
0.01031
-0.01936 to
-0.001263
P ≤ 0.05
Sub vs. CA2-CA3 0.01601 0.006958 to
0.02505
P ≤ 0.0001
CA1 vs. CA2-CA3 0.01887 0.009818 to
0.02791
P ≤ 0.0001
CA2-CA3 vs. Hp
tail
-
0.02414
-0.03319 to
-0.01510
P ≤ 0.0001
CA2-CA3 vs. Hp
head
-
0.02118
-0.03022 to
-0.01213
P ≤ 0.0001
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Figure A.3: Validation of pre-operative R2* with 9.4T ex-vivo imaging of a resected
hippocampus. Left: Coronal slice of the pre-op R2* at 7T with a zoomed-in view of
the sclerotic hippocampus before epilepsy surgery excision. Middle: Magnitude image
of the patient’s resected hippocampus imaged at 9.4T resulting in a 0.1 mm isotropic
resolution (top); R2* image of the hippocampus, where the subfield delineation was
performed (bottom). Right: Graph of comparison between pre-op (blue) and ex-vivo
(purple) R2* values within the subfields.
A.4. Discussion & conclusion 215
Figure A.4: Figure 4. Validation of our QS values in the basal ganglia with Deistung
et al. [31] and Wharton and Bowtell [32]. Left: Axial slice of a QS map from a single
subject showing the outlines of the basal ganglia structures. Right: Graph
demonstrating QS values within the basal ganglia for three papers.
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average across all reported subfields) demonstrates the sensitivity of this quantitative
measure to local magnetic changes. The reported QS values show higher variability
within each small hippocampal substructure, which could be due to phase variations
from the sinus interface or reconstruction artifacts.
The ANOVA analysis suggests that there are more apparent differences between
the subfields on the maps than the magnitude images. These differences between sub-
fields can be caused by many factors, one of which may be different iron distribution
within the CA1-CA3 region as compared to the CA4-DG region. Antharam et al. [33]
mapped iron distribution, R2 and R2* for the subfields in three unfixed post-mortem
control cases and five Alzheimer’s disease (AD) specimens. They have validated the
relationship between R2, R2* and tissue iron content of the hippocampal subfields and
reported higher mean R2 and R2* in the CA4-DG region as compared to the CA1-CA3
region in both groups; which is consistent with our R2 values, if CA1 through CA3 are
combined. Their evidence demonstrates that regions of increasing R2* correspond to
regions of higher iron content, which is consistent with literature [34] and the hypoth-
esis that iron concentration affects R2* contrast. The present work is the first in vivo
quantification susceptibility values within the hippocampal subfields at 7T
It is evident at this detailed level of segmentation that the contrast cannot be at-
tributed solely to varying iron concentrations. Other parameters affecting water diffu-
sion and susceptibility, including the variation in compartmentalization due to cell di-
mensions and density of packing, and differences in hydration between gray and white
matter, are also presumed relevant [33]. The changes in QS may also be due to the
subependymal intrahippocampal veins and the sulcual intrahippocampal veins, which
are manifested as susceptibility changes within the CA1 and the CA2/3 transition, re-
spectively.
A.4. Discussion & conclusion 217
Yushkevich et al. [35] developed a normalized atlas of the subfields using five post-
mortem specimens at 9.4T. In this publication we focused on the quantification of R2*
and QS values in the subfields. This quantification requires in-vivo scanning since fix-
ation affects metal ions, protein cross-linking and water diffusion properties. Shepherd
et al. [36] have shown, as well, that fixation in 4% formaldehyde results in a reduction
of up to 80% in estimated T2 values. Hence, we were constrained by the requirement
of imaging in-vivo unfixed tissue, with which achieving a sufficient SNR for subfield
segmentation is more challenging than postmortem imaging. Figure A.3 demonstrates
an example ex-vivo scan at 9.4T of a resected hippocampal specimen after anterior tem-
poral lobectomy. This specimen represents the potential of ex-vivo imaging of excised
hippocampal specimens. Previous reports have identified concerns with T2* imaging
of the hippocampus. In our imaging protocol we do see loss of signal at the gyrus rectus
within the medial frontal lobe due to susceptibility artifact from the sinuses; however
this is only anterior to the optic chiasm and does not affect the amygdala or anterior
region of the hippocampus, as shown by the sagittal slice in Figure A.2. Similarly we
experienced some signal loss within the inferior region of the fusiform gyrus but this is
only contained in the neocortex and does not extend past the collateral sulcus.
Cho et al. [20] reported R2* values within the subfields at 7T, as follows: Sub= 34.3,
CA1= 42.59, CA2+CA3=39.2 (combining both subfields), CA4=43.66. Our values for
these subfields were 32.2, 25.5, 30.0, and 30.4, respectively. Both the values reported
by Cho et al. [20] and our values follow the trend of increased R2* in the CA4-DG
label as compared to the combined CA1-CA3 label, demonstrated by Antharam et al.
[33] on unfixed ex-vivo specimens at 14T. However, their method suffers from some
limitations such as the use of only one ROI composed of 21 pixels, taken on a single
coronal slice, to represent a subfield. That is pixels within the ROI may not represent
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the entire subfield due to the limited sampling. Another limitation may be the use
of a dual echo, instead of a multi-echo, sequence in their imaging protocol which is
less effective to compute R2* values. It should also be noted, that Cho et al. [20]
obtained a consistently higher standard deviation per subfield than our study. We have
demonstrated, as well, the reliability of our R2* values in the basal ganglia comparison
with Deistung et al. [31] and our ex-vivo 9.4T validation.
The results of our reliability analysis are presented in Table 1 and they validate re-
peatability of our manual segmentation protocol. One potential source of error leading
to inter-rater differences is the learning curve in segmentation as Rater 2 only seg-
mented five subjects of the dataset. As expected, the Dice coefficient was lower for
the smaller subfields due to the bias of the measure towards bigger structures. It is,
however, difficult to objectively assess the volumes of subfields across protocols, due
to the underlying differences in the protocols, the different imaging parameters and the
combination of certain subfields into a singular label depending on the protocol. For
instance, [12] combined CA3 with DG in a single label while [14] combined CA1, CA2
and CA3 in a single label. Similarly, some protocols restrict subfield delineation to the
body of the hippocampus [28, 12] and others [14, 15] claim that approach insufficient
for detection of disease progression and instead segment the subfields along the whole
length of the hippocampus. Several boundaries, such as that between the CA4/DG are
not agreed upon and might require definitions based on histological detail to be re-
solved. Since an in-plane resolution of 0.5 mm is insufficient to resolve small detail
between the subfields, we therefore decided to combine the CA4/DG label, and applied
the same rationale to the CA2/CA3 boundary. Of those protocols used as comparators
in this paper, only two of them attempted to resolve CA2 as a distinct subfield [15, 12],
by defining the border between CA2 and CA3 as the medial side of a virtual square or
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define a CA1-CA2 transition to account of the overlap of the dorsomedial part of CA1
into CA2 label.
Our average Dice values between the hippocampus labels in the atlas space, with a
mean of 0.69 ± 0.03, are comparable to the best performing methods reported in a re-
cent evaluation of nonlinear brain registration [37], which reported Dice overlaps with
the SyN registration algorithm on two different datasets, CUMC (Columbia Univer-
sity Medical Centre) and LPBA (LONI Probabilistic Brain Atlas), made up of 12 and
40 subjects respectively. The hippocampal Dice overlaps were 0.68 and 0.75 for the
CUMC12 and LPBA40 datasets respectively.
Several techniques have been presented for solving the field-to-source inverse prob-
lem for quantitative susceptibility mapping, most notably the calculation of suscepti-
bility through multiple orientation sampling (COSMOS), truncated K-space division
(TKD), and morphology enabled dipole inversion (MEDI). While maps obtained us-
ing COSMOS demonstrate high agreement with post-mortem measurements of brain
iron, the method relies on multiple acquisitions with different head orientations which
limits the technique for use in a clinical setting. The available single head orientation
algorithms suffer to varying degrees from non-local artifacts, instability or underes-
timation of susceptibility values [31]. We employed the Bayesian regularized solu-
tion developed by de Rochefort et al. [26], which makes use of spatial priors from the
magnitude images, and provides accurate delineation of both anatomical structure and
volume magnetic susceptibility in the brain. Phase shifts induced by eddy currents,
B1+ non-uniformity, or flow can introduce errors in the QS maps. However, these er-
rors were minimized in our QS pipeline since the first echo was subtracted from all
subsequent echoes using the hermitian product method. Such subtraction removes the
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influence of temporally invariant background phase offsets caused by external field in-
homogeneities. Flow-related errors in QS, however, are not temporally invariant. When
blood flow through veins is present, the accrual of phase as a function of echo time may
become non-linear. Under this condition, performing a linear fit of the phase to the echo
time will not yield accurate estimates of the frequency shift. However, close inspection
of our LFS and QS maps registered to the template space does not reveal significant
presence of large vessels in the hippocampal subfields. For this reason, we believe the
effects of venous flow artifacts in our data are minimal.
One application of the atlas-based approach presented here would be the study of
quantitative intrinsic MR measures in the subfields in neurological diseases. The sig-
nificant differences found in the ANOVA analysis of R2* and QS across adjacent sub-
fields (Table 4) reveals that these quantitative maps may be superior in sensitivity to
detect abnormalities in specific subfields compared to magnitude images. The subfield
labels, presented in Table 2, could also be used for volumetric or morphometric analy-
sis. Evaluation of neurological disorders that affect the hippocampal subfields, such as
temporal lobe epilepsy or Alzheimer’s disease, would benefit greatly from the use of
these techniques. Another application could be in targeting for deep brain stimulation
(DBS), since quantitative T2* [38] and susceptibility contrast [39] allow for improved
visualization of commonly targeted deep GM structures. For these stereotactic neuro-
surgical applications, subject-atlas registration could be used to improve accuracy of
electrode placement in deep GM nuclei to alleviate motoric disorders due to tremor as
Parkinson’s disease or dystonia.
We have constructed a normative atlas of the hippocampal subfields from in vivo
susceptibility-weighted images of seventeen healthy volunteers acquired using 7T MRI.
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Using our reliable manual delineation protocol of the subfields, we demonstrated the
feasibility of subfield specific analyses of the hippocampus. The average atlas ac-
curately aligns the subtle anatomical features of the hippocampus, producing high-
resolution maps of quantitative susceptibility and R2*. This work represents the first
in vivo quantification of susceptibility values within the hippocampal subfields at ultra-
high-field strengths. It can be further complemented by investigation of these quantita-
tive MRI parameters in patient populations where hippocampal subfields are known to
be selectively affected, such as temporal lobe epilepsy or Alzheimer’s disease.
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